"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_RIZZOLI",2000,159,7,4.09433962264151,0.654088050314465,0.584905660377358,0.842767295597484,2.41635687732342,1.50724637681159,2.16279069767442,1.38144329896907,0.132075471698113,7,52,37,22,24,0.33,0.23,0.14,0.15,52.95,1.16806846694559,NA,0.232704402515723,0.647798742138365,0.535,0.435,0.446,0.443,"ALDO TONI;PIERO PICCI;SUSANNA STEA;G. CIAPETTI;DONATELLA GRANCHI;L. SAVARINO;MILENA FINI;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;CRISTIANA FORNI;KATIA SCOTLANDI;MAURILIO MARCACCI;PATRIZIA BACCHINI;GAETANO BACCI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;16;15;14;13;13;12;12;11;11;11;10;10;8;8;8;8;8;7;7","ALDO TONI;SUSANNA STEA;DONATELLA GRANCHI;SANDRO GIANNINI;MARCO VICECONTI;MASSIMILIANO BALEANI;LUCA CRISTOFOLINI;G. CIAPETTI;PIERO PICCI;MILENA FINI;A. PIZZOFERRATO;L. SAVARINO;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;WILLIAM L. BLALOCK;MAURILIO MARCACCI;E. CENNI;BATTISTA BORGHI;A. CASATI","3.61;2.94;2.63;2.46;2.2;2.2;2.12;2.04;1.99;1.77;1.75;1.75;1.71;1.6;1.49;1.23;1.21;1.21;1.14;1.14","ALDO TONI;PIERO PICCI;SUSANNA STEA;G. CIAPETTI;DONATELLA GRANCHI;L. SAVARINO;MILENA FINI;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;CRISTIANA FORNI;KATIA SCOTLANDI;MAURILIO MARCACCI;PATRIZIA BACCHINI;GAETANO BACCI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;16;15;14;13;13;12;12;11;11;11;10;10;8;8;8;8;8;7;7","ALDO TONI;SUSANNA STEA;DONATELLA GRANCHI;SANDRO GIANNINI;MARCO VICECONTI;MASSIMILIANO BALEANI;LUCA CRISTOFOLINI;G. CIAPETTI;PIERO PICCI;MILENA FINI;A. PIZZOFERRATO;L. SAVARINO;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;WILLIAM L. BLALOCK;MAURILIO MARCACCI;E. CENNI;BATTISTA BORGHI;A. CASATI","3.61;2.94;2.63;2.46;2.2;2.2;2.12;2.04;1.99;1.77;1.75;1.75;1.71;1.6;1.49;1.23;1.21;1.21;1.14;1.14","PIERO PICCI;ROBERTO GIARDINO;GAETANO BACCI;ALDO TONI;MARCO VICECONTI;PATRIZIA BACCHINI;LUCA CRISTOFOLINI;FRANCO BERTONI;MAURILIO MARCACCI;ALESSANDRA LONGHI;STEFANO FERRARI;CRISTIANA FORNI;M. ROCCA;ANGELO CAPPELLO;ELIZAVETA KON;RANIERI CANCEDDA;RODOLFO QUARTO;A. BOYDE;ALESSANDRO CORSI;ANITA MURAGLIA","1567;1123;1085;1057;1047;1040;1035;1028;1011;971;958;948;871;844;754;754;754;751;751;751","PIERO PICCI;ROBERTO GIARDINO;GAETANO BACCI;ALDO TONI;FRANCO BERTONI;MAURILIO MARCACCI;ALESSANDRA LONGHI;STEFANO FERRARI;CRISTIANA FORNI;MARCO VICECONTI;M. ROCCA;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIANO MERLINI;DAVIDE MAR√çA DONATI;G. CIAPETTI;MARCO MANFRINI;ALBERTO LEARDINI;PIETRO RUGGIERI;MICHELA VERSARI","1567;1123;1085;1050;1028;1011;971;958;948;947;871;754;697;693;657;617;579;577;549;522","PIERO PICCI;ALDO TONI;SUSANNA STEA;L. SAVARINO;G. CIAPETTI;ROBERTO GIARDINO;MILENA FINI;DONATELLA GRANCHI;M. ROCCA;ALESSANDRA LONGHI;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;STEFANO FERRARI;MAURILIO MARCACCI;CRISTIANA FORNI;GAETANO BACCI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;15;14;13;13;12;12;12;11;11;9;9;9;9;8;8;8;8;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;POLITICAL SCIENCE;PHILOSOPHY;PSYCHOLOGY;ART;GEOLOGY;BUSINESS;ECONOMICS;HISTORY;SOCIOLOGY","129;62;34;26;22;16;16;8;5;4;3;2;2;1;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;ANATOMY;CELL BIOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;METALLURGY;OPTICS;ENVIRONMENTAL HEALTH;RADIOLOGY;ENDOCRINOLOGY;ORTHODONTICS;ANESTHESIA;DENTISTRY;PHYSICAL MEDICINE AND REHABILITATION;STRUCTURAL ENGINEERING","66;55;48;40;33;23;22;21;21;21;20;15;13;12;11;11;10;9;8;8;8;8","GENE;IN VITRO;CHEMOTHERAPY;OSTEOSARCOMA;IMPLANT;CANCER;SARCOMA;POPULATION;PROSTHESIS;ALTERNATIVE MEDICINE;APOPTOSIS;RECEPTOR;ARTHROPLASTY;BIOPSY;CELL CULTURE;CYTOKINE;DNA;IMMUNOHISTOCHEMISTRY;CARTILAGE;CEMENT;DISEASE;INCIDENCE (GEOMETRY);KINEMATICS;LESION;MUSCULAR DYSTROPHY;OSTEOPOROSIS;RADIATION THERAPY;RADIOGRAPHY;TUMOR NECROSIS FACTOR ALPHA","28;17;14;14;13;12;12;11;11;10;10;10;9;8;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6","FIXATION (POPULATION GENETICS);ALLELE;BREAST CANCER;CHROMOSOME;GENE EXPRESSION;BONE CEMENT;PROGRAMMED CELL DEATH;TRANSCRIPTION FACTOR;CYTOTOXICITY;EWING'S SARCOMA;MUSCLE BIOPSY;MYOGENESIS;OSSEOINTEGRATION;OSTEOARTHRITIS;PERIPHERAL BLOOD MONONUCLEAR CELL;POLYMERASE CHAIN REACTION;AMENORRHEA;BIOREMEDIATION;CELL CYCLE;CHEMOKINE;CISPLATIN;CYTOTOXIC T CELL;ETOPOSIDE;FEMORAL CONDYLE;GAIT ANALYSIS;GIANT CELL TUMORS;GROUND REACTION FORCE;METASTASIS;MUTATION;RECEPTOR TYROSINE KINASE;RHABDOMYOSARCOMA;VASCULITIS","9;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ADJUVANT CHEMOTHERAPY;IFOSFAMIDE;NUCLEAR PROTEIN;BIOSTIMULATION;GIANT CELL ARTERITIS;PROPIDIUM IODIDE;ARTICULAR CARTILAGE;C2C12;CHEMOKINE RECEPTOR;DNA FRAGMENTATION;EMBRYONAL RHABDOMYOSARCOMA;FLUORESCENCE IN SITU HYBRIDIZATION;GENE MAPPING;IN SITU HYBRIDIZATION;INTERFACE (MATTER);LOSS OF HETEROZYGOSITY;MISSENSE MUTATION;MYOGENIN;NEUTRAL RED;ONCOGENE;PRIMARY TUMOR;XQ28","5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;BONE NEOPLASMS;FEMALE;MALE;;ADULT;OSTEOSARCOMA;MIDDLE AGED;ADOLESCENT;AGED;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ANIMALS;KNEE JOINT;MUSCLE, SKELETAL;SARCOMA, EWING;BIOCOMPATIBLE MATERIALS;CHILD;DOXORUBICIN;TIBIA;FEMUR","96;59;58;57;44;44;40;33;26;25;24;23;20;18;18;16;15;15;15;14","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;LOW-LEVEL LASER THERAPY IN BIOMEDICAL APPLICATIONS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;DESIGN AND CONTROL OF SOFT ROBOTIC SYSTEMS;EFFECTS OF BLOOD TRANSFUSION IN CLINICAL PRACTICE;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF RAS SIGNALING PATHWAYS;PATHOPHYSIOLOGY OF MYOCARDIAL REPERFUSION INJURY;ROLE OF CHEMOKINE RECEPTORS IN CANCER METASTASIS","27;21;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;OSTEOSARCOMA;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;ADJUVANT CHEMOTHERAPY;BONE CEMENT;PROSTHETIC JOINT INFECTIONS;BIOCOMPATIBILITY;BIOMATERIAL;BIOMECHANICS;BONE REGENERATION;BONE RESORPTION;FEMORAL FRACTURES;HIP FRACTURE;KNEE BIOMECHANICS;REGIMEN;BIOSTIMULATION;CHEMOKINE RECEPTORS;CHONDROSARCOMA","15;9;9;7;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","NEOADJUVANT CHEMOTHERAPY;TOTAL HIP;HIP PROSTHESES;PATIENTS TREATED;BONE CEMENT;BONE CEMENTS;GIANT CELL;GROWTH FACTOR;HIP ARTHROPLASTY;ISTITUTO ORTOPEDICO;MUSCULAR DYSTROPHY;RISK FACTORS;STROMAL CELLS;BONE MARROW;EWINGS SARCOMA;EXPERIMENTAL STUDY;FEMALE PATIENTS;GENETIC MAPPING;HIGH-GRADE OSTEOSARCOMA;HUMAN OSTEOSARCOMA;LOCALIZED OSTEOSARCOMA;MARROW STROMAL;ORTOPEDICO RIZZOLI;POLYMYALGIA RHEUMATICA;REFINED GENETIC;REPRODUCTIVE FUNCTIONS;SISTER CHROMATID;THALASSEMIC PATIENTS;AC GENE;ACCELERATE BONE","8;7;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","ALLOGENIC BLOOD;CELL LINES;GIANT CELL;RHABDOMYOSARCOMA CELL;AUTOLOGOUS BLOOD;BLOOD TRANSFUSION;II ALPHA;ANTI-TOPO II;ODDS RATIO;RATIO CI;LASER BIOSTIMULATION;AUTOTRANSFUSION REGIMEN;CELL TUMOR;DAYS -TH;DAYS NA;ENDURANCE LIMIT;GROWTH FACTOR;HAEMOGLOBIN CONCENTRATION;HERERBB RECEPTORS;HIP REVISION;HUMAN RHABDOMYOSARCOMA;INTEGRATED AUTOTRANSFUSION;KNEE ARTHROPLASTY;LEFT UNTREATED;PATIENTS UNDERGOING;SURFACE EXPRESSION;AGE RANGE;CELL RICH;CELL TUMORS;CERAMIC FEMORAL","12;10;10;10;8;8;8;7;6;6;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,1,0,1,2,0,2.33333333333333,1.08,1,0,0,3,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FINI MILENA;GIARDINO ROBERTO;TORRICELLI PAOLA","3;3;1","ISTITUTI ORTOPEDICI RIZZOLI;INSTITUTI ORTOPEDICI RIZZOLI","2;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","4;2",NA,NA,"5.3 MEDICAL DEVICES","2","A61B17/00;A61B17/80;A61F2/00;A61M37/00;C12N;C12Q","2;2;2;2;1;1","A61B17/80;A61B2017/00004;A61F2/0077","2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,1472257.43,153139.67,3.42857142857143,10.7142857142857,4.42857142857143,0.857142857142857,23.8333333333333,341425.955808081,0.46569394416333,"ISTITUTO ORTOPEDICO RIZZOLI;IMPERIAL COLLEGE LONDON;CINECA;UNIVERSITY OF BOLOGNA;UNIVERSIT√â LIBRE DE BRUXELLES;ACADEMIC MEDICAL CENTER;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;AUSTRIAN ACADEMY OF SCIENCES;AZIENDA OSPEDALIERA UNIVERSITARIA PISANA;BAMBINO GES√ô CHILDREN'S HOSPITAL;BIOMECHANICS INSTITUTE OF VALENCIA;CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTER FOR ADVANCED STUDIES RESEARCH AND DEVELOPMENT IN SARDINIA;CGS GROUP (ITALY);CLAUSTHAL UNIVERSITY OF TECHNOLOGY;DANISH CANCER SOCIETY;DE MONTFORT UNIVERSITY;D√âL√âGATION PARIS 11;FRENCH MUSCULAR DYSTROPHY ASSOCIATION;GLYND≈¥R UNIVERSITY","7;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","7","COALITION S;EC & ERC - EUROPEAN UNION","7;7","CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-IST - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON A ""USER-FRIENDLY INFORMATION SOCIETY, 1998-2002"" (PROGRAMME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);ACM - PREPARATORY, ACCOMPANYING AND SUPPORT MEASURES (FUNDING SCHEME);BUR - BURSARIES, GRANTS, FELLOWSHIPS (FUNDING SCHEME);FP5-GROWTH - PROGRAMME FOR RESEARCH TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""COMPETITIVE AND SUSTAINABLE GROWTH 1998-2002"" (PROGRAMME);FP5-HUMAN POTENTIAL - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""IMPROVING THE HUMAN RESEARCH POTENTIAL AND THE SOCIO-ECONOMIC KNOWLEDGE BASE"" (1998-2002) (PROGRAMME);RGI - RESEARCH GRANTS (INDIVIDUAL FELLOWSHIPS) (FUNDING SCHEME);THN - THEMATIC NETWORK CONTRACTS (FUNDING SCHEME)","3;3;2;1;1;1;1;1;1","40 ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;4003 BIOMEDICAL ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;4005 CIVIL ENGINEERING;4607 GRAPHICS, AUGMENTED REALITY AND GAMES","3;3;2;1;1;1;1","BIOENGINEERING;CANCER;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD)","3;1;1","MUSCULOSKELETAL","1","5.3 MEDICAL DEVICES","1",NA,NA,NA,NA,"B11 COMPUTER SCIENCE AND INFORMATICS;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;B12 ENGINEERING;C23 EDUCATION","2;1;1;1","4 QUALITY EDUCATION","1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2001,191,6.17277486910995,3.47643979057592,0.738219895287958,0.544502617801047,0.74869109947644,2.32982456140351,1.51612903225806,1.73333333333333,1.50526315789474,0.141361256544503,3,55,36,18,59,0.29,0.19,0.09,0.31,36.74,0.804032980552058,NA,0.172774869109948,0.591623036649215,0.502,0.42,0.46,0.414,"MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;ALDO TONI;PAOLA TORRICELLI;LUCIANO MERLINI;ALESSANDRA LONGHI;DONATELLA GRANCHI;MARCO VICECONTI;BATTISTA BORGHI;G. BACCI;RAFFAELE PASCARELLA;DOMENICO TIGANI;LUCA CRISTOFOLINI;G. CIAPETTI;E. CENNI;CARLA RENATA ARCIOLA;ARMANDO GIUNTI;CRISTIANA FORNI","25;21;18;16;12;12;9;9;9;9;9;8;8;8;8;8;8;7;7;7","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCA CRISTOFOLINI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;ALBERTO LEARDINI;BATTISTA BORGHI;RAFFAELE PASCARELLA;SAVERIO AFFATATO;GIOVANNI LUIGI DI GENNARO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;MARIO MERCURI;MASSIMILIANO BALEANI;DOMENICO TIGANI;DONATELLA GRANCHI;L CAMPANACCI","4.36;3.9;3.26;2.72;2.23;2.21;2.15;2.02;1.75;1.72;1.72;1.65;1.65;1.6;1.6;1.56;1.5;1.46;1.39;1.32","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;ALDO TONI;PAOLA TORRICELLI;LUCIANO MERLINI;ALESSANDRA LONGHI;DONATELLA GRANCHI;MARCO VICECONTI;BATTISTA BORGHI;G. BACCI;RAFFAELE PASCARELLA;DOMENICO TIGANI;LUCA CRISTOFOLINI;G. CIAPETTI;E. CENNI;CARLA RENATA ARCIOLA;ARMANDO GIUNTI;CRISTIANA FORNI","25;21;18;16;12;12;9;9;9;9;9;8;8;8;8;8;8;7;7;7","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCA CRISTOFOLINI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;ALBERTO LEARDINI;BATTISTA BORGHI;RAFFAELE PASCARELLA;SAVERIO AFFATATO;GIOVANNI LUIGI DI GENNARO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;MARIO MERCURI;MASSIMILIANO BALEANI;DOMENICO TIGANI;DONATELLA GRANCHI;L CAMPANACCI","4.36;3.9;3.26;2.72;2.23;2.21;2.15;2.02;1.75;1.72;1.72;1.65;1.65;1.6;1.6;1.56;1.5;1.46;1.39;1.32","MILENA FINI;PIERO PICCI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;STEFANO FERRARI;LUCIANO MERLINI;ALESSANDRA LONGHI;G. BACCI;ANDREA FACCHINI;M. MERCURI;L CAMPANACCI;ENRICO BERTINI;PATRIZIA SABATELLI;CRISTIANA FORNI;R. BIAGINI;FRANCO BERTONI;DAVIDE MAR√çA DONATI;GUGLIELMINA PEPE;FRANCESCO BERTONI;BRUNELLA GRIGOLO","1108;1091;894;835;723;704;703;696;615;600;532;501;494;482;427;426;416;408;372;362","MILENA FINI;PIERO PICCI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;LUCIANO MERLINI;STEFANO FERRARI;ALESSANDRA LONGHI;G. BACCI;ANDREA FACCHINI;L CAMPANACCI;M. MERCURI;DAVIDE MAR√çA DONATI;CRISTIANA FORNI;PATRIZIA SABATELLI;BRUNELLA GRIGOLO;LIVIA ROSETI;FRANCO BERTONI;STEFANO BANDIERA;A BRICCOLI;N. NICOLI ALDINI","1090;906;817;733;704;643;623;597;569;532;514;416;402;367;362;360;322;320;317;315","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;PAOLA TORRICELLI;ALDO TONI;DONATELLA GRANCHI;LUCIANO MERLINI;MARCO VICECONTI;STEFANO FERRARI;G. CIAPETTI;BATTISTA BORGHI;E. CENNI;L CAMPANACCI;G. BACCI;L. SAVARINO;LUCA CRISTOFOLINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCIO MONTANARO","24;18;17;13;12;11;9;9;9;9;8;8;8;7;7;7;7;7;7;6","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;GEOLOGY;ECONOMICS;ART;SOCIOLOGY","164;55;40;35;22;18;18;17;6;4;3;2;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;GENETICS;BIOCHEMISTRY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;ENDOCRINOLOGY;DENTISTRY;RADIOLOGY;IMMUNOLOGY;ORTHODONTICS;ANESTHESIA;MOLECULAR BIOLOGY;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;GEOMETRY;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;STRUCTURAL ENGINEERING","97;53;42;35;30;29;25;21;17;15;15;14;14;13;13;12;11;8;8;8;8;8","GENE;FEMUR;IN VITRO;IMPLANT;OSTEOSARCOMA;PROSTHESIS;ORTHOPEDIC SURGERY;ALTERNATIVE MEDICINE;CANCER;CHEMOTHERAPY;OSTEOPOROSIS;LESION;ENZYME;RECEPTOR;BACTERIA;POPULATION;CARTILAGE;CEMENT;LUMBAR;METHOTREXATE;OSTEOTOMY;RADIOGRAPHY;SARCOMA;TIBIA","23;19;18;17;15;13;12;11;11;11;11;10;9;9;8;8;7;7;7;7;7;7;7;7","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);STAPHYLOCOCCUS AUREUS;BONE MINERAL;MUTATION;OSSEOINTEGRATION;ALKALINE PHOSPHATASE;BONE CEMENT;CHONDROCYTE;CISPLATIN;GROWTH FACTOR;METASTASIS;STRESS SHIELDING;UMBILICAL VEIN;BREAST CANCER;DOXORUBICIN;OSTEOBLAST;OVARIECTOMIZED RAT;BRACHIAL PLEXUS BLOCK;EXON;FEMORAL CONDYLE;GENE DUPLICATION;PROGRAMMED CELL DEATH","9;8;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3","IFOSFAMIDE;STAPHYLOCOCCUS EPIDERMIDIS;NEOADJUVANT THERAPY;OSTEOCALCIN;OSTEOPENIA;ARTICULAR CARTILAGE;COMPARATIVE GENOMIC HYBRIDIZATION;HIGH TIBIAL OSTEOTOMY;KARYOTYPE;LIMB-GIRDLE MUSCULAR DYSTROPHY;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROCOCCACEAE;NUCLEAR PROTEIN;PERIPHERAL MYELIN PROTEIN 22;PRIMARY TUMOR;STAPHYLOCOCCUS;ANEUPLOIDY;ANTIRHEUMATIC DRUGS;ARTHROPATHY;BASIC FIBROBLAST GROWTH FACTOR;BIOSTIMULATION;BONE HISTOMORPHOMETRY;CARDIAC INDEX;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CASPASE;CEFAMANDOLE;CHEMOKINE RECEPTOR;COENZYME Q ‚Äì CYTOCHROME C REDUCTASE;COMPOUND HETEROZYGOSITY;CYSTATIN;CYTOGENETICS;DEHYDROEPIANDROSTERONE SULFATE;DISTORTION (MUSIC);DNA METHYLATION;ENTEROCOCCUS FAECALIS;ETHYLENE OXIDE;FAS LIGAND;FIBRONECTINS;FLUORESCENCE IN SITU HYBRIDIZATION;GENE EXPRESSION PROFILING;GENU VARUM;IMIPENEM;INSULIN-LIKE GROWTH FACTOR;INTERFACE (MATTER);JURKAT CELLS;KNEE PAIN;LACHMAN TEST;LEIGH DISEASE;LOW LEVEL LASER THERAPY;MAMMOGRAPHY;METAPHASE;MHC CLASS I;MISSENSE MUTATION;MMP2;MMP9;OPERON;OSTEOPOROTIC FRACTURE;POINT MUTATION;RETINOBLASTOMA PROTEIN;RIBONUCLEOPROTEIN;SOLITARY FIBROUS TUMOR;STAPHYLOCOCCAL INFECTIONS;STERILIZATION (ECONOMICS);STROKE VOLUME;THROMBOMODULIN;TOBRAMYCIN;TRYPSINIZATION;TUMOR SUPPRESSOR GENE;VANCOMYCIN;VINCRISTINE;VITRONECTIN;VON KOSSA STAIN","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BONE NEOPLASMS;OSTEOSARCOMA;ADULT;MIDDLE AGED;ADOLESCENT;CHILD;;AGED;ANIMALS;FEMUR;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;KNEE JOINT;ORTHOPEDIC PROCEDURES;TIME FACTORS;BIOMECHANICAL PHENOMENA;FRACTURES, BONE;PROSTHESIS DESIGN","141;79;74;67;54;47;43;41;31;28;27;27;24;20;19;18;18;16;16;16","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;OSTEOPOROSIS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;LOW-LEVEL LASER THERAPY IN BIOMEDICAL APPLICATIONS;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BONE TISSUE ENGINEERING AND BIOMATERIALS;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US","30;17;8;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","OSTEOSARCOMA;TOTAL HIP REPLACEMENT;INTERNAL FIXATION;BIOMECHANICS;HIP ARTHROPLASTY;TOTAL KNEE REPLACEMENT;BONE CEMENT;HIP JOINT MECHANICS;HIP MORPHOLOGY;POSTOPERATIVE PAIN;STRESS SHIELDING;ANATOMICAL RECONSTRUCTION;BONE REGENERATION;CHONDROCYTE;FEMORAL NERVE;FRACTURE CLASSIFICATION;LOW-LEVEL LASER THERAPY;REHABILITATION;SKELETAL MUSCLE ATROPHY;ANIMAL MODEL","13;12;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3","MUSCULAR DYSTROPHY;NEOADJUVANT CHEMOTHERAPY;ACRYLIC BONE;ENDOTHELIAL CELLS;BONE CEMENT;BONE CEMENTS;GROWTH FACTOR;HIP ARTHROPLASTY;EXPERIMENTAL STUDY;HUMAN ENDOTHELIAL;RAT BONE;STAPHYLOCOCCUS AUREUS;TOTAL HIP;ANKLE COMPLEX;BONE MARROW;BONE TUMOUR;BREAST LESIONS;CELLS INCUBATED;COMPOSITE FEMURS;DAY SURGERY;DIODE LASER;EWINGS SARCOMA;HIP STEM;HUMAN OSTEOSARCOMA;HYDROXYAPATITE-COATED TAPERED;INTERCELLULAR ADHESION;INTERLEUKIN- EXPRESSION;LOWER LIMB;MARROW STROMAL;MODULAR PROSTHETIC","6;6;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;MUSCLE FIBERS;MHC CLASS;DE JONGHE;INTERMEDIATE CMT;NEUROL -CROSSREF;X-LINKED VACUOLATED;PUBMED GOOGLE;VACUOLATED MYOPATHY;MEMBRANE ATTACK;ATTACK COMPLEX;TUMOR NECROSIS;CHARCOT-MARIE-TOOTH DISEASE;AUTOSOMAL DOMINANT;VAN BROECKHOVEN;AL DE;CHARCOT-MARIE-TOOTH NEUROPATHY;LOUBOUTIN JP;SURFACE MEMBRANE;COMPLEMENT MEMBRANE;DOMINANT INTERMEDIATE;FIBERSANN NEUROL;FMS FARDEAU;INFLAMMATORY MYOPATHIES;INJURED MUSCLE;JP CHATEAU;MARTIN J-J;MUSCLE FIBERSANN;MYOPATHY COMPLEMENT","56;46;22;21;20;19;18;18;17;17;14;12;12;11;10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,7,0,0,0,0,0,0,0,0,1,0,6,3,3.14285714285714,3.31,1.42857142857143,3,3,2,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"ROTINI ROBERTO;BOSIO LUCA;DE MICHELI MATTIA DENIS;FADDA MARCO;MARCACCI MAURILIO;MARTELLI SANDRA;PARRINI GIANLUCA;BILOTTA TERESA WANDA;BIOLI GIANLUCA;FONTANA MAURIZIO","3;2;2;2;2;2;2;1;1;1","ISTITUTI ORTOPEDICI RIZZOLI;S M SCIENZIA MACHINALE S R L;ISTITUTI ORTOPEDICI RIZZOLI IS;ROTINI ROBERTO","6;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;3203 DENTISTRY","6;4;4;1",NA,NA,"6.4 SURGERY","2","A61B;A61B/;A61B17/04;A61F2/08;A61F;A61F/;G01N","2;2;2;2;1;1;1","A61B17/0401;A61B2017/0404;A61B2017/0417;A61F2/0811;A61F2002/0882;A61F2002/0888","2;2;2;2;2;2",1,5,246,0.41,0,0,3,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,"Italy","1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,890026.8,243857.83,3.2,3.4,3,0.8,3.33333333333333,677011.053030303,0.282122424951681,"ISTITUTO ORTOPEDICO RIZZOLI;ESI (FRANCE);UNIVERSIT√â LIBRE DE BRUXELLES;CARDIFF UNIVERSITY;CINECA;DE MONTFORT UNIVERSITY;FRAUNHOFER INSTITUTE FOR INDUSTRIAL MATHEMATICS;INSTITUT NATIONAL DES SCIENCES APPLIQU√âES DE LYON;SPANISH NATIONAL RESEARCH COUNCIL;UNIVERSITY OF BEDFORDSHIRE;VICON (UNITED KINGDOM)","5;2;2;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","5","COALITION S;EC & ERC - EUROPEAN UNION","5;5","FP5-IST - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON A ""USER-FRIENDLY INFORMATION SOCIETY, 1998-2002"" (PROGRAMME);CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);CRS - COOPERATIVE RESEARCH CONTRACTS (FUNDING SCHEME);FP5-GROWTH - PROGRAMME FOR RESEARCH TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""COMPETITIVE AND SUSTAINABLE GROWTH 1998-2002"" (PROGRAMME);FP5-HUMAN POTENTIAL - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""IMPROVING THE HUMAN RESEARCH POTENTIAL AND THE SOCIO-ECONOMIC KNOWLEDGE BASE"" (1998-2002) (PROGRAMME);RGI - RESEARCH GRANTS (INDIVIDUAL FELLOWSHIPS) (FUNDING SCHEME);THN - THEMATIC NETWORK CONTRACTS (FUNDING SCHEME)","3;2;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;4607 GRAPHICS, AUGMENTED REALITY AND GAMES","3;3;1;1;1","BIOENGINEERING;ASSISTIVE TECHNOLOGY;REHABILITATION","3;1;1","MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE","2;1","5.3 MEDICAL DEVICES","2",NA,NA,NA,NA,"B12 ENGINEERING;B11 COMPUTER SCIENCE AND INFORMATICS;C23 EDUCATION","2;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2002,182,6.58791208791209,3.58791208791209,0.714285714285714,0.554945054945055,0.785714285714286,2.32384341637011,1.75675675675676,1.71186440677966,1.72289156626506,0.181318681318681,5,65,39,13,44,0.36,0.21,0.07,0.24,48.18,0.873345021665432,NA,0.236263736263736,0.648351648351648,0.543,0.466,0.481,0.468,"MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;DONATELLA GRANCHI;ANGELO CAPPELLO;SAULO MARTELLI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;DAVIDE MAR√çA DONATI;N. NICOLI ALDINI;MASSIMO SERRA;MAURILIO MARCACCI;E. CENNI;ARMANDO GIUNTI;KATIA SCOTLANDI;NICOLA BALDINI;SUSANNA STEA","20;19;18;16;15;11;10;10;10;9;9;9;9;8;8;8;7;7;7;7","ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SAULO MARTELLI;GIANLUCA GIAVARESI;DONATELLA GRANCHI;MARCO VICECONTI;ANGELO CAPPELLO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;ALBERTO LEARDINI;SANDRO GIANNINI;DAVIDE CAMPOCCIA;BATTISTA BORGHI;LUCIANO MERLINI;SUSANNA STEA;PAOLA TORRICELLI;E. CENNI;BERIL TALIM;S PADERNI","3.34;3.21;3.15;2.93;2.91;2.78;2.68;2.19;1.89;1.89;1.79;1.78;1.75;1.53;1.53;1.51;1.5;1.47;1.43;1.34","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;DONATELLA GRANCHI;ANGELO CAPPELLO;SAULO MARTELLI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;DAVIDE MAR√çA DONATI;N. NICOLI ALDINI;MASSIMO SERRA;MAURILIO MARCACCI;E. CENNI;ARMANDO GIUNTI;KATIA SCOTLANDI;NICOLA BALDINI;SUSANNA STEA","20;19;18;16;15;11;10;10;10;9;9;9;9;8;8;8;7;7;7;7","ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SAULO MARTELLI;GIANLUCA GIAVARESI;DONATELLA GRANCHI;MARCO VICECONTI;ANGELO CAPPELLO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;ALBERTO LEARDINI;SANDRO GIANNINI;DAVIDE CAMPOCCIA;BATTISTA BORGHI;LUCIANO MERLINI;SUSANNA STEA;PAOLA TORRICELLI;E. CENNI;BERIL TALIM;S PADERNI","3.34;3.21;3.15;2.93;2.91;2.78;2.68;2.19;1.89;1.89;1.79;1.78;1.75;1.53;1.53;1.51;1.5;1.47;1.43;1.34","LUCIANO MERLINI;MILENA FINI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;PIERO PICCI;DAVIDE MAR√çA DONATI;ALICE STEINBRECHER;ANA-ELINA LEHESJOKI;BERT VAN DER ZWAAG;BRU CORMAND;CHRISTOPHER A. WALSH;DANIEL BELTR√ÅN-VALERO DE BERNAB√â;DAVID CHITAYAT;ELLEN VAN BEUSEKOM;HAN G. BRUNNER;HANS VAN BOKHOVEN;H√úLYA KAYSERILI;JACOPO CELLI;JES√öS CRUCES;SOPHIE CURRIER","2323;984;971;877;698;685;680;680;680;680;680;680;680;680;680;680;680;680;680;680","LUCIANO MERLINI;MILENA FINI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;PIERO PICCI;ANDREA FACCHINI;STEFANO FERRARI;A. PIACENTINI;N. NICOLI ALDINI;MASSIMO SERRA;GINA LISIGNOLI;G. BACCI;NICOLA BALDINI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;BERIL TALIM;KATIA SCOTLANDI;ALDO TONI;DAVIDE CAMPOCCIA;M. MERCURI","2161;971;929;752;698;584;548;527;523;506;491;482;477;457;454;448;448;441;436;429","MILENA FINI;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;ROBERTO GIARDINO;SAULO MARTELLI;MARCO VICECONTI;DONATELLA GRANCHI;PIERO PICCI;PAOLA TORRICELLI;N. NICOLI ALDINI;E. CENNI;M. MERCURI;MASSIMO SERRA;MAURILIO MARCACCI;G. CIAPETTI;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;L. SAVARINO;NICOLA BALDINI","19;17;15;14;14;10;10;10;9;9;9;8;8;8;8;7;7;7;7;6","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PHYSICS;ECONOMICS;PHILOSOPHY;GEOLOGY;POLITICAL SCIENCE;GEOGRAPHY;PSYCHOLOGY;ART;BUSINESS;SOCIOLOGY","148;68;38;31;30;21;18;18;6;4;3;3;2;2;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;GENETICS;MOLECULAR BIOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;RADIOLOGY;CELL BIOLOGY;ORTHODONTICS;ARTIFICIAL INTELLIGENCE;IMMUNOLOGY;ENVIRONMENTAL HEALTH;DENTISTRY;CANCER RESEARCH;ENDOCRINOLOGY;METALLURGY;PHYSICAL THERAPY;STRUCTURAL ENGINEERING","87;47;39;37;34;34;26;25;25;21;20;20;17;17;16;14;11;11;11;10;10","GENE;IMPLANT;IN VITRO;POPULATION;FEMUR;OSTEOSARCOMA;CELL CULTURE;ORTHOPEDIC SURGERY;ALTERNATIVE MEDICINE;CHEMOTHERAPY;ENZYME;OSTEOPOROSIS;IN VIVO;RECEPTOR;TIBIA;CANCER;PROSTHESIS;BIOMECHANICS;CARTILAGE;DISEASE;MUSCULAR DYSTROPHY;SARCOMA;TITANIUM","31;20;17;16;13;13;12;12;10;10;10;10;9;9;9;8;8;7;7;7;7;7;7","OSSEOINTEGRATION;FIXATION (POPULATION GENETICS);OSTEOBLAST;ALKALINE PHOSPHATASE;MUTATION;OSTEOARTHRITIS;CHEMOKINE;EXTERNAL FIXATION;POLYMERASE CHAIN REACTION;BONE CEMENT;EXON;GENE EXPRESSION;MAXIMUM BUBBLE PRESSURE METHOD;METASTASIS;OVARIECTOMIZED RAT;PHENOTYPE;PROGRAMMED CELL DEATH;TRANSFECTION;ALLELE;BONE MINERAL;BREAST CANCER;CELL CYCLE;CHONDROCYTE;CISPLATIN;COLLAGEN VI;CONGENITAL MUSCULAR DYSTROPHY;CUBIC ZIRCONIA;DEMENTIA;EWING'S SARCOMA;FEMORAL NECK;FIBROBLAST;GROWTH FACTOR;TRANSCRIPTION FACTOR;ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE","12;10;9;8;8;7;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","INTERFACE (MATTER);CHEMOKINE RECEPTOR;MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;DBM;DIACYLGLYCEROL KINASE;DNA FRAGMENTATION;HAPLOTYPE;IL-2 RECEPTOR;MOLECULAR MEDICINE;NEOADJUVANT THERAPY;NUCLEAR PROTEIN;ONCOGENE;OSTEOCALCIN;POINT MUTATION;PROPIDIUM IODIDE;STAPHYLOCOCCUS EPIDERMIDIS;ACHILLES TENDON RUPTURE;ALLELE FREQUENCY;ALPHA (FINANCE);ALTERNATIVE SPLICING;ALVEOLAR RHABDOMYOSARCOMA;AMPLICON;ANTISENSE RNA;ARTICULAR CARTILAGE;AUTOPHOSPHORYLATION;BASIC FIBROBLAST GROWTH FACTOR;BONE HISTOMORPHOMETRY;BRADYCARDIA;CARBOPLATIN;CAVEOLIN 3;CEFAMANDOLE;CXCL10;CYCLIN-DEPENDENT KINASE 2;CYSTATIN;DEHYDROEPIANDROSTERONE SULFATE;DEPHOSPHORYLATION;DIFFERENTIAL DISPLAY;DISMUTASE;ETHYLENE OXIDE;EXOME SEQUENCING;FEBRILE NEUTROPENIA;FRAMESHIFT MUTATION;FUNCTIONAL RESIDUAL CAPACITY;GENE EXPRESSION PROFILING;GLYCINE RECEPTOR;HEMATOPOIETIC GROWTH FACTOR;HETEROZYGOTE ADVANTAGE;HIGH TIBIAL OSTEOTOMY;IFOSFAMIDE;IMIPENEM;IMMUNOTOXIN;KNEE SURGERY;LEUCINE ZIPPER;LMNA;MASTECTOMY;METHACRYLATE;OSTEOPENIA;OSTEOPROTEGERIN;PEAK INSPIRATORY PRESSURE;PENETRANCE;PILON FRACTURE;PKC ALPHA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PRIMARY TUMOR;PROTEIN PHOSPHORYLATION;PROXIMAL MUSCLE WEAKNESS;RANKL;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;RESTRICTION SITE;REVERSE TRANSCRIPTASE;RNA SPLICING;SERIAL MANIPULATOR;SMN1;TELERADIOLOGY;TELEROBOTICS;THROMBOMODULIN;TOBRAMYCIN;TROCHANTER;TROGLITAZONE;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VANCOMYCIN;VASCULAR DEMENTIA;VON KOSSA STAIN","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;BONE NEOPLASMS;MALE;OSTEOSARCOMA;ADULT;MIDDLE AGED;AGED;OSTEOBLASTS;;RNA, MESSENGER;ADOLESCENT;FOLLOW-UP STUDIES;SARCOMA, EWING;ANIMALS;ARTHROPLASTY, REPLACEMENT, HIP;FEMUR;OSTEOPOROSIS;MUSCULAR DYSTROPHIES;TUMOR CELLS, CULTURED","122;72;67;63;53;45;43;38;38;35;34;29;24;24;23;23;23;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TISSUE ENGINEERING AND BIOMATERIALS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;DESIGN AND CONTROL OF SOFT ROBOTIC SYSTEMS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;OPERATIVE MANAGEMENT OF PELVIC FRACTURES;ROLE OF CHEMOKINE RECEPTORS IN CANCER METASTASIS;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;DUAL-ENERGY COMPUTED TOMOGRAPHY;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;OSTEOARTHRITIS AND CARTILAGE REPAIR;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND TREATMENT OF CLAVICLE AND ACROMIOCLAVICULAR INJURIES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MICROSURGICAL RECONSTRUCTION TECHNIQUES","24;13;10;8;7;6;5;4;4;4;4;4;3;3;3;3;2;2;2;2","TOTAL HIP REPLACEMENT;OSTEOSARCOMA;OSTEOBLAST ADHESION;TOTAL KNEE REPLACEMENT;BIOMECHANICS;INTERNAL FIXATION;CANCELLOUS BONE;EWING'S SARCOMA;HIP ARTHROPLASTY;BONE REGENERATION;HIP JOINT MECHANICS;IMPLANT STABILITY;KNEE BIOMECHANICS;SURGICAL PLANNING;BONE CEMENT;FRACTURE CLASSIFICATION;HIP FRACTURE;INTERFACE (MATTER);K-EDGE IMAGING;SKELETAL MUSCLE ATROPHY","14;10;9;9;7;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4","MUSCULAR DYSTROPHY;ACRYLIC BONE;BONE CEMENT;EXTERNAL FIXATION;OSTEOBLAST-LIKE CELLS;BONE CEMENTS;ENMC INTERNATIONAL;INTERNATIONAL WORKSHOP;TOTAL HIP;BONE TUMORS;CEMENT EXTRACTS;CONGENITAL MUSCULAR;FEMORAL NECK;FINITE ELEMENT;HIP ARTHROPLASTY;HIP JOINT;HIP PROSTHESES;HIP PROSTHESIS;HIP REPLACEMENT;KNEE REPLACEMENT;MG OSTEOBLAST-LIKE;NEOADJUVANT CHEMOTHERAPY;OSTEOSARCOMA CELLS;TITANIUM IMPLANTS;TOTAL KNEE;ACETABULAR CUPS;ALKALINE PHOSPHATASE;ANIMAL STUDY;ANKLE REPLACEMENT;ARTICULAR SURFACES","8;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;CELL LINES;LAMIN AC;PUBMED GOOGLE;CELL LINE;EWINGS SARCOMA;AUTOSOMAL RECESSIVE;MUSCULOSKELETAL CELLS;RBCC EXPRESSION;MUSCULAR DYSTROPHY;OSTEOSARCOMA CELL;PARTIAL LIPODYSTROPHY;AUTOSOMAL DOMINANT;DI BARLETTA;GROWTH FACTOR;LMNA GENE;RAFFAELE DI;CCN EXPRESSION;HUMAN OSTEOSARCOMA;NEPHROBLASTOMA OVEREXPRESSED;FAMILIAL PARTIAL;GENE NOV;GENET -CROSSREF;RB EXPRESSION;CCN FAMILY;COLLAGEN VI;CONGENITAL MUSCULAR;CONNECTIVE TISSUE;ES CELLS","59;53;30;25;23;21;20;14;14;14;13;13;13;11;11;11;11;11;10;10;10;9;9;9;9;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,1,3,0,0,0,0,1,0,0,0,3,0,3,2,2.33333333333333,2.14,1.16666666666667,2,1,3,0,1,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"GIARDINO ROBERTO;MARTELLI SANDRA;CATANI FABIO;FINI MILENA;FONTANA MAURIZIO;FONTANESI GIORGIO;GIANNINI SANDRO;LEARDINI ALBERTO;O'CONNOR J JOHN;PIERINI GIOVANNI","2;2;1;1;1;1;1;1;1;1","ISTITUTI ORTOPEDICI RIZZOLI;INSTITUTI ORTOPEDICI RIZZOLI;MARTELLI, SANDRA","4;2;1","40 ENGINEERING;42 HEALTH SCIENCES;4207 SPORTS SCIENCE AND EXERCISE;37 EARTH SCIENCES;4003 BIOMEDICAL ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES","2;2;2;1;1;1","ASSISTIVE TECHNOLOGY;BIOENGINEERING;REHABILITATION","1;1;1",NA,NA,"A61B5/103;A61B17/17;A61B5/107;A61F;A61F/;A61F2/00;A61F2/30;A61F2/42;A61F2/46;C12N","2;1;1;1;1;1;1;1;1;1","A61B5/103;A61B5/4528;A61B17/1775;A61F2/30767;A61F2/4202;A61F2/4606;A61F2/4657;A61F2/4684;A61F2002/30224;A61F2002/30604","2;2;1;1;1;1;1;1;1;1",1,14,100,0.39,0,0,6,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PATIENT SAFETY;RARE DISEASES","1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","1;1",4,1932380.5,294235.08,4.25,6.25,4.25,1,4.25,831541.364935065,0.218870651148199,"ISTITUTO ORTOPEDICO RIZZOLI;CINECA;CONMED (FINLAND);D√âL√âGATION PARIS 11;ETH ZURICH;FIDIA FARMACEUTICI (ITALY);GENETHON (FRANCE);HEBREW UNIVERSITY OF JERUSALEM;HELMHOLTZ CENTRE FOR INFECTION RESEARCH;NATIONAL RESEARCH COUNCIL;PHILIPPS UNIVERSITY OF MARBURG;QUEEN MARY UNIVERSITY OF LONDON;ROYAL INSTITUTE OF TECHNOLOGY;TAMPERE UNIVERSITY;TECHNION ‚Äì ISRAEL INSTITUTE OF TECHNOLOGY;UNIVERSITY OF BASEL;UNIVERSITY OF BEDFORDSHIRE;UNIVERSITY OF EDINBURGH;UNIVERSITY OF MANCHESTER;UNIVERSITY OF SALFORD","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","4","COALITION S;EC & ERC - EUROPEAN UNION","4;4","CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-GROWTH - PROGRAMME FOR RESEARCH TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""COMPETITIVE AND SUSTAINABLE GROWTH 1998-2002"" (PROGRAMME);CRS - COOPERATIVE RESEARCH CONTRACTS (FUNDING SCHEME);FP5-IST - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON A ""USER-FRIENDLY INFORMATION SOCIETY, 1998-2002"" (PROGRAMME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME)","3;2;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;46 INFORMATION AND COMPUTING SCIENCES;4602 ARTIFICIAL INTELLIGENCE","2;2;1;1;1;1","BIOENGINEERING;ARTHRITIS;REGENERATIVE MEDICINE;AGING;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;CHRONIC PAIN;GENE THERAPY;GENETICS;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);OSTEOARTHRITIS;PAIN RESEARCH;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL","2;2","5.2 CELLULAR AND GENE THERAPIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;B11 COMPUTER SCIENCE AND INFORMATICS","1;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2003,195,7,4.02564102564103,0.692307692307692,0.656410256410256,0.794871794871795,2.59933774834437,1.75324675324675,2.32727272727273,1.72222222222222,0.133333333333333,6,68,55,17,44,0.35,0.28,0.09,0.23,54.93,1.03779298536119,NA,0.235897435897436,0.692307692307692,0.502,0.438,0.468,0.466,"MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;ARMANDO GIUNTI;ALESSANDRA LONGHI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;L. SAVARINO;FRANCO BERTONI;CRISTIANA FORNI;MARIO MERCURI;N. NICOLI ALDINI;MAURILIO MARCACCI","23;22;17;16;14;13;13;12;12;12;11;11;11;11;10;10;9;9;9;8","MARCO VICECONTI;ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SANDRO GIANNINI;SAVERIO AFFATATO;LUCIANO MERLINI;L. SAVARINO;GIANLUCA GIAVARESI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;ARMANDO GIUNTI;ANGELO CAPPELLO;GAETANO BACCI;FRANCO BERTONI;LUCA CRISTOFOLINI;SANDRA MARTELLI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;PATRIZIA BACCHINI","3.79;3.61;3.43;3.31;2.57;2.31;2.1;2.06;1.98;1.74;1.67;1.56;1.53;1.53;1.51;1.4;1.39;1.39;1.32;1.32","MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;ARMANDO GIUNTI;ALESSANDRA LONGHI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;L. SAVARINO;FRANCO BERTONI;CRISTIANA FORNI;MARIO MERCURI;N. NICOLI ALDINI;MAURILIO MARCACCI","23;22;17;16;14;13;13;12;12;12;11;11;11;11;10;10;9;9;9;8","MARCO VICECONTI;ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SANDRO GIANNINI;SAVERIO AFFATATO;LUCIANO MERLINI;L. SAVARINO;GIANLUCA GIAVARESI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;ARMANDO GIUNTI;ANGELO CAPPELLO;GAETANO BACCI;FRANCO BERTONI;LUCA CRISTOFOLINI;SANDRA MARTELLI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;PATRIZIA BACCHINI","3.79;3.61;3.43;3.31;2.57;2.31;2.1;2.06;1.98;1.74;1.67;1.56;1.53;1.53;1.51;1.4;1.39;1.39;1.32;1.32","ROBERTO GIARDINO;STEFANO FERRARI;DAVIDE MAR√çA DONATI;LUCIANO MERLINI;MILENA FINI;PIERO PICCI;FRANCO BERTONI;ALESSANDRA LONGHI;PAOLA TORRICELLI;GAETANO BACCI;MARIO MERCURI;CRISTIANA FORNI;PATRIZIA SABATELLI;A BRICCOLI;GIANLUCA GIAVARESI;MARCO VICECONTI;LIA RIMONDINI;MARTA COLUMBARO;MARCO MANFRINI;PATRIZIA BACCHINI","1639;1318;1285;1269;1251;1205;1065;1050;1043;972;968;905;854;842;775;744;734;730;729;700","ROBERTO GIARDINO;LUCIANO MERLINI;MILENA FINI;PIERO PICCI;STEFANO FERRARI;DAVIDE MAR√çA DONATI;PAOLA TORRICELLI;FRANCO BERTONI;GAETANO BACCI;MARIO MERCURI;ALESSANDRA LONGHI;GIANLUCA GIAVARESI;MARTA COLUMBARO;MARCO VICECONTI;CRISTIANA FORNI;A BRICCOLI;SANDRO GIANNINI;ALDO TONI;L. SAVARINO;ARMANDO GIUNTI","1430;1268;1220;1200;1081;1043;1043;1009;972;907;813;775;730;726;668;661;652;620;576;544","MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;PAOLA TORRICELLI;ARMANDO GIUNTI;L. SAVARINO;ALESSANDRA LONGHI;FRANCO BERTONI;N. NICOLI ALDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;CRISTIANA FORNI;KATIA SCOTLANDI","22;17;16;15;14;12;12;12;12;12;11;10;10;9;9;9;8;8;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHYSICS;GEOLOGY;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;ART;POLITICAL SCIENCE;SOCIOLOGY","163;60;47;42;31;29;25;19;8;6;4;3;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;CELL BIOLOGY;GENETICS;ORTHODONTICS;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;GEOMETRY;IMMUNOLOGY;METALLURGY;RADIOLOGY;DENTISTRY;CANCER RESEARCH;PHYSICAL THERAPY;ONCOLOGY","92;60;46;41;38;34;34;22;22;21;19;16;15;15;15;15;14;13;13;12","GENE;FEMUR;CHEMOTHERAPY;IN VITRO;OSTEOSARCOMA;IMPLANT;RADIOGRAPHY;RECEPTOR;ALTERNATIVE MEDICINE;BIOMECHANICS;ENZYME;POPULATION;SARCOMA;CANCER;IN VIVO;OSTEOPOROSIS;DISEASE;RADIATION THERAPY;TITANIUM;ORIENTATION (VECTOR SPACE);ORTHOPEDIC SURGERY;OSTEOLYSIS","22;21;19;18;18;15;13;13;11;11;11;11;11;10;10;10;9;9;9;8;8;8","FIXATION (POPULATION GENETICS);OSTEOBLAST;OSSEOINTEGRATION;CISPLATIN;ALKALINE PHOSPHATASE;BONE MINERAL;FEMORAL NECK;METASTASIS;OSTEOARTHRITIS;BREAST CANCER;CHEMOKINE;DOXORUBICIN;EWING'S SARCOMA;GAIT ANALYSIS;GROWTH FACTOR;KYPHOSIS;OSTEOCLAST;PROTEIN KINASE B;SUBLUXATION;ALLELE;AUTOCRINE SIGNALLING;BONE CEMENT;CELL CYCLE;DEMENTIA;GENE EXPRESSION;GENOTYPE;GIANT-CELL TUMOR OF BONE;MUTATION;PI3K/AKT/MTOR PATHWAY;PROGRAMMED CELL DEATH;TRANSCRIPTION FACTOR;VIABILITY ASSAY","8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","IFOSFAMIDE;CHEMOKINE RECEPTOR;CXCL10;ONCOGENE;OSTEOCALCIN;ARTICULAR CARTILAGE;GIANT CELL ARTERITIS;INTERFACE (MATTER);NEOADJUVANT THERAPY;NUCLEAR PROTEIN;OSTEOPENIA;PRIMARY TUMOR;RANKL;RNA SPLICING;TRANSLATION (BIOLOGY);ACTIN CYTOSKELETON;ACTINOMYCES NAESLUNDII;ADENOMATOUS POLYPOSIS COLI;AKT1;AMP DEAMINASE;ANTERIOR TALOFIBULAR LIGAMENT;ANTIFOLATE;AZOOSPERMIA;BACTERIAL ADHESIN;BETA-CATENIN;BONE METASTASIS;C2C12;CAPROLACTONE;CASPASE;CASPASE 3;CATHEPSIN K;CAVEOLIN;CAVEOLIN 3;COGNITIVE DECLINE;COMPARATIVE GENOMIC HYBRIDIZATION;CTGF;DIFFUSING CAPACITY;DISTORTION (MUSIC);DNA MICROARRAY;FAMILIAL ADENOMATOUS POLYPOSIS;FLUORESCENCE IN SITU HYBRIDIZATION;GENE EXPRESSION PROFILING;GENETICALLY MODIFIED MOUSE;GENOTYPING;HAPLOTYPE;HUMAN GENOME;INSULIN-LIKE GROWTH FACTOR;LIMB-GIRDLE MUSCULAR DYSTROPHY;LMNA;LOSS OF HETEROZYGOSITY;LY294002;MAMMARY GLAND;MAMMARY TUMOR;MASTECTOMY;MEAN ARTERIAL PRESSURE;MEK INHIBITOR;METALORGANIC VAPOUR PHASE EPITAXY;MITOCHONDRIAL FUSION;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;MMP2;MMP9;MOLECULAR MEDICINE;NERVE BIOPSY;NUCLEOPLASM;OLIGOMYCIN;OSTEOPOROTIC FRACTURE;OSTEOPROTEGERIN;P-GLYCOPROTEIN;PATELLAR LIGAMENT;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PROTO-ONCOGENE PROTEINS C-AKT;PTEN;SECONDARY HYPERPARATHYROIDISM;STAPHYLOCOCCUS EPIDERMIDIS;TAMOXIFEN;THIN PLATE SPLINE;TIMP1;TRANSACTIVATION;TROPISETRON;VASCULAR DEMENTIA;VINCRISTINE;WARBURG EFFECT;WORTMANNIN","7;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;OSTEOSARCOMA;ADULT;FEMUR;SARCOMA, EWING;MIDDLE AGED;OSTEOBLASTS;ADOLESCENT;NEOPLASM RECURRENCE, LOCAL;AGED;;ANIMALS;CHILD;GIANT CELL TUMOR OF BONE;MATERIALS TESTING;MUSCLE, SKELETAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","145;101;86;73;68;55;51;47;44;40;38;35;30;28;28;28;26;25;25;22","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MULTIPOTENT MESENCHYMAL STEM CELLS;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY","32;18;10;7;5;5;4;3;3;3;3;3;3;3;3;3;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;BIOMECHANICS;OSTEOSARCOMA;HIP ARTHROPLASTY;OSTEOBLAST ADHESION;KNEE BIOMECHANICS;OSTEOLYSIS;TOTAL KNEE REPLACEMENT;INTERNAL FIXATION;SOFT TISSUE SARCOMA;BIOCOMPATIBILITY;GIANT CELL TUMOR;HIP FRACTURE;TREATMENT;FRACTURE CLASSIFICATION;HIP ARTHROSCOPY;HIP JOINT MECHANICS;IMPLANT STABILITY;KYPHOSIS","20;13;11;10;9;9;8;8;8;6;6;5;5;5;5;4;4;4;4;4","EWINGS SARCOMA;TOTAL HIP;NEOADJUVANT CHEMOTHERAPY;PATIENTS TREATED;FINITE ELEMENT;GIANT CELL;HIP REPLACEMENT;TOTAL KNEE;CELL TUMOR;CEMENTED HIP;HIP ARTHROPLASTY;HUMAN OSTEOBLASTS;MICRO-DIFFRACTION ANALYSIS;MUSCLE STANDARDIZED;OSTEOSARCOMA CELLS;PROSTHETIC SURFACE;RECONSTRUCTED BONE;RHEUMATOID ARTHRITIS;SOFT TISSUE;SPATIAL RESOLUTION;STAINLESS STEEL;STANDARDIZED FEMUR;STEM CELLS;TISSUE ENGINEERING;X-RAY MICRO-DIFFRACTION;ZR PROSTHETIC;AMBULANT CHILDREN;BACTERIAL COLONIZATION;BONE REPAIR;BOTULINUM TOXIN","7;7;6;6;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","GIANT CELL;CELL TUMORS;U- OS;PLASMA THCY;BRACHIAL PLEXUS;COMPLETE SURGERY;EWINGS SARCOMA;INTERSCALENE BRACHIAL;KNEE REPLACEMENT;LIMB SALVAGE;MOTOR FUNCTION;TOTAL KNEE;ATRIAL FIBRILLATIONFLUTTER;INTERSCALENE ANALGESIA;LOCAL ANESTHETIC;LUNG METASTASES;NEOADJUVANT CHEMOTHERAPY;ONSET TIME;PATHOLOGIC FRACTURE;POSTOPERATIVE ANALGESIA;ROPIVACAINE POSTOPERATIVE;SIGNIFICANT INCREASE;SKELETAL MUSCLE;SURGICAL BLOCK;THCY CONCENTRATIONS;ACHIEVED REMISSION;ATRIAL STANDSTILL;BONERESORBING ACTIVITY;CELL LINE;CELL TUMOR","11;8;8;7;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0.13,1,1,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BILOTTA TERESA WANDA","1","ISTITUTI ORTOPEDICI RIZZOLI","1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,6,52,0.71,0,0,4,0,0,0,0,1,0,0,1,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1;1;1","CLINICAL RESEARCH;AGING;ARTHRITIS;CHRONIC PAIN;OSTEOARTHRITIS;OSTEOPOROSIS;PAIN RESEARCH;TRANSPLANTATION","2;1;1;1;1;1;1;1","MUSCULOSKELETAL","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2004,181,6.59116022099448,3.65745856353591,0.646408839779006,0.607734806629834,0.674033149171271,2.35106382978723,1.48101265822785,2,1.46987951807229,0.209944751381215,6,71,34,20,46,0.39,0.19,0.11,0.25,37.28,0.792325297386241,NA,0.287292817679558,0.679558011049724,0.495,0.458,0.453,0.454,"MARCO VICECONTI;MILENA FINI;NICOLA BALDINI;PATRIZIA BACCHINI;ALBERTO LEARDINI;FRANCO BERTONI;ARMANDO GIUNTI;GIANLUCA GIAVARESI;PIERO PICCI;FRANCESCO BERTONI;G. CIAPETTI;KATIA SCOTLANDI;ALDO TONI;STEFANIA PAGANI;ROBERTO GIARDINO;PAOLA TORRICELLI;MASSIMO SERRA;FRANCESCO TRAINA;DONATELLA GRANCHI;SANDRO GIANNINI","17;15;15;15;13;13;12;12;12;9;9;8;8;8;8;8;7;7;7;7","MARCO VICECONTI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;PATRIZIA BACCHINI;FRANCO BERTONI;NICOLA BALDINI;MARCO MANFRINI;ARMANDO GIUNTI;MILENA FINI;ALDO TONI;PIERO PICCI;SANDRO GIANNINI;FRANCESCO TRAINA;FRANCESCO BERTONI;AGNESE ANDOLLINA;G. CIAPETTI;FABIO CATANI;BATTISTA BORGHI;ANDREA CASATI;L. SAVARINO","3.8;3.2;2.95;2.8;2.37;2.13;1.93;1.81;1.79;1.69;1.64;1.51;1.39;1.35;1.32;1.28;1.21;1.17;1.17;1.16","MARCO VICECONTI;MILENA FINI;NICOLA BALDINI;PATRIZIA BACCHINI;ALBERTO LEARDINI;FRANCO BERTONI;ARMANDO GIUNTI;GIANLUCA GIAVARESI;PIERO PICCI;FRANCESCO BERTONI;G. CIAPETTI;KATIA SCOTLANDI;ALDO TONI;STEFANIA PAGANI;ROBERTO GIARDINO;PAOLA TORRICELLI;MASSIMO SERRA;FRANCESCO TRAINA;DONATELLA GRANCHI;SANDRO GIANNINI","17;15;15;15;13;13;12;12;12;9;9;8;8;8;8;8;7;7;7;7","MARCO VICECONTI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;PATRIZIA BACCHINI;FRANCO BERTONI;NICOLA BALDINI;MARCO MANFRINI;ARMANDO GIUNTI;MILENA FINI;ALDO TONI;PIERO PICCI;SANDRO GIANNINI;FRANCESCO TRAINA;FRANCESCO BERTONI;AGNESE ANDOLLINA;G. CIAPETTI;FABIO CATANI;BATTISTA BORGHI;ANDREA CASATI;L. SAVARINO","3.8;3.2;2.95;2.8;2.37;2.13;1.93;1.81;1.79;1.69;1.64;1.51;1.39;1.35;1.32;1.28;1.21;1.17;1.17;1.16","MILENA FINI;PAOLA TORRICELLI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;LUCIANO MERLINI;PATRIZIA BACCHINI;PIERO PICCI;ANTONELLA MOTTA;CLAUDIO MIGLIARESI;MARCO VICECONTI;MATILDE TSCHON;ALBERTO LEARDINI;N. NICOLI ALDINI;SANDRO GIANNINI;FRANCO BERTONI;ANDREW H. CROSBY;CHRISTIAN WINDPASSINGER;CHRISTINE VERELLEN;CHRISTOS PROUKAKIS;ERWIN PETEK","966;787;732;638;476;464;447;431;431;429;398;396;387;377;362;361;361;361;361;361","MILENA FINI;PAOLA TORRICELLI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;LUCIANO MERLINI;PATRIZIA BACCHINI;MARCO VICECONTI;ALBERTO LEARDINI;PIERO PICCI;N. NICOLI ALDINI;MATILDE TSCHON;FRANCO BERTONI;STEFANO FERRARI;CARLA RENATA ARCIOLA;LUCIO MONTANARO;GAETANO BACCI;MASSIMO SERRA;NICOLA BALDINI;GIORDANO NICOLETTI;LORENA LANDUZZI","966;787;732;638;476;441;429;396;393;387;386;362;340;336;336;311;291;290;284;284","MARCO VICECONTI;NICOLA BALDINI;MILENA FINI;FRANCO BERTONI;PATRIZIA BACCHINI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;PIERO PICCI;G. CIAPETTI;KATIA SCOTLANDI;PAOLA TORRICELLI;STEFANIA PAGANI;ROBERTO GIARDINO;ALDO TONI;DONATELLA GRANCHI;L. SAVARINO;MASSIMO SERRA;R. GIARDINO;FRANCESCO BERTONI;FRANCESCO TRAINA","17;15;15;13;13;13;12;10;9;8;8;8;8;7;7;7;7;7;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;ECONOMICS;GEOLOGY;PSYCHOLOGY;BUSINESS;HISTORY","141;72;35;30;25;19;17;14;6;4;4;3;2;2","SURGERY;PATHOLOGY;INTERNAL MEDICINE;BIOCHEMISTRY;GENETICS;ANATOMY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;CANCER RESEARCH;CELL BIOLOGY;ORTHODONTICS;IMMUNOLOGY;MOLECULAR BIOLOGY;RADIOLOGY;METALLURGY;PROGRAMMING LANGUAGE;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;ONCOLOGY;DENTISTRY;MICROBIOLOGY","75;49;46;33;32;31;26;25;25;21;20;17;15;15;12;12;11;10;10;9;9","GENE;OSTEOSARCOMA;CANCER;IN VITRO;RECEPTOR;IMPLANT;ORTHOPEDIC SURGERY;CHEMOTHERAPY;TIBIA;ALTERNATIVE MEDICINE;OSTEOPOROSIS;SARCOMA;SOFTWARE;ANKLE;ENZYME;FEMUR;IMMUNOHISTOCHEMISTRY;BIOCOMPATIBILITY;CELL;APOPTOSIS;BACTERIA;CELL CULTURE;CYTOKINE;IN VIVO;KINEMATICS","24;19;18;16;14;13;12;11;11;10;10;10;10;9;9;9;9;8;8;7;7;7;7;7;7","OSTEOBLAST;METASTASIS;ALKALINE PHOSPHATASE;BONE CEMENT;BONE MINERAL;FIXATION (POPULATION GENETICS);GENE EXPRESSION;OSTEOARTHRITIS;ACTIVATOR (GENETICS);CYCLOPHOSPHAMIDE;EWING'S SARCOMA;FEMORAL NECK;FIBULA;MULTIPLE DRUG RESISTANCE;OSTEOCLAST;STAPHYLOCOCCUS AUREUS;BIOFILM;BREAST CANCER;CELL CYCLE;CHONDROCYTE;DOXORUBICIN;FIBROBLAST;HIP FRACTURE;MUTATION;OSSEOINTEGRATION;PROGRAMMED CELL DEATH;PROTOCOL (SCIENCE);SOFTWARE DEVELOPMENT;VIRULENCE","10;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","COMPARATIVE GENOMIC HYBRIDIZATION;ONCOGENE;OSTEOPROTEGERIN;RANKL;ACTIN CYTOSKELETON;ALVEOLAR RHABDOMYOSARCOMA;CHEMOKINE RECEPTOR;COMPONENT-BASED SOFTWARE ENGINEERING;ECORI;ENTEROCOCCUS FAECALIS;LACTIDE;METALORGANIC VAPOUR PHASE EPITAXY;PROSTATE DISEASE;PROSTATE-SPECIFIC ANTIGEN;RIBOTYPING;STAPHYLOCOCCUS EPIDERMIDIS;ADENOCARCINOMA OF THE LUNG;ADJUVANT CHEMOTHERAPY;AMPLICON;ANAPLASTIC LYMPHOMA KINASE;ANOIKIS;ANTERIOR TALOFIBULAR LIGAMENT;ANTHRACYCLINE;ARTHROPATHY;BACTERIAL ADHESIN;BONE METASTASIS;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREFELDIN A;CASPASE;CATHEPSIN K;CD99;CONNEXIN;CTGF;CTL*;CYSTECTOMY;DNA METHYLATION;DNA MICROARRAY;EMBRYONAL RHABDOMYOSARCOMA;EPIRUBICIN;FAS LIGAND;FAS RECEPTOR;FIBROBLAST GROWTH FACTOR RECEPTOR 1;GENE DOSAGE;GENE MUTATION;GENETICALLY MODIFIED MOUSE;HEMOLYSIN;HER2/NEU;INTERLEUKIN 21;KNEE SURGERY;LOW LEVEL LASER THERAPY;METHACRYLATE;METHYL METHACRYLATE;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MISSENSE MUTATION;MMP2;OSTEOCALCIN;OSTEOPOROTIC FRACTURE;P-GLYCOPROTEIN;PLACENTA;POINT MUTATION;PRIMARY TUMOR;PROPIDIUM IODIDE;PTEN;PUSTULOSIS;RIBOSOME;SECONDARY HYPERPARATHYROIDISM;SOFTWARE CONSTRUCTION;SOFTWARE RENDERING;STAPHYLOCOCCUS;SYNOVIAL FLUID;TARTRATE-RESISTANT ACID PHOSPHATASE;THORACIC VERTEBRAE;TIMP1;TRANSPOSABLE ELEMENT;TROPOMYOSIN RECEPTOR KINASE B;TUMOR SUPPRESSOR GENE;TUOHY NEEDLE;VINCRISTINE;VIRULENCE FACTOR;VON KOSSA STAIN","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;MALE;FEMALE;OSTEOSARCOMA;ADULT;MIDDLE AGED;;AGED;OSTEOBLASTS;ADOLESCENT;FEMUR;BIOCOMPATIBLE MATERIALS;AGED, 80 AND OVER;ANIMALS;MEMBRANE GLYCOPROTEINS;ARTHROPLASTY, REPLACEMENT, HIP;BONE AND BONES;TIBIA;CHILD","125;81;61;60;60;46;41;36;36;31;24;24;23;20;20;20;19;19;19;18","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOPOROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIODEGRADABLE POLYMERS AS BIOMATERIALS AND PACKAGING;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;OSTEOARTHRITIS AND CARTILAGE REPAIR;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOMEDICAL APPLICATIONS OF SILK BIOMATERIALS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CANCER OF UNKNOWN PRIMARY SITE;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES","19;19;9;8;8;5;5;5;4;3;3;3;3;3;2;2;2;2;2;2","OSTEOSARCOMA;EWING'S SARCOMA;TOTAL KNEE REPLACEMENT;BIOCOMPATIBILITY;KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;FRACTURE CLASSIFICATION;HIP ARTHROPLASTY;OSTEOBLAST ADHESION;BIOMECHANICS;BONE CEMENT;HIP FRACTURE;INTERNAL FIXATION;IDENTIFICATION (BIOLOGY);MANDIBULAR RECONSTRUCTION;MICROSURGICAL RECONSTRUCTION;REGIMEN;BIOMATERIAL;BONE MINERAL DENSITY;BONE REGENERATION","10;9;9;8;8;8;6;6;6;5;5;5;5;4;4;4;4;3;3;3","EWINGS SARCOMA;APPLICATION FRAMEWORK;MULTIMOD APPLICATION;TOTAL HIP;BONE TUMORS;CELL LINE;EPIDURAL NEEDLE;HIP REPLACEMENT;IIN VITROI;KNEE ARTHROPLASTY;MULTIDRUG RESISTANT;NEEDLE ROTATION;OSTEOSARCOMA CELLS;PRE-OPERATIVE PLANNING;ANKLE CENTER;AXIS IDENTIFICATION;BENIGN LESION;BIOCOMPATIBILITY EVALUATION;BONE CEMENT;CANCER MHRPC;CENTER LOCATION;CHEMICAL VAPOUR;CORTICAL BONE;DEGENERATIVE ATYPIA;DELIVERY SYSTEMS;DIAGNOSTIC TECHNIQUES;DISTAL RADIAL;DRUG DELIVERY;FEMORAL NECK;FIBROUS DYSPLASIA","5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AMINO ACID;CENTRAL LOW-GRADE;LOW-GRADE OSTEOSARCOMA;PRIMARY TUMOR;CELL LINES;CELL VACCINE;EPIDURAL CATHETER;LUNG METASTASES;NEUT-ŒúMT MICE;TUMOR ONSET;BDNF SECRETION;IL--ENGINEERED CELL;LOCAL ANESTHETIC;MESOTHELIAL CELLS;MM CELLS;NONMALIGNANT MESOTHELIAL;PLASMA AMINO;POSITIVE STAINING;PTHR GENE;PULMONARY METASTASES;RHABDOMYOSARCOMA CELLS;AMINO ACIDS;BALB-NEUT MICE;BOLOGNA ITALY;BONE-CEMENT INTERFACE;CELL LINE;CELL PROLIFERATION;CELL TYPES;CELLS EXPRESSING;CONTROL SUBJECTS","7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,1,0,0,0,0,1,0,0,0,2,0,1,15.5,2,0.9,1.33333333333333,2,1,2,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BILOTTA WANDA TERESA;CAPPELLO ANGELO;CRISTOFOLINI LUCA;ROTINI ROBERTO;TONI ALDO;VICECONTI MARCO","1;1;1;1;1;1","ISTITUTI ORTOPEDICI RIZZOLI;INSTITUTI ORTOPEDICI RIZZOLI;UNIVERSITA DI BOLOGNA","2;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","3;1;1;1","BIOENGINEERING;REHABILITATION","1;1",NA,NA,"A61B/;A61B17/04;A61F2/08;A61F2/36;A61F2/46;A61H3/00;A61H3/04;G01L1/00;G01P3/00","1;1;1;1;1;1;1;1;1","A61B17/0401;A61B2017/0404;A61B2017/0417;A61B5/4528;A61F2/0811;A61F2/36;A61F2/3662;A61F2/4603;A61F2/4607;A61F2/4657","1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1881500,220916.67,3.5,9.5,4.5,1,14.5,580574.66468254,0.311760073269769,"ISTITUTO ORTOPEDICO RIZZOLI;HAROKOPIO UNIVERSITY;ISTITUTO NAZIONALE DI RIPOSO E CURA PER ANZIANI;MEDICAL UNIVERSITY OF LODZ;NATIONAL HELLENIC RESEARCH FOUNDATION;NATIONAL RESEARCH COUNCIL;ROMA TRE UNIVERSITY;SEMMELWEIS UNIVERSITY;SPANISH NATIONAL CANCER RESEARCH CENTRE;UNILEVER (UNITED KINGDOM);UNIVERSITY OF FLORENCE;UNIVERSITY OF FRANCHE-COMT√â;UNIVERSITY OF KONSTANZ;UNIVERSITY OF PADUA;UNIVERSITY OF PERUGIA;UNIVERSITY OF T√úBINGEN;UNIVERSIT√ÑTSKLINIKUM AACHEN;UNIVERSIT√â PARIS-CIT√â","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","1;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","FP6-2002-FOOD-1 (CALL FOR PROPOSAL);FP6-FOOD - FOOD QUALITY AND SAFETY: THEMATIC PRIORITY 5 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME);TELETHON GRANT PROJECTS - 2004 (PROGRAM)","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3208 MEDICAL PHYSIOLOGY","2;1;1;1","AGING;BRAIN DISORDERS;GENETICS;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NEUROSCIENCES;NUTRITION;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;3.3 NUTRITION AND CHEMOPREVENTION;5.1 PHARMACEUTICALS","2;1;1;1","NOT SITE-SPECIFIC CANCER","1","1.1 NORMAL FUNCTIONING;2.3 INTERACTIONS OF GENES AND/OR GENETIC POLYMORPHISMS WITH EXOGENOUS AND/OR ENDOGENOUS FACTORS","1;1","A01 CLINICAL MEDICINE","2",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2005,191,7,3.79581151832461,0.643979057591623,0.649214659685864,0.675392670157068,2.40863787375415,1.43023255813953,2.33962264150943,1.53571428571429,0.198952879581152,2,74,42,23,40,0.39,0.22,0.12,0.21,54.95,1.03784990961959,NA,0.267015706806283,0.738219895287958,0.463,0.378,0.428,0.402,"PIERO PICCI;MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;MAURILIO MARCACCI;ALBERTO LEARDINI;NICOLA BALDINI;ALDO TONI;MARCO VICECONTI;ARMANDO GIUNTI;GAETANO BACCI;SANDRO GIANNINI;MARIO MERCURI;ANDREA FACCHINI;BRUNELLA GRIGOLO;ANGELO CAPPELLO;ALESSANDRA LONGHI;STEFANO BORIANI;FRANCO BERTONI;A. FACCHINI","16;14;14;12;12;11;11;11;11;10;10;9;9;9;8;8;8;8;8;8","MARCO VICECONTI;ALBERTO LEARDINI;ALDO TONI;MAURILIO MARCACCI;MILENA FINI;ROBERTO GIARDINO;PIERO PICCI;FABIO CATANI;ANGELO CAPPELLO;ARMANDO GIUNTI;NICOLA BALDINI;SANDRO GIANNINI;GIANLUCA GIAVARESI;GAETANO BACCI;M. FRAVISINI;STEFANO BORIANI;ANDREA FACCHINI;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;BRUNELLA GRIGOLO","2.44;2.43;2.28;2;1.88;1.88;1.82;1.73;1.73;1.7;1.66;1.61;1.51;1.43;1.38;1.36;1.34;1.25;1.23;1.22","PIERO PICCI;MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;MAURILIO MARCACCI;ALBERTO LEARDINI;NICOLA BALDINI;ALDO TONI;MARCO VICECONTI;ARMANDO GIUNTI;GAETANO BACCI;SANDRO GIANNINI;MARIO MERCURI;ANDREA FACCHINI;BRUNELLA GRIGOLO;ALESSANDRA LONGHI;STEFANO BORIANI;FRANCO BERTONI;A. FACCHINI;MICHELA VERSARI","16;14;14;12;12;11;11;11;11;10;10;9;9;9;8;8;8;8;8;7","MARCO VICECONTI;ALBERTO LEARDINI;ALDO TONI;MAURILIO MARCACCI;MILENA FINI;ROBERTO GIARDINO;PIERO PICCI;FABIO CATANI;ARMANDO GIUNTI;NICOLA BALDINI;SANDRO GIANNINI;GIANLUCA GIAVARESI;GAETANO BACCI;M. FRAVISINI;STEFANO BORIANI;ANDREA FACCHINI;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;BRUNELLA GRIGOLO;CARLA RENATA ARCIOLA","2.44;2.43;2.28;2;1.88;1.88;1.82;1.73;1.7;1.66;1.61;1.51;1.43;1.38;1.36;1.34;1.25;1.23;1.22;1.18","PIERO PICCI;ALBERTO LEARDINI;GAETANO BACCI;CARLA RENATA ARCIOLA;DAVIDE CAMPOCCIA;LUCIO MONTANARO;MILENA FINI;ROBERTO GIARDINO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;ENRICO LUCARELLI;KATIA SCOTLANDI;MARIA CRISTINA MANARA;STEFANIA BENINI;GIANLUCA GIAVARESI;MARIO MERCURI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MASSIMO SERRA;MARTA COLUMBARO","1185;961;872;775;775;775;681;681;677;632;629;627;627;627;621;611;573;563;557;546","ALBERTO LEARDINI;GAETANO BACCI;PIERO PICCI;CARLA RENATA ARCIOLA;DAVIDE CAMPOCCIA;LUCIO MONTANARO;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;GIANLUCA GIAVARESI;KATIA SCOTLANDI;ALESSANDRA LONGHI;MARIO MERCURI;ROBERTO GIARDINO;MARTA COLUMBARO;ANDREA FACCHINI;STEFANO FERRARI;FRANCO BERTONI;MICHELA VERSARI;MARIA BENEDETTA DONATI","961;872;837;775;775;775;641;632;622;621;593;573;558;549;546;544;542;531;520;505","PIERO PICCI;MILENA FINI;MAURILIO MARCACCI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;ALDO TONI;MARCO VICECONTI;ROBERTO GIARDINO;ANDREA FACCHINI;GAETANO BACCI;NICOLA BALDINI;SANDRO GIANNINI;A. FACCHINI;ARMANDO GIUNTI;FRANCO BERTONI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MARIO MERCURI;STEFANO FERRARI;CARLA RENATA ARCIOLA","13;13;12;12;11;11;11;11;10;10;10;9;8;8;8;8;7;7;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PSYCHOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;ART;BUSINESS;GEOLOGY;HISTORY","162;60;32;31;25;20;19;15;6;4;3;3;3;1;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;BIOMEDICAL ENGINEERING;GENETICS;CELL BIOLOGY;RADIOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;ORTHODONTICS;DENTISTRY;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;CLASSICAL MECHANICS;COMPUTER VISION;METALLURGY;ONCOLOGY","95;69;62;37;33;25;25;20;20;19;18;17;16;16;16;13;12;10;10;9;9;9","GENE;ALTERNATIVE MEDICINE;OSTEOSARCOMA;CHEMOTHERAPY;IN VITRO;CANCER;POPULATION;CARTILAGE;FEMUR;ORTHOPEDIC SURGERY;RADIOGRAPHY;SARCOMA;IMPLANT;KINEMATICS;PROSTHESIS;DISEASE;TIBIA;ARTHROPLASTY;BACTERIA;LESION;PROSPECTIVE COHORT STUDY;RECEPTOR","21;19;17;16;16;15;15;13;13;13;12;12;11;10;10;9;9;8;8;8;8;8","OSTEOARTHRITIS;BREAST CANCER;CHONDROCYTE;FIXATION (POPULATION GENETICS);MUTATION;STAPHYLOCOCCUS AUREUS;METASTASIS;PHENOTYPE;EWING'S SARCOMA;FIBULA;GROWTH FACTOR;LAMIN;MOTION CAPTURE;OSSEOINTEGRATION;OSTEOBLAST;PLATELET-RICH PLASMA;TRANSCRIPTION FACTOR;ALKALINE PHOSPHATASE;BONE MINERAL;CD44;CHEMOKINE;CISPLATIN;CYTOTOXICITY;DEMENTIA;DOXORUBICIN;DYNAMIC HIP SCREW;FIBROBLAST;GAIT ANALYSIS;RNA;SOFT TISSUE SARCOMA;T CELL;TITANIUM ALLOY;TRANSFECTION;TYPE II COLLAGEN","16;9;7;7;7;7;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;STAPHYLOCOCCUS EPIDERMIDIS;ADJUVANT CHEMOTHERAPY;NEOADJUVANT THERAPY;LMNA;NUCLEAR PROTEIN;STAPHYLOCOCCUS;CAPROLACTONE;CHEMOKINE RECEPTOR;GIANT CELL ARTERITIS;HETEROCHROMATIN;IFOSFAMIDE;INTERFACE (MATTER);LIMB-GIRDLE MUSCULAR DYSTROPHY;OSTEOCALCIN;STERILIZATION (ECONOMICS);VANCOMYCIN;VASCULAR DEMENTIA;AMES TEST;ANTIFOLATE;ANTIRETROVIRAL THERAPY;BACTERIAL ADHESIN;BASIC FIBROBLAST GROWTH FACTOR;CASPASE 3;CD28;CD3;CD40;CD86;CD99;CHONDROITIN SULFATE PROTEOGLYCAN;CHONDROMATOSIS;CTLA-4;CXCL10;CXCR4;CYTOSTASIS;DNA MISMATCH REPAIR;EMBRYONAL RHABDOMYOSARCOMA;FOLINIC ACID;GENETICALLY MODIFIED MOUSE;GLYCOPROTEIN 130;HIGH TIBIAL OSTEOTOMY;HISTONE DEACETYLASE;IL-2 RECEPTOR;IMMUNOTOXIN;INSULIN-LIKE GROWTH FACTOR;INTESTINAL CANCER;KERATAN SULFATE;KNEE SURGERY;LYMPHOPOIESIS;MAMMARY GLAND;MAMMARY TUMOR;MEDIAL MENISCUS;METASTASECTOMY;MICROARRAY ANALYSIS TECHNIQUES;MICROSATELLITE;MISSENSE MUTATION;MOLECULAR MEDICINE;MULTICENTER TRIAL;MULTIPLEX POLYMERASE CHAIN REACTION;ONCOGENE;P-GLYCOPROTEIN;PEROXIREDOXIN;PEROXYNITRITE;PLASMA CELL GRANULOMA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POLY ADP RIBOSE POLYMERASE;PRENATAL DIAGNOSIS;PRIMARY TUMOR;RADIAL HEAD FRACTURE;RIBOSOME;RNA INTERFERENCE;RNA SPLICING;SISTER CHROMATIDS;STEROL REGULATORY ELEMENT-BINDING PROTEIN;TELEROBOTICS;THORACIC VERTEBRAE;TLR2;TOBRAMYCIN;TRASTUZUMAB;VINCRISTINE;VIRULENCE FACTOR","11;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BONE NEOPLASMS;ADULT;OSTEOSARCOMA;MIDDLE AGED;;AGED;CHONDROCYTES;ADOLESCENT;CARTILAGE, ARTICULAR;KNEE JOINT;TREATMENT OUTCOME;AGED, 80 AND OVER;OSTEOBLASTS;SARCOMA, EWING;ANIMALS;ARTHROPLASTY, REPLACEMENT, HIP;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","135;75;69;64;56;49;45;42;41;32;30;29;27;25;23;22;22;21;21;17","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BONE TISSUE ENGINEERING AND BIOMATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT OF SPINAL METASTATIC TUMORS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DUAL-ENERGY COMPUTED TOMOGRAPHY;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS","24;19;14;8;7;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;OSTEOSARCOMA;EWING'S SARCOMA;OSTEOBLAST ADHESION;DISTAL RADIUS FRACTURES;INTERNAL FIXATION;OSTEOLYSIS;AGGRECAN;CHONDROCYTE;HIP JOINT MECHANICS;SOFT TISSUE SARCOMA;ADJUVANT CHEMOTHERAPY;ANTERIOR CRUCIATE LIGAMENT;BONE MINERAL DENSITY;HIP ARTHROPLASTY;HIP FRACTURE;MOTION CAPTURE;NEOADJUVANT THERAPY","15;11;11;10;9;8;6;6;6;5;5;5;5;4;4;4;4;4;4;4","TOTAL HIP;HIP ARTHROPLASTY;SOFT TISSUE;NEOADJUVANT CHEMOTHERAPY;ANTERIOR CRUCIATE;CLINICAL ISOLATES;CRUCIATE LIGAMENT;EWINGS SARCOMA;SURGICAL TREATMENT;CEMENTLESS HIP;COGNITIVE IMPAIRMENT;EXTERNAL FIXATION;FINITE ELEMENT;GROWTH FACTOR;IIN VITROI;IIN VIVOI;LIGAMENT RECONSTRUCTION;MILD COGNITIVE;ORTHOPEDIC INFECTIONS;OSTEOID OSTEOMA;PERTROCHANTERIC FRACTURES;PROSPECTIVE RANDOMIZED;RANDOMIZED STUDY;STEM CELLS;TOTAL KNEE;ADULT PATIENTS;ANTIBIOTIC RESISTANCE;ARTHROPLASTY RESULTS;AUTOLOGOUS CELL;AUTOLOGOUS CHONDROCYTE","8;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LAMIN AC;GROWTH FACTOR;MUSCULAR DYSTROPHY;POSTERIOR SLOPE;TIBIAL COMPONENT;ASEPTIC LOOSENING;BONE SARCOMA;GENE EXPRESSION;HYLAMER POLYETHYLENE;AC PHOSPHORYLATION;BONE LOSS;CDCDNULL T-CELLS;CELL LINES;CLINICAL ISOLATES;EWINGS SARCOMA;GIRDLE MUSCULAR;GROWTH FACTORS;LIMB GIRDLE;MG MG;OSTEOCHONDRAL LESIONS;PATIENTS UNDERGOING;PMR PATIENTS;REGRESSION LINE;SERUM LEVELS;STAPHYLOCOCCUS EPIDERMIDIS;TIBIAL PLATEAU;ANGIOGENIC FACTORS;ANGULAR DIFFERENCE;CD CD;COX REGRESSION","11;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,1,0,2,1,0,4,1.66,2.33333333333333,0,3,3,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CAPPELLO ANGELO;CRISTOFOLINI LUCA;TONI ALDO;VICECONTI MARCO","3;3;3;3","UNIVERSITA DI BOLOGNA;INSTITUTI ORTOPEDICI RIZZOLI;ISTITUTI ORTOPEDICI RIZZOLI;ISTITUTI ORTOPEDICI RIZZOLI BO;UNI DEGLI STUDI DI BOLOGNA BOL;UNIV BOLOGNA","2;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","6;3","ASSISTIVE TECHNOLOGY;BIOENGINEERING;REHABILITATION","3;3;3",NA,NA,"A61F2/36;A61F2/46;G01L1/00;G01P3/00","3;3;3;3","A61B5/4528;A61F2/36;A61F2/3662;A61F2/4603;A61F2/4607;A61F2/4657;A61F2/468;A61F2002/30772;A61F2002/3625;A61F2002/3631","3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,5159130,347534.48,4.16666666666667,11.1666666666667,7,1,10,814326.481349206,0.234549660823438,"ISTITUTO ORTOPEDICO RIZZOLI;NATIONAL INTERUNIVERSITY CONSORTIUM OF MATERIALS SCIENCE AND TECHNOLOGY;NATIONAL RESEARCH COUNCIL;UNIVERSITAT POLIT√àCNICA DE CATALUNYA;UNIVERSITY OF ULM;√âCOLE POLYTECHNIQUE F√âD√âRALE DE LAUSANNE;AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY;AUDI (GERMANY);BIOMECHANICS INSTITUTE OF VALENCIA;BRIDGEPOINT (UNITED KINGDOM);CHARIT√â - UNIVERSITY MEDICINE BERLIN;COLOROBBIA (ITALY);DANAHER (SWEDEN);D√âL√âGATION PARIS 11;EMORY UNIVERSITY;FCT SYSTEME (GERMANY);GENERAL ELECTRIC (ITALY);GETINGE (NETHERLANDS);GHENT UNIVERSITY;GRIFOLS (SPAIN)","6;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","6","COALITION S;EC & ERC - EUROPEAN UNION","6;6","FP6-NMP - NANOTECHNOLOGIES AND NANOSCIENCES, KNOWLEDGE-BASED MULTIFUNCTIONAL MATERIALS AND NEW PRODUCTION PROCESSES AND DEVICES: THEMATIC PRIORITY 3 UNDER THE 'FOCUSING AND INTEGRATING COMMUNITY RESEARCH' OF THE 'INTEGRATING AND STRENGTHENING THE EUROPEAN RESEARCH AREA' SPECIFIC PROGRAMME 2002-2006. (PROGRAMME);FP6-2003-NMP-TI-3-MAIN (CALL FOR PROPOSAL);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME);FP6-2002-LIFESCIHEALTH (CALL FOR PROPOSAL);FP6-2002-MOBILITY-6 (CALL FOR PROPOSAL);FP6-2002-NMP-1 (CALL FOR PROPOSAL);FP6-2003-NMP-NI-3 (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);FP6-MOBILITY - HUMAN RESOURCES AND MOBILITY IN THE SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ""STRUCTURING THE EUROPEAN RESEARCH AREA"" UNDER THE SIXTH FRAMEWORK PROGRAMME 2002-2006 (PROGRAMME);IP - INTEGRATED PROJECT (FUNDING SCHEME);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME);OIF - MARIE CURIE ACTIONS-OUTGOING INTERNATIONAL FELLOWSHIPS (FUNDING SCHEME);STIP - SPECIFIC TARGETED INNOVATION PROJECT (FUNDING SCHEME)","4;2;2;1;1;1;1;1;1;1;1;1;1","40 ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;4003 BIOMEDICAL ENGINEERING;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3403 MACROMOLECULAR AND MATERIALS CHEMISTRY;4016 MATERIALS ENGINEERING","4;3;3;1;1;1;1;1","BIOENGINEERING;REGENERATIVE MEDICINE;AGING;BIOTECHNOLOGY;OSTEOPOROSIS;ESTROGEN;PEDIATRIC;RARE DISEASES","3;3;2;2;2;1;1;1","MUSCULOSKELETAL;CANCER;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM","2;1;1;1","5.2 CELLULAR AND GENE THERAPIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;1.3 CHEMICAL AND PHYSICAL SCIENCES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES","2;1;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1;1","A01 CLINICAL MEDICINE;B12 ENGINEERING;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C17 BUSINESS AND MANAGEMENT STUDIES","2;2;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2006,191,7.25130890052356,3.7696335078534,0.581151832460733,0.643979057591623,0.638743455497382,2.66296296296296,1.46052631578947,2.36538461538462,1.50617283950617,0.225130890052356,0,78,41,28,36,0.41,0.21,0.15,0.19,50.94,0.997341355326309,NA,0.361256544502618,0.769633507853403,0.51,0.423,0.45,0.437,"MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;ALESSANDRA LONGHI;FRANCO BERTONI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;MAURILIO MARCACCI;NICOLA BALDINI;ALDO TONI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;LUCA CRISTOFOLINI;MARIA GRAZIA BENEDETTI;GAETANO BACCI;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIO MONTANARO;FRANCESCO TRAINA","20;19;18;15;14;13;12;12;12;12;12;11;11;10;10;10;9;9;9;9","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;FRANCO BERTONI;PIERO PICCI;ALDO TONI;ALBERTO LEARDINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;MARIA GRAZIA BENEDETTI;ROBERTO GIARDINO;SAVERIO AFFATATO;NICOLA BALDINI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;LUCIO MONTANARO;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI","3.45;2.98;2.73;2.3;2.27;2.16;2.15;2.07;2;1.96;1.96;1.82;1.69;1.63;1.61;1.55;1.49;1.48;1.43;1.4","MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;ALESSANDRA LONGHI;FRANCO BERTONI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;MAURILIO MARCACCI;NICOLA BALDINI;ALDO TONI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;LUCA CRISTOFOLINI;MARIA GRAZIA BENEDETTI;GAETANO BACCI;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIO MONTANARO;FRANCESCO TRAINA","20;19;18;15;14;13;12;12;12;12;12;11;11;10;10;10;9;9;9;9","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;FRANCO BERTONI;PIERO PICCI;ALDO TONI;ALBERTO LEARDINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;MARIA GRAZIA BENEDETTI;ROBERTO GIARDINO;SAVERIO AFFATATO;NICOLA BALDINI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;LUCIO MONTANARO;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI","3.45;2.98;2.73;2.3;2.27;2.16;2.15;2.07;2;1.96;1.96;1.82;1.69;1.63;1.61;1.55;1.49;1.48;1.43;1.4","PIERO PICCI;SANDRO GIANNINI;ALBERTO LEARDINI;GAETANO BACCI;ALESSANDRA LONGHI;MILENA FINI;MICHELA VERSARI;MAURILIO MARCACCI;FRANCO BERTONI;PATRIZIA BACCHINI;MARIO MERCURI;MARCO VICECONTI;A BRICCOLI;ELIZAVETA KON;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;LISA BERTI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;D. BETTINELLI","1668;1141;1084;1069;1059;989;916;898;845;833;799;790;789;753;711;679;664;651;645;622","PIERO PICCI;MILENA FINI;ALESSANDRA LONGHI;GAETANO BACCI;MICHELA VERSARI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;MARCO VICECONTI;PATRIZIA BACCHINI;FRANCO BERTONI;ELIZAVETA KON;A BRICCOLI;MARIA GRAZIA BENEDETTI;MARIO MERCURI;GIANLUCA GIAVARESI;LISA BERTI;ROBERTO GIARDINO;D. BETTINELLI;R. NATIVO","1629;985;967;924;901;898;882;870;790;779;777;753;712;711;708;675;664;645;622;622","MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;NICOLA BALDINI;MAURILIO MARCACCI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;FRANCO BERTONI;ROBERTO GIARDINO;ALDO TONI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;FRANCESCO TRAINA;CARLA RENATA ARCIOLA;ELIZAVETA KON;STEFANO ZAFFAGNINI;LUCIO MONTANARO;PAOLA TORRICELLI","19;19;17;12;12;12;11;11;11;11;11;11;10;10;9;9;9;8;8;8","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;MATHEMATICS;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;ART;HISTORY;PSYCHOLOGY;SOCIOLOGY","147;66;55;47;36;26;25;9;8;4;4;1;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;BIOCHEMISTRY;COMPOSITE MATERIAL;ANATOMY;BIOMEDICAL ENGINEERING;GENETICS;CANCER RESEARCH;CELL BIOLOGY;ORTHODONTICS;ARTIFICIAL INTELLIGENCE;METALLURGY;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENDOCRINOLOGY;ONCOLOGY;MOLECULAR BIOLOGY;OPTICS;ORGANIC CHEMISTRY","81;57;52;37;37;36;33;30;26;21;21;17;17;15;13;12;12;11;11;10","CANCER;CHEMOTHERAPY;GENE;OSTEOSARCOMA;ALTERNATIVE MEDICINE;SARCOMA;CARTILAGE;IN VITRO;RECEPTOR;IMPLANT;RADIOGRAPHY;CELL CULTURE;ENZYME;BACTERIA;FEMUR;TENDON;GAIT;ARTHROPLASTY;DISEASE;IMMUNOHISTOCHEMISTRY;KINEMATICS;POLYETHYLENE;SOFTWARE","22;22;20;20;19;16;15;15;14;13;11;10;10;9;9;9;8;7;7;7;7;7;7","OSTEOARTHRITIS;METASTASIS;ACTIVATOR (GENETICS);ALKALINE PHOSPHATASE;BREAST CANCER;CELL CYCLE;OSTEOBLAST;OSTEOCLAST;STAPHYLOCOCCUS AUREUS;BIOFILM;GAIT ANALYSIS;CHONDROCYTE;ETOPOSIDE;EWING'S SARCOMA;OSSEOINTEGRATION;CANCER CELL;CHONDROGENESIS;CISPLATIN;CYCLOPHOSPHAMIDE;MAXIMUM BUBBLE PRESSURE METHOD;MENISCUS;ROTATOR CUFF INJURY;TRANSFECTION","15;9;7;7;7;6;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;RANKL;OSTEOCALCIN;OSTEOPROTEGERIN;IFOSFAMIDE;INTERFACE (MATTER);NEOADJUVANT THERAPY;PRIMARY TUMOR;STAPHYLOCOCCUS;ADJUVANT CHEMOTHERAPY;BONE METASTASIS;CD99;CYCLIN;ENTEROCOCCUS FAECALIS;GIANT CELL ARTERITIS;MEDIAL MENISCUS;ONCOGENE;RESONANCE FREQUENCY ANALYSIS;VANCOMYCIN;VINCRISTINE;VIRULENCE FACTOR","8;7;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;BONE NEOPLASMS;OSTEOSARCOMA;FEMALE;MALE;;ADULT;MIDDLE AGED;ANIMALS;ADOLESCENT;AGED;KNEE JOINT;OSTEOBLASTS;BIOMECHANICAL PHENOMENA;NEOPLASM RECURRENCE, LOCAL;TREATMENT OUTCOME;SARCOMA, EWING;FEMUR;BIOCOMPATIBLE MATERIALS;BIOMARKERS, TUMOR","111;105;73;58;58;48;48;30;27;25;24;24;24;23;21;21;20;19;18;18","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIOMECHANICS OF RUNNING-RELATED INJURIES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ANALYSIS OF THREE-DIMENSIONAL SHAPE STRUCTURES;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;CORROSION INHIBITORS AND PROTECTION MECHANISMS;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES","29;25;10;10;9;7;5;5;4;4;3;3;2;2;2;2;2;2;2;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;OSTEOSARCOMA;EWING'S SARCOMA;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;BIOMECHANICS;SURFACE MODIFICATION;BIOCOMPATIBILITY;BIOMATERIAL;BONE REMODELING;GAIT ANALYSIS;IMAGING;METAL-ON-METAL BEARINGS;OSTEOBLAST ADHESION;ROTATOR CUFF TEARS;BIOMECHANICAL ANALYSIS;BONE REGENERATION;BONE RESORPTION;CHONDROGENESIS","16;14;14;12;9;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3","NEOADJUVANT CHEMOTHERAPY;EWINGS SARCOMA;TOTAL HIP;GAIT ANALYSIS;JOINT SIMULATOR;OSTEOSARCOMA PATIENTS;ROTATOR CUFF;SERUM LEVELS;SINGLE INSTITUTION;STROMAL CELLS;TOTAL KNEE;ACETABULAR CUPS;ACL RECONSTRUCTION;BONE CEMENT;CEMENTLESS HIP;HIP ARTHROPLASTY;HIP JOINT;HIP REPLACEMENT;KNEE ARTHROPLASTY;MARROW STROMAL;MUSCULAR DYSTROPHY;OSTEOBLAST-LIKE CELLS;PATIENTS TREATED;RECEPTOR ACTIVATOR;ACID SCAFFOLD;ACRYLIC BONE;ALLOGRAFT TRANSPLANTATION;ANKLE ARTHROSIS;ANKLE JOINT;BIOPHYSICAL STIMULATION","8;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","OSTEOSARCOMA PATIENTS;NUCLEAR IRS-;ORTHOPAEDIC RESEARCH;PATIENTS TREATED;PG SYNTHESIS;BONE LOSS;CELL LINES;LOCAL RECURRENCE;NEOADJUVANT CHEMOTHERAPY;SURGICAL MARGINS;ALKALINE PHOSPHATASE;BREAST CANCER;COLLAGEN FIBRILS;COLON CANCER;HISTOLOGIC RESPONSE;INTERSCALENE ANALGESIA;LUNG METASTASES;MM CELLS;ORTHOP RES;PATIENT-CONTROLLED INTERSCALENE;RESEARCH SOCIETY;TUMOUR CELLS;BENIGN TUMOURS;BONE METASTASES;BONE RESORPTION;CELL CYCLE;CHEMOTHERAPY PROTOCOLS;CLINICAL SAMPLES;COLLAGEN TYPE;DUCTAL CANCER","7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,4,1.11,1.5,0,1,2,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CATANI FABIO;GIANNINI SANDRO;LEARDINI ALBERTO;O'CONNOR J JOHN","2;2;2;2","INSTITUTI ORTOPEDICI RIZZOLI;IST ORTOPEDICI RIZZOLI;ISTITUTI ORTOPEDICI RIZZOLI","1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","4;2","REHABILITATION","1",NA,NA,"A61B17/17;A61F2/00;A61F2/30;A61F2/42;A61F2/46","2;2;2;2;2","A61B17/1775;A61F2/30767;A61F2/4202;A61F2/4606;A61F2/4657;A61F2/4684;A61F2002/30224;A61F2002/30604;A61F2002/30616;A61F2002/30892","2;2;2;2;2;2;2;2;2;2",3,5,208,1.16,0,0,16,0,0,2,0,1,0,0,0,0,1,0,0,0,0,0,0,0,3,0,0,1,2,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;OSTEOPOROSIS","1;1;1","INJURIES AND ACCIDENTS;MUSCULOSKELETAL","2;1","6.1 PHARMACEUTICALS","1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",6,4277257.67,364961.16,4.33333333333333,10.5,6.16666666666667,1,19.6,1242453.0752381,0.153728139763667,"ISTITUTO ORTOPEDICO RIZZOLI;UNIVERSITY COLLEGE LONDON;ERASMUS MC;UNIVERSITY OF BEDFORDSHIRE;UNIVERSITY OF M√úNSTER;UNIVERSITY OF OXFORD;UNIVERSIT√â LIBRE DE BRUXELLES;AALBORG UNIVERSITY;AALBORG UNIVERSITY HOSPITAL;ACADEMIC MEDICAL CENTER;AZIENDA ULSS 9 TREVISO;CENTER FOR ADVANCED STUDIES RESEARCH AND DEVELOPMENT IN SARDINIA;CINECA;DURHAM UNIVERSITY;D√âL√âGATION PARIS 11;FRANCE EUROPE INNOVATION;FRENCH INSTITUTE FOR RESEARCH IN COMPUTER SCIENCE AND AUTOMATION;GERMAN CANCER RESEARCH CENTER;HEBREW UNIVERSITY OF JERUSALEM;HEINRICH HEINE UNIVERSITY D√úSSELDORF","6;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","6","COALITION S;EC & ERC - EUROPEAN UNION","6;6","FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME);FP6-2004-LIFESCIHEALTH-5 (CALL FOR PROPOSAL);FP6-IST - INFORMATION SOCIETY TECHNOLOGIES: THEMATIC PRIORITY UNDER THE SPECIFIC PROGRAMME ""INTEGRATING AND STRENGTHENING THE EUROPEAN RESEARCH AREA"" (2002-2006). (PROGRAMME);CA - COORDINATION ACTION (FUNDING SCHEME);FP6-2005-LIFESCIHEALTH-6 (CALL FOR PROPOSAL);FP6-2005-MOBILITY-1 (CALL FOR PROPOSAL);FP6-MOBILITY - HUMAN RESOURCES AND MOBILITY IN THE SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ""STRUCTURING THE EUROPEAN RESEARCH AREA"" UNDER THE SIXTH FRAMEWORK PROGRAMME 2002-2006 (PROGRAMME);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME);RTN - MARIE CURIE ACTIONS-RESEARCH TRAINING NETWORKS (FUNDING SCHEME)","3;3;2;2;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;33 BUILT ENVIRONMENT AND DESIGN;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR;42 HEALTH SCIENCES;4207 SPORTS SCIENCE AND EXERCISE;4610 LIBRARY AND INFORMATION STUDIES","3;2;2;1;1;1;1;1;1;1;1;1","GENETICS;RARE DISEASES;BIOTECHNOLOGY;ORPHAN DRUG;PEDIATRIC;AGING;BIOENGINEERING;BRAIN DISORDERS;CANCER;DIABETES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);NEUROSCIENCES;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;STEM CELL RESEARCH","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL","2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","3;2;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA;BRAIN TUMOR;LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA","2;2;1;1;1","1.3 CANCER INITIATION: ONCOGENES AND TUMOR SUPPRESSOR GENES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS;A05 BIOLOGICAL SCIENCES;C13 ARCHITECTURE, BUILT ENVIRONMENT AND PLANNING","3;2;1;1","3 GOOD HEALTH AND WELL BEING","1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2007,187,6.88235294117647,3.9144385026738,0.631016042780749,0.6524064171123,0.647058823529412,2.46464646464646,1.45679012345679,2.10344827586207,1.57142857142857,0.245989304812834,2,71,58,21,21,0.38,0.31,0.11,0.11,49.42,0.936457260447404,NA,0.310160427807487,0.711229946524064,0.478,0.427,0.467,0.435,"MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;STEFANO FERRARI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;MILENA FINI;NICOLA BALDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIER‚ÄêLUIGI LOLLINI;ALESSANDRA LONGHI;FULVIA TADDEI;MARIO MERCURI;FRANCO BERTONI;PATRIZIA NANNI;KATIA SCOTLANDI;LORENA LANDUZZI","27;15;15;14;12;12;11;10;10;10;9;8;8;8;8;8;8;7;7;7","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;BARBARA BORDINI;FULVIA TADDEI;STEFANO ZAFFAGNINI;NICOLA BALDINI;ROBERTO GIARDINO;STEFANO FERRARI;ALDO TONI;SANDRO GIANNINI;ANDREA FACCHINI;MARIO MERCURI;FRANCO BERTONI;MILENA FINI;PAOLO ERANI;MASSIMILIANO BALEANI;FABIO BARUFFALDI","5.21;3.84;2.4;2.2;1.85;1.61;1.59;1.54;1.51;1.45;1.45;1.38;1.3;1.29;1.28;1.26;1.22;1.16;1.15;1.14","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;STEFANO FERRARI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;MILENA FINI;NICOLA BALDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIER‚ÄêLUIGI LOLLINI;ALESSANDRA LONGHI;FULVIA TADDEI;MARIO MERCURI;FRANCO BERTONI;PATRIZIA NANNI;KATIA SCOTLANDI;LORENA LANDUZZI","27;15;15;14;12;12;11;10;10;10;9;8;8;8;8;8;8;7;7;7","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;BARBARA BORDINI;FULVIA TADDEI;STEFANO ZAFFAGNINI;NICOLA BALDINI;ROBERTO GIARDINO;STEFANO FERRARI;ALDO TONI;SANDRO GIANNINI;ANDREA FACCHINI;MARIO MERCURI;FRANCO BERTONI;MILENA FINI;PAOLO ERANI;MASSIMILIANO BALEANI;FABIO BARUFFALDI","5.21;3.84;2.4;2.2;1.85;1.61;1.59;1.54;1.51;1.45;1.45;1.38;1.3;1.29;1.28;1.26;1.22;1.16;1.15;1.14","MARCO VICECONTI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;FULVIA TADDEI;ELIZAVETA KON;ENRICO SCHILEO;PIERO PICCI;STEFANO FERRARI;ROBERTO GIARDINO;ALBERTO LEARDINI;ANDREI LAVROUKOV;MADDALENA MASTROGIACOMO;RANIERI CANCEDDA;RODOLFO QUARTO;VLADIMIR MOUKHACHEV;–°. –ú. –ö–£–¢–ï–ü–û–í;FRANCO BERTONI;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI;MARIO MERCURI","1724;1147;1141;1052;880;775;670;670;614;566;566;566;566;566;566;566;550;538;527;516","MARCO VICECONTI;MAURILIO MARCACCI;FULVIA TADDEI;LUCA CRISTOFOLINI;ELIZAVETA KON;ENRICO SCHILEO;PIERO PICCI;STEFANO FERRARI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCO BERTONI;STEFANO ZAFFAGNINI;MARIO MERCURI;PATRIZIA BACCHINI;MARIA GRAZIA BENEDETTI;FABIO BARUFFALDI;KATIA SCOTLANDI;GABRIELE PAOLINI;R. NATIVO;S. INGROSSO","1660;1141;1052;1010;880;775;670;656;614;566;550;527;516;506;444;436;417;389;389;389","MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;STEFANO FERRARI;LUCA CRISTOFOLINI;PATRIZIA BACCHINI;ROBERTO GIARDINO;NICOLA BALDINI;MILENA FINI;GIANLUCA GIAVARESI;STEFANO ZAFFAGNINI;FRANCO BERTONI;FULVIA TADDEI;MARIO MERCURI;DONATELLA GRANCHI;ALESSANDRA LONGHI;BARBARA BORDINI;FABIO BARUFFALDI;KATIA SCOTLANDI;PAOLA TORRICELLI","24;15;14;14;14;11;11;10;10;9;9;8;8;8;7;7;7;7;7;7","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;GEOLOGY;HISTORY;ECONOMICS;PSYCHOLOGY;SOCIOLOGY;GEOGRAPHY","149;74;37;37;20;19;18;17;6;5;4;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;GENETICS;CELL BIOLOGY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;ORTHODONTICS;CANCER RESEARCH;ENDOCRINOLOGY;RADIOLOGY;DENTISTRY;MOLECULAR BIOLOGY;IMMUNOLOGY;STRUCTURAL ENGINEERING;STATISTICS;ARTIFICIAL INTELLIGENCE;ONCOLOGY","85;57;54;39;35;34;30;26;23;23;19;18;15;14;14;13;12;11;10;9","GENE;ALTERNATIVE MEDICINE;CHEMOTHERAPY;ORTHOPEDIC SURGERY;IMPLANT;SARCOMA;IN VITRO;RECEPTOR;CANCER;CARTILAGE;OSTEOSARCOMA;OSTEOPOROSIS;RADIOGRAPHY;FEMUR;ARTHROPLASTY;ENZYME;CHONDROSARCOMA;POPULATION;PROSTHESIS;TIBIA","31;19;17;17;16;16;15;14;13;13;13;12;12;11;10;10;8;8;8;8","OSTEOARTHRITIS;OSTEOBLAST;GENE EXPRESSION;OSSEOINTEGRATION;ALKALINE PHOSPHATASE;CELL CYCLE;FIXATION (POPULATION GENETICS);STAPHYLOCOCCUS AUREUS;ACTIVATOR (GENETICS);ANTIBIOTIC RESISTANCE;BONE DENSITY;CD34;CELLULAR DIFFERENTIATION;CHONDROCYTE;CHROMATIN;CISPLATIN;GROWTH FACTOR;LAMIN;METASTASIS;OSTEOCLAST","14;8;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;IFOSFAMIDE;OSTEOCALCIN;HETEROCHROMATIN;RANKL;VANCOMYCIN;BASIC FIBROBLAST GROWTH FACTOR;CAPROLACTONE;ENDOSSEOUS IMPLANTS;ENTEROCOCCUS FAECALIS;IMATINIB MESYLATE;INSULIN RECEPTOR;NUCLEAR PROTEIN;ONCOGENE;OSTEOPROTEGERIN;RIBOTYPING;ACHILLES TENDON RUPTURE;ACTIVE IMMUNOTHERAPY;ADJUVANT CHEMOTHERAPY;ALTERNATIVE SPLICING;ANTHRACYCLINE;BUSULFAN;C2C12;CANCER VACCINE;CD146;CD90;CD99;CHEMOKINE RECEPTOR;CHONDROMATOSIS;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;CRACK GROWTH RESISTANCE CURVE;CTGF;CYCLIN D1;DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;DNA METHYLATION;DNA MISMATCH REPAIR;DNA-BINDING PROTEIN;DOUBLE BLIND;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;EMBRYONAL RHABDOMYOSARCOMA;EZRIN;FLUORESCENCE IN SITU HYBRIDIZATION;FUSION PROTEIN;GENTAMICIN SULFATE;GENU VARUM;GIANT CELL ARTERITIS;HEMOLYSIN;HIGH TIBIAL OSTEOTOMY;INSULIN-LIKE GROWTH FACTOR;INTERFACE (MATTER);INTRAVASATION;IŒöB KINASE;JURKAT CELLS;KERATAN SULFATE;KRAS;LAMINOTOMY;LMNA;MAMMARY TUMOR;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROSATELLITE;MISSENSE MUTATION;MOLECULAR EPIDEMIOLOGY;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPLEX POLYMERASE CHAIN REACTION;MYOEPITHELIOMA;OLIGOMYCIN;OPIOID PEPTIDE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PATELLAR LIGAMENT;PDGFRA;PHOSPHOINOSITIDE 3-KINASE;PROMOTER;PSEUDOMONAS INFECTION;PTEN;RETINOBLASTOMA PROTEIN;RNA SPLICING;STAPHYLOCOCCUS EPIDERMIDIS;STERILIZATION (ECONOMICS);SYNOVIAL FLUID;TARTRATE-RESISTANT ACID PHOSPHATASE;TRABECTEDIN;TRAMP;TRANSLATION (BIOLOGY);VARUS DEFORMITY;VINCRISTINE","7;6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;ADULT;MIDDLE AGED;;SARCOMA, EWING;AGED;ANIMALS;FEMUR;OSTEOSARCOMA;ADOLESCENT;OSTEOBLASTS;CHONDROCYTES;CHONDROSARCOMA;BIOMECHANICAL PHENOMENA;KNEE JOINT;ARTHROPLASTY, REPLACEMENT, KNEE;BIOCOMPATIBLE MATERIALS","125;81;62;59;52;43;42;35;30;27;27;24;23;22;20;19;18;18;17;17","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOPOROSIS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;IMMUNOBIOLOGY OF DENDRITIC CELLS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;ROLE OF CCN PROTEINS IN SIGNALING PATHWAYS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS","30;17;13;11;9;9;6;5;5;4;3;3;3;3;3;2;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;CHONDROSARCOMA;INTERNAL FIXATION;OSTEOSARCOMA;IMPLANT STABILITY;MESENCHYMAL CHONDROSARCOMA;REPEATABILITY;BIOMECHANICS;FRACTURE CLASSIFICATION;OSTEOBLAST ADHESION;OSTEOCLAST DIFFERENTIATION;POLYMERIC SCAFFOLDS;BONE REGENERATION;CHONDROCYTE;OSSEOINTEGRATION;REGULATION OF BONE HOMEOSTASIS","14;12;12;11;9;7;7;7;6;6;6;5;5;5;5;5;4;4;4;4","TOTAL KNEE;EWINGS SARCOMA;HIP ARTHROPLASTY;MUSCULAR DYSTROPHY;BONE CEMENTS;BONE MARROW;CANCELLOUS BONE;CEMENTED HIP;EWING SARCOMA;FAMILY TUMORS;FINITE ELEMENT;GENE EXPRESSION;HIP STEMS;IIN VITROI;KNEE ARTHROPLASTY;NAVIGATION SYSTEM;OSTEOARTHRITIC CHONDROCYTES;SARCOMA FAMILY;TRABECULAR BONE;ARTICULAR CARTILAGE;BIOFUNCTIONALIZED POLY-Œï-CAPROLACTONE;CANCER CELLS;CARTILAGE DEFECTS;CARTILAGE LESIONS;CELL CARCINOMA;CEMENT MANTLE;CHONDROSARCOMAS ARISING;CONGENITAL MUSCULAR;DEDIFFERENTIATED CHONDROSARCOMAS;ELEMENT MODELS","6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","DNA METHYLATION;CCN PROTEINS;FOLD INCREASES;FOLD NA;NGML ŒúM;CELL GROWTH;GLUCOSAMINE CONCENTRATIONS;MAMMARY CANCER;MUSCULAR DYSTROPHY;SYNOVIAL FLUID;TOTAL HIP;TRANSCRIPTION FACTOR;CANCER CELLS;CARTILAGE DEFECTS;COLLAGEN TYPE;CONGENITAL MUSCULAR;EWINGS SARCOMA;GENE EXPRESSION;HUMAN CHONDROCYTES;IL-Œí EXPRESSION;INFLAMMATORY CYTOKINES;MORQUIO SYNDROME;NEOADJUVANT CHEMOTHERAPY;NONMETASTATIC OSTEOSARCOMA;TOTAL KNEE;TRANSGENIC MICE;TRUNCATED CCN;ULLRICH CONGENITAL;VV ROTATION;ADVERSE EVENTS","12;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,4,0.55,2,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"CATANI FABIO;GIANNINI SANDRO;LEARDINI ALBERTO;O'CONNOR JOHN","1;1;1;1","IST ORTOPEDICI RIZZOLI;ISTITUTI ORTOPEDICI RIZZOLI","1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1",NA,NA,NA,NA,"A61B17/17;A61F2/00;A61F2/30;A61F2/42;A61F2/46","1;1;1;1;1","A61B17/1775;A61F2/30767;A61F2/4202;A61F2/4606;A61F2/4657;A61F2/4684;A61F2002/30224;A61F2002/30604;A61F2002/30616;A61F2002/30892","1;1;1;1;1;1;1;1;1;1",2,9,176,0.71,1,0.5,26.5,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;2","CANCER;RARE DISEASES;BIOTECHNOLOGY;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE","2;2;1;1;1;1;1;1;1","CANCER","1",NA,NA,"SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2008,241,6.92116182572614,3.81327800829875,0.614107883817427,0.609958506224066,0.651452282157676,2.89589905362776,1.60869565217391,2.82692307692308,1.67021276595745,0.228215767634855,2,95,70,18,27,0.39,0.29,0.07,0.11,41.86,0.762924063177741,NA,0.286307053941909,0.688796680497925,0.514,0.464,0.466,0.461,"MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;ROBERTO GIARDINO;LUCA CRISTOFOLINI;ALBERTO LEARDINI;STEFANO ZAFFAGNINI;FULVIA TADDEI;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;DOMENICO TIGANI;FRANCESCO TRAINA;ARMANDO GIUNTI;ALDO TONI;DONATELLA GRANCHI;MANUELE LAMPASI;SAVERIO AFFATATO;PAOLA TORRICELLI","33;20;18;18;17;17;16;15;14;14;12;10;10;10;9;9;9;8;8;8","MARCO VICECONTI;SANDRO GIANNINI;LUCA CRISTOFOLINI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCESCO TRAINA;FULVIA TADDEI;NICOLA BALDINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;MANUELE LAMPASI;DOMENICO TIGANI;ALDO TONI;MASSIMILIANO BALEANI;O DONZELLI;GIANLUCA GIAVARESI;DAVIDE MAR√çA DONATI;CLAUDIA DI BELLA","6.85;3.43;2.99;2.89;2.82;2.68;2.62;2.61;2.51;2.23;2.18;2.15;1.82;1.77;1.61;1.55;1.48;1.4;1.37;1.34","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;ROBERTO GIARDINO;LUCA CRISTOFOLINI;ALBERTO LEARDINI;STEFANO ZAFFAGNINI;FULVIA TADDEI;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;DOMENICO TIGANI;FRANCESCO TRAINA;ARMANDO GIUNTI;ALDO TONI;DONATELLA GRANCHI;MANUELE LAMPASI;SAVERIO AFFATATO;PAOLA TORRICELLI","33;20;18;18;17;17;16;15;14;14;12;10;10;10;9;9;9;8;8;8","MARCO VICECONTI;SANDRO GIANNINI;LUCA CRISTOFOLINI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCESCO TRAINA;FULVIA TADDEI;NICOLA BALDINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;MANUELE LAMPASI;DOMENICO TIGANI;ALDO TONI;MASSIMILIANO BALEANI;O DONZELLI;GIANLUCA GIAVARESI;DAVIDE MAR√çA DONATI;CLAUDIA DI BELLA","6.85;3.43;2.99;2.89;2.82;2.68;2.62;2.61;2.51;2.23;2.18;2.15;1.82;1.77;1.61;1.55;1.48;1.4;1.37;1.34","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ADRIANA BIGI;STEFANO ZAFFAGNINI;PAOLA TORRICELLI;ALBERTO MARTEGANI;BJ√òRN SKJOLDBYE;CARLO F√åLICE;CHRISTIAN NOLS√òE;CHRISTOPH F. DIETRICH;D LINDSELL;DAVID H. EVANS;DAVID O. COSGROVE;EDWARD LEEN;F. TRANQUART;FABIO PISCAGLIA;FABRIZIO CALLIADA;G SEIDEL","1126;1071;996;848;786;760;759;755;755;755;755;755;755;755;755;755;755;755;755;755","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;FULVIA TADDEI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;NICOLA BALDINI;SPARTACO SANTI;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;MARCO DELCOGLIANO;ENRICO DALL‚ÄôARA;LUCA CRISTOFOLINI;MARIO MERCURI;G. CIAPETTI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO","1093;1071;983;848;747;742;719;662;646;548;510;504;497;497;448;434;419;414;397;379","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;MAURILIO MARCACCI;ROBERTO GIARDINO;NICOLA BALDINI;ALBERTO LEARDINI;FULVIA TADDEI;LUCA CRISTOFOLINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;DOMENICO TIGANI;DONATELLA GRANCHI;ALDO TONI;G. CIAPETTI;SAVERIO AFFATATO;ARMANDO GIUNTI;DAVIDE MAR√çA DONATI","32;20;18;17;17;16;15;14;14;13;12;10;10;10;9;9;8;8;8;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;GEOLOGY;POLITICAL SCIENCE;BUSINESS;ART;GEOGRAPHY","190;78;54;51;39;31;30;25;7;5;4;4;4;3;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;COMPOSITE MATERIAL;GENETICS;CELL BIOLOGY;ORTHODONTICS;BIOMEDICAL ENGINEERING;RADIOLOGY;CANCER RESEARCH;PHYSICAL THERAPY;ENVIRONMENTAL HEALTH;DENTISTRY;ORGANIC CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;METALLURGY;GEOMETRY;ARTIFICIAL INTELLIGENCE;CLASSICAL MECHANICS;IMMUNOLOGY;MOLECULAR BIOLOGY;STRUCTURAL ENGINEERING","109;65;62;45;42;38;32;31;30;29;24;22;21;16;15;15;15;14;12;11;11;11;11;11","GENE;IN VITRO;ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;IMPLANT;ARTHROPLASTY;POPULATION;OSTEOSARCOMA;PROSTHESIS;ANKLE;CANCER;CHEMOTHERAPY;FEMUR;RADIOGRAPHY;KINEMATICS;RECEPTOR;CELL CULTURE;BACTERIA;BIOMECHANICS;FINITE ELEMENT METHOD","26;24;22;21;19;18;16;15;15;14;14;12;12;12;11;11;10;9;9;9","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);OSTEOBLAST;STAPHYLOCOCCUS AUREUS;GENE EXPRESSION;ALKALINE PHOSPHATASE;ANTIBIOTIC RESISTANCE;METASTASIS;OSSEOINTEGRATION;OSTEOCLAST;CELLULAR DIFFERENTIATION;GAIT ANALYSIS;ACTIVATOR (GENETICS);BONE CEMENT;CELL CYCLE;KNEE REPLACEMENT;POLYLACTIC ACID;TRABECULAR BONE;TRANSCRIPTION FACTOR;COPOLYMER;DOXORUBICIN;FIBULA;GENOTYPE;MYOGENESIS;PERIPHERAL BLOOD MONONUCLEAR CELL;PROGRAMMED CELL DEATH;PROSTATE CANCER;PROSTHESIS DESIGN;PROTOCOL (SCIENCE)","17;12;12;9;7;6;6;6;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;OSTEOCALCIN;VANCOMYCIN;ARTHROPATHY;C2C12;MEROPENEM;STAPHYLOCOCCUS EPIDERMIDIS;BRAIN-DERIVED NEUROTROPHIC FACTOR;CHEMOKINE RECEPTOR;CYCLIN;GSTP1;MEDIAL MENISCUS;OSTEOPROTEGERIN;PSYCHOLOGICAL REPRESSION;QUANTITATIVE COMPUTED TOMOGRAPHY;RIBOTYPING;STAPHYLOCOCCAL INFECTIONS;ADENOSINE RECEPTOR;ANTHRACYCLINE;ANTIFOLATE;ANTIRETROVIRAL THERAPY;BONE METASTASIS;CASPASE;CAVEOLIN 3;CD99;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;CXCL10;DEFENSIVE MEDICINE;DEGENERATIVE ARTHRITIS;DKK1;DNA METHYLATION;DNA MISMATCH REPAIR;E2F;ENDOCYTIC CYCLE;ENOS;EPH RECEPTOR A2;ERYTHROPOIETIN-PRODUCING HEPATOCELLULAR (EPH) RECEPTOR;FLOXURIDINE;GENE DOSAGE;GENE EXPRESSION PROFILING;GENOTYPING;GERIATRIC DEPRESSION SCALE;GIANT CELL ARTERITIS;HEPATIC ARTERIAL INFUSION;HISTONE DEACETYLASE;IFOSFAMIDE;IMATINIB MESYLATE;IMMATURE TERATOMA;INHIBITOR OF APOPTOSIS;INTERLEUKIN 1Œí;INTERLEUKIN-4 RECEPTOR;INTRA ARTICULAR;IŒöB KINASE;LACHMAN TEST;LACTIDE;LINCOSAMIDES;LMNA;LOCALIZED DISEASE;METASTATIC BREAST CANCER;METASTATIC LESION;MICROSATELLITE;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;MOBILE GENETIC ELEMENTS;MULTILOCUS SEQUENCE TYPING;NEOADJUVANT THERAPY;NUCLEAR PROTEIN;OLIGOMER RESTRICTION;ONCOGENE;PIOGLITAZONE;PIVOT-SHIFT TEST;POROSIMETRY;PRIMARY TUMOR;RANKL;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;SINGULAR BOUNDARY METHOD;STAPHYLOCOCCUS;THORACIC VERTEBRAE;TRANSLATION (BIOLOGY);TRASTUZUMAB;TROPOMYOSIN RECEPTOR KINASE B;VCAM-1;VINORELBINE;WOMAC","4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;OSTEOSARCOMA;TREATMENT OUTCOME;ANIMALS;OSTEOBLASTS;FEMUR;ARTHROPLASTY, REPLACEMENT, HIP;FOLLOW-UP STUDIES;KNEE JOINT;JOINT INSTABILITY;TISSUE ENGINEERING;ADOLESCENT;AGED, 80 AND OVER","142;78;70;66;61;59;54;47;45;32;31;31;26;24;24;22;21;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;SARCOMA RESEARCH AND TREATMENT;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;OSTEOPOROSIS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MANAGEMENT OF SPINAL METASTATIC TUMORS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY","29;13;12;10;8;7;7;6;5;4;4;4;3;3;3;3;3;3;3;3","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;BIOMECHANICS;HIP JOINT MECHANICS;IMPLANT STABILITY;SCAFFOLDS;BONE MINERAL DENSITY;HIP ARTHROSCOPY;INTERNAL FIXATION;LIMB RECONSTRUCTION;OSTEOBLAST ADHESION;OSTEOSARCOMA;POLYMERIC SCAFFOLDS;BIOMATERIAL;BONE CEMENT;CADAVERIC SPASM;CURETTAGE;FRACTURE CLASSIFICATION","21;15;13;10;9;8;6;6;5;5;5;5;5;5;5;4;4;4;4;4","TOTAL HIP;HIP ARTHROPLASTY;BONE MARROW;TOTAL KNEE;GAIT ANALYSIS;KNEE REPLACEMENT;STROMAL CELLS;MARROW STROMAL;SURGICAL TREATMENT;TISSUE ENGINEERING;ACL RECONSTRUCTION;ANTERIOR CRUCIATE;BONE CEMENT;CELL TUMOURS;CRUCIATE LIGAMENT;ELECTROMAGNETIC FIELDS;FINITE ELEMENT;FOLLOW-UP STUDY;GIANT CELL;HUMAN OSTEOSARCOMA;MESENCHYMAL STEM;NAVIGATION SYSTEM;OSTEOSARCOMA CELL;STEM CELLS;ACETABULAR NON-UNION;ACRYLIC BONE;ACRYLIC CEMENT;ADOLESCENT IDIOPATHIC;ANIMAL PET;ANKLE REPLACEMENT","8;7;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","LARSEN SYNDROME;PUBMED SCOPUS;CROSSREF PUBMED;HUMERO-SPINAL DYSOSTOSIS;JOINT DISLOCATIONS;CELL LINES;RECESSIVE LARSEN;CHST DEFICIENCY;STROMAL CELLS;SULFATE TRANSPORTER;GROWTH FACTOR;MED GENET;PEDIATR -ABSTRACT;SPONDYLOEPIPHYSEAL DYSPLASIA;CONGENITAL DISLOCATIONS;CONGENITAL JOINT;DIASTROPHIC DYSPLASIA;DYSPLASIA OMANI;GENE EXPRESSION;GENET -CROSSREF;OMANI TYPE;PROGRESSIVE SPINAL;PUBMED GOOGLE;ARTICULAR CARTILAGE;CHONDROITIN SULFATE;DOMINANT LARSEN;FLEXED POSTURE;LARSENS SYNDROME;TRABECULAR BONE;ACL RECONSTRUCTION","38;36;25;12;12;11;11;10;9;9;8;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,2,0,0,1,3.5,0.76,5,0,2,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BUDA ROBERTO;GIANNINI SANDRO;GRIGOLO BRUNELLA;KNUUTILA SAKARI;PICCI PIERO;SAVOLA SUVI;SCOTLANDI KATIA","1;1;1;1;1;1;1","BUDA ROBERTO;GIANNINI SANDRO;GRIGOLO BRUNELLA;ISTITUTI ORTOPEDICI RIZZOLI DI;ISTITUTO ORTOPEDICO RIZZOLI;KNUUTILA SAKARI;PICCI PIERO;SAVOLA SUVI;SCOTLANDI KATIA;UNIV HELSINKI","1;1;1;1;1;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1","STEM CELL RESEARCH","1",NA,NA,"A61K35/28;C12Q1/68","1;1","A61K35/28;A61L27/3804;A61L27/3843;A61P29/00;A61P31/00;A61P31/10;A61P31/12;A61P9/00;C12Q1/6886;C12Q2600/106","1;1;1;1;1;1;1;1;1;1",3,2,180,0.96,0,0,3,0,0,1,0,1,0,0,1,0,2,0,0,0,0,0,0,0,3,0,0,1,1,0,1,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","3;2;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;RARE DISEASES","1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","2;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",3,5802828.33,357092.14,4.66666666666667,14,6.33333333333333,0.666666666666667,38,1099025.23579479,0.219285228537736,"ISTITUTO ORTOPEDICO RIZZOLI;D√âL√âGATION PARIS 11;UNIVERSITY OF SHEFFIELD;ANSYS (FRANCE);BRAINLAB (GERMANY);CHARIT√â - UNIVERSITY MEDICINE BERLIN;CINECA;CLAUDE BERNARD UNIVERSITY LYON 1;EINDHOVEN UNIVERSITY OF TECHNOLOGY;EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;ETH ZURICH;EUROPEAN MOLECULAR BIOLOGY LABORATORY;EUROPEAN RESEARCH CONSORTIUM FOR INFORMATICS AND MATHEMATICS;FRENCH INSTITUTE FOR RESEARCH IN COMPUTER SCIENCE AND AUTOMATION;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;INSTITUT MUNICIPAL D'ASSIST√àNCIA SANIT√ÄRIA;INSTITUT NATIONAL DES SCIENCES APPLIQU√âES DE LYON;JOSEPH FOURIER UNIVERSITY;KAROLINSKA INSTITUTET;KU LEUVEN","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2007-2 (CALL FOR PROPOSAL);CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);FP7-PEOPLE - SPECIFIC PROGRAMME ""PEOPLE"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);FP7-PEOPLE-2007-4-2-IIF (CALL FOR PROPOSAL);MC-IIF - INTERNATIONAL INCOMING FELLOWSHIPS (IIF) (FUNDING SCHEME);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME)","2;2;1;1;1;1;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES","2;1;1;1;1;1;1;1","CLINICAL RESEARCH;AGING;ASSISTIVE TECHNOLOGY;BIOENGINEERING;BIOMEDICAL IMAGING;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);OSTEOPOROSIS;PREVENTION;REHABILITATION","2;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE;INJURIES AND ACCIDENTS","2;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.3 MEDICAL DEVICES","1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS","2;1",NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1","BIOENGINEERING;BIOTECHNOLOGY;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1;1;1;1","MUSCULOSKELETAL","1","5.2 CELLULAR AND GENE THERAPIES","1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"IRCCS_RIZZOLI",2009,234,7.53418803418803,3.8034188034188,0.534188034188034,0.572649572649573,0.551282051282051,2.54,1.50602409638554,2.12698412698413,1.57317073170732,0.243589743589744,2,97,76,31,14,0.41,0.32,0.13,0.06,47.33,1.02317124884171,NA,0.320512820512821,0.760683760683761,0.501,0.456,0.48,0.45,"MARCO ALBERGHINI;MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;D. VANEL;ELIZAVETA KON;ERIC L. STAALS;MILENA FINI;SAVERIO AFFATATO;STEFANO BORIANI;ARMANDO GIUNTI;M. SPINELLI;MASSIMO SERRA;ALDO TONI","22;22;21;18;15;14;13;12;12;11;11;10;10;10;10;10;9;9;8;8","MARCO VICECONTI;MARCO ALBERGHINI;ALBERTO LEARDINI;MAURILIO MARCACCI;SANDRO GIANNINI;STEFANO BORIANI;PIERO PICCI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;M. SPINELLI;NICOLA BALDINI;STEFANO ZAFFAGNINI;D. VANEL;ALDO TONI;MASSIMILIANO BALEANI;GIUSEPPE FILARDO;LUCIANO MERLINI;SUSANNA STEA;ERIC L. STAALS;ARMANDO GIUNTI","5.01;2.91;2.57;2.47;2.44;2.34;2.2;2.18;2;1.98;1.79;1.71;1.69;1.57;1.52;1.51;1.45;1.44;1.4;1.33","MARCO ALBERGHINI;MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;D. VANEL;ELIZAVETA KON;ERIC L. STAALS;MILENA FINI;SAVERIO AFFATATO;STEFANO BORIANI;ARMANDO GIUNTI;M. SPINELLI;MASSIMO SERRA;ALDO TONI","22;22;21;18;15;14;13;12;12;11;11;10;10;10;10;10;9;9;8;8","MARCO VICECONTI;MARCO ALBERGHINI;ALBERTO LEARDINI;MAURILIO MARCACCI;SANDRO GIANNINI;STEFANO BORIANI;PIERO PICCI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;M. SPINELLI;NICOLA BALDINI;STEFANO ZAFFAGNINI;D. VANEL;ALDO TONI;MASSIMILIANO BALEANI;GIUSEPPE FILARDO;LUCIANO MERLINI;SUSANNA STEA;ERIC L. STAALS;ARMANDO GIUNTI","5.01;2.91;2.57;2.47;2.44;2.34;2.2;2.18;2;1.98;1.79;1.71;1.69;1.57;1.52;1.51;1.45;1.44;1.4;1.33","MAURILIO MARCACCI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MARCO ALBERGHINI;PIER MARIA FORNASARI;MARCO DELCOGLIANO;ROBERTO BUDA;ALESSANDRO DI MARTINO;ANNARITA CENACCHI;ALESSANDRO RUSSO;MILENA FINI;BRUNELLA GRIGOLO;STEFANO ZAFFAGNINI;ROBERTO GIARDINO;STEFANO FERRARI;MARIO MERCURI;ANTONIO TIMONCINI;ALBERTO LEARDINI","2816;1939;1906;1460;1301;1299;1199;1035;962;863;860;766;695;641;633;577;555;552;548;546","MAURILIO MARCACCI;GIUSEPPE FILARDO;ELIZAVETA KON;SANDRO GIANNINI;PIER MARIA FORNASARI;MARCO ALBERGHINI;PIERO PICCI;ROBERTO BUDA;MARCO DELCOGLIANO;ALESSANDRO DI MARTINO;ANNARITA CENACCHI;ALESSANDRO RUSSO;MILENA FINI;BRUNELLA GRIGOLO;STEFANO ZAFFAGNINI;ROBERTO GIARDINO;MARIO MERCURI;ANTONIO TIMONCINI;ALBERTO LEARDINI;ERIC L. STAALS","2816;1939;1906;1291;1199;998;994;962;870;863;860;766;695;641;633;577;552;548;546;516","MARCO VICECONTI;MARCO ALBERGHINI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;GIUSEPPE FILARDO;STEFANO FERRARI;STEFANO ZAFFAGNINI;D. VANEL;MARIA GRAZIA BENEDETTI;SAVERIO AFFATATO;ELIZAVETA KON;MILENA FINI;ERIC L. STAALS;MASSIMO SERRA;STEFANO BORIANI;ALDO TONI;ROBERTO GIARDINO","22;20;18;18;14;13;12;12;12;11;11;11;10;10;10;10;8;8;8;8","MEDICINE;BIOLOGY;MATERIALS SCIENCE;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;ECONOMICS;GEOLOGY;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY","192;86;40;35;32;30;26;18;4;3;3;3;2;2;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;GENETICS;CANCER RESEARCH;BIOCHEMISTRY;CELL BIOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;RADIOLOGY;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ORTHODONTICS;IMMUNOLOGY;QUANTUM MECHANICS;ENVIRONMENTAL HEALTH;PHYSICAL THERAPY;CLASSICAL MECHANICS;ORGANIC CHEMISTRY;STATISTICS;STRUCTURAL ENGINEERING","103;81;67;56;41;39;36;36;28;27;23;18;18;17;15;14;13;12;10;10;10;10","GENE;ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;PROSTHESIS;CANCER;SARCOMA;CARTILAGE;CHEMOTHERAPY;OSTEOSARCOMA;ARTHROPLASTY;IN VITRO;POPULATION;BONE MARROW;IMPLANT;APOPTOSIS;GAIT;KINEMATICS;KNEE JOINT;REGENERATION (BIOLOGY);TRANSPLANTATION","39;30;21;21;20;19;18;18;16;15;14;14;13;13;12;10;10;10;10;10","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);GENE EXPRESSION;GAIT ANALYSIS;OSTEOBLAST;CYCLOPHOSPHAMIDE;EWING'S SARCOMA;METASTASIS;CHONDROCYTE;MYOGENESIS;PLATELET-RICH PLASMA;BONE MINERAL;CELL CYCLE;CELLULAR DIFFERENTIATION;FIBULA;LUMBAR VERTEBRAE;NEUROBLASTOMA;PERIPROSTHETIC;PROGRAMMED CELL DEATH;RELIABILITY (SEMICONDUCTOR);RHABDOMYOSARCOMA;STAPHYLOCOCCUS AUREUS","26;9;9;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;C2C12;COMPARATIVE GENOMIC HYBRIDIZATION;SYNOVIAL FLUID;IFOSFAMIDE;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;DNA METHYLATION;EZRIN;GENE EXPRESSION PROFILING;HIGH TIBIAL OSTEOTOMY;INSULIN-LIKE GROWTH FACTOR;MISSENSE MUTATION;MMP2;MYOGENIN;NUCLEAR PROTEIN;OSTEOPROTEGERIN;PDGFRA;RETINOID;UNICOMPARTMENTAL KNEE ARTHROPLASTY;ACHILLES TENDON RUPTURE;ADAMANTINOMA;ALVEOLAR RHABDOMYOSARCOMA;AMPLICON;ANEUPLOIDY;AURORA INHIBITOR;AURORA KINASE;BACTERIAL ADHESIN;BONE DENSITY CONSERVATION AGENTS;BONE MORPHOGENETIC PROTEIN 7;BUSULFAN;CAPROLACTONE;CD99;CELL CYCLE CHECKPOINT;CHEMOKINE RECEPTOR;CHROMOSOME INSTABILITY;COMPOUND HETEROZYGOSITY;CONSENSUS SEQUENCE;COPY-NUMBER VARIATION;CYANOACRYLATE;CYCLIN D1;CYP1A2;CYP2C9;CYP2E1;CYP3A4;CYTOGENETICS;DIACYLGLYCEROL KINASE;DIIMIDE;DNA FRAGMENTATION;DNA MICROARRAY;DNA VACCINATION;DOUBLE BLIND;DUAL ENERGY;ENDOGLIN;ENTEROCOCCUS FAECALIS;FLI1;FLUORESCENCE IN SITU HYBRIDIZATION;GANGLIONEUROMA;GENOME INSTABILITY;GENOTYPING;HSP70;IN SITU HYBRIDIZATION;IN UTERO;INSULIN RECEPTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INSULIN-LIKE GROWTH FACTOR 2;INTERFACE (MATTER);LACHMAN TEST;LMNA;LOCALIZED DISEASE;MCL1;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MITOCHONDRIAL FUSION;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MYOD;ONCOGENE;OSTEOCALCIN;OXFORD KNEE SCORE;PANEL REACTIVE ANTIBODY;PERIAQUEDUCTAL GRAY;PIVOT-SHIFT TEST;QUALITY MANAGEMENT SYSTEM;RANKL;RESPIRATORY RATE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBOTYPING;RNA INTERFERENCE;SELECTED REACTION MONITORING;SINGLE-NUCLEOTIDE POLYMORPHISM;SPINDLE APPARATUS;STAPHYLOCOCCUS EPIDERMIDIS;SYSTEMIC THERAPY;TAMOXIFEN;TENDINOSIS;TERIPARATIDE;THORACIC VERTEBRAE;TRANSCRIPTIONAL REGULATION;TRANSCRIPTOME;TROLOX;VANCOMYCIN;VARUS DEFORMITY;VIROTHERAPY","14;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;;ADULT;AGED;ADOLESCENT;OSTEOSARCOMA;ANIMALS;SARCOMA, EWING;TIBIA;YOUNG ADULT;KNEE JOINT;TREATMENT OUTCOME;OSTEOBLASTS;FEMUR;RNA, MESSENGER;OSTEOARTHRITIS, KNEE","148;82;81;65;65;61;56;48;36;33;32;28;27;27;26;26;24;23;23;22","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TISSUE ENGINEERING AND BIOMATERIALS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;NEUROBLASTOMA RESEARCH AND TREATMENT;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;MANAGEMENT OF SPINAL METASTATIC TUMORS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES","25;25;12;11;10;7;7;7;6;5;4;4;4;4;3;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;OSTEOSARCOMA;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;AUTOLOGOUS CHONDROCYTE IMPLANTATION;BIOMECHANICS;HIP JOINT MECHANICS;METASTATIC SPINE TUMORS;PLATELET-RICH PLASMA;PROXIMAL HUMERUS FRACTURES;REPEATABILITY;SKELETAL MUSCLE ATROPHY;BONE REGENERATION;C2C12;CHONDROSARCOMA;COMPARATIVE GENOMIC HYBRIDIZATION;HYALINE CARTILAGE","20;20;18;15;11;11;7;6;6;5;5;5;5;5;5;4;4;4;4;4","BONE MARROW;GAIT ANALYSIS;MARROW STROMAL;OSTEOCHONDRAL LESIONS;TISSUE ENGINEERING;TOTAL HIP;CHONDROCYTE IMPLANTATION;EWINGS SARCOMA;HIP ARTHROPLASTY;IIN VITROI;KNEE ARTHROPLASTY;MESENCHYMAL STEM;PLATELET-RICH PLASMA;SARCOMA FAMILY;STEM CELLS;STROMAL CELLS;SYNOVIAL FLUID;TOTAL KNEE;AUTOLOGOUS CHONDROCYTE;CELL TRANSPLANTATION;EWING SARCOMA;FAMILY TUMORS;FINITE ELEMENT;HIGH-GRADE OSTEOSARCOMA;HIP JOINT;HUMAN BONE;KIDSCANCERKINOME VALIDATION;KNEE PROSTHESIS;MINIMALLY INVASIVE;MUSCLE APOPTOSIS","5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;EN BLOC;LOCAL RECURRENCE;MONTH WOMAC;PATIENTS TREATED;KING IV;LOWER LIMB;BLOC RESECTION;FEMORAL HEAD;FUNCTIONAL ABILITY;GENE EXPRESSION;LEVEL TDR;LOCAL TREATMENT;LOCALIZED DISEASE;WOMAC FUNCTIONAL;WOMAC STIFFNESS;BONE MARROW;CLINICAL OUTCOME;ENDOTHELIAL CELLS;GAIT ANALYSIS;KNEE ARTHROPLASTY;LUMBAR CURVE;MINIMALLY INVASIVE;PRP INJECTIONS;SKELETAL MUSCLE;STATISTICAL ANALYSIS;ABILITY MONTH;BASAL WOMAC;BONE MARROW-DERIVED;CARTILAGE REPAIR","12;10;9;8;8;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,2,1,8,0,0,0,0,0,0,0,0,11,0,0,3.33333333333333,3.45454545454545,4.27,4.54545454545455,0,10,4,1,1,1,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,3,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FINI MILENA;GIARDINO ROBERTO;BIGI ADRIANA;PANZAVOLTA SILVIA;BONDIOLI ELENA;BUDA ROBERTO;GIANNINI SANDRO;GRIGOLO BRUNELLA;MELANDRI DAVIDE;BAIGORRIA CARLOS ALBERTO","6;6;4;4;2;2;2;2;2;1","ISTITUTO ORTOPEDICO RIZZOLI;FINI MILENA;GIARDINO ROBERTO;A U S L AZIENDA UNITA SANITARI;BIGI ADRIANA;BONDIOLI ELENA;MELANDRI DAVIDE;PANZAVOLTA SILVIA;UNIV BOLOGNA ALMA MATER;ALMA MATER STUDIORUM-UNIVERSITA' DI BOLOGNA","11;4;4;2;2;2;2;2;2;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","18;9;4;1;1","CLINICAL RESEARCH;STEM CELL RESEARCH;CANCER;GENETICS;HEMATOLOGY;RARE DISEASES","2;2;1;1;1;1",NA,NA,"A61L27/46;A61L27/56;A61L27/20;A61L27/22;A61F2/10;A61K35/28;A61K35/32;A61L27/42;A61N5/10;A61B17/80","4;4;3;3;2;2;2;2;2;1","A61L27/46;A61L27/56;A61P19/00;A61K35/28;A61K41/0023;A61K41/10;A61K41/17;A61L2/0011;A61L2/0035;A61L27/3804","4;4;4;2;2;2;2;2;2;2",4,9,446.75,1.23,1,0.25,76,0,0,1,0,2,0,1,0,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","4;4;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ARTHRITIS;CANCER;PEDIATRIC;RARE DISEASES;STEM CELL RESEARCH;BIOTECHNOLOGY;CHRONIC PAIN;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC RESEARCH INITIATIVE;PREVENTION","4;3;2;2;2;2;2;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL","2;1;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","4;2","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LUNG CANCER;SARCOMA","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2010,217,7.57142857142857,3.5668202764977,0.56221198156682,0.599078341013825,0.585253456221198,2.41875,1.40229885057471,2.40740740740741,1.3804347826087,0.368663594470046,1,92,59,18,19,0.42,0.27,0.08,0.09,46,1.0178089734422,NA,0.36405529953917,0.788018433179724,0.444,0.43,0.464,0.425,"MARCO VICECONTI;MAURILIO MARCACCI;MARCO ALBERGHINI;SANDRO GIANNINI;PIERO PICCI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;STEFANO BORIANI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;D. VANEL;PIER‚ÄêLUIGI LOLLINI;DOMENICO TIGANI;GIORDANO NICOLETTI;EUGENIO RIMONDI;COSTANTINO ERRANI;MICHELA BATTISTELLI","19;16;14;14;14;12;12;12;10;9;9;8;8;7;7;7;7;7;7;7","MARCO VICECONTI;STEFANO BORIANI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ALBERTO LEARDINI;MASSIMILIANO BALEANI;MARCO ALBERGHINI;PIERO PICCI;PIETRO RUGGIERI;ELIZAVETA KON;DOMENICO TIGANI;MARIA GRAZIA BENEDETTI;STEFANO ZAFFAGNINI;PETER K√ñHL;LUCA CRISTOFOLINI;ALESSANDRO GASBARRINI;EUGENIO RIMONDI","4.62;2.59;2.41;2.2;2.01;1.85;1.75;1.71;1.65;1.63;1.57;1.52;1.45;1.35;1.3;1.07;1.05;1.03;1.03;1.01","MARCO VICECONTI;MAURILIO MARCACCI;MARCO ALBERGHINI;SANDRO GIANNINI;PIERO PICCI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;STEFANO BORIANI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;D. VANEL;PIER‚ÄêLUIGI LOLLINI;DOMENICO TIGANI;GIORDANO NICOLETTI;EUGENIO RIMONDI;COSTANTINO ERRANI;MICHELA BATTISTELLI","19;16;14;14;14;12;12;12;10;9;9;8;8;7;7;7;7;7;7;7","MARCO VICECONTI;STEFANO BORIANI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ALBERTO LEARDINI;MASSIMILIANO BALEANI;MARCO ALBERGHINI;PIERO PICCI;PIETRO RUGGIERI;ELIZAVETA KON;DOMENICO TIGANI;MARIA GRAZIA BENEDETTI;STEFANO ZAFFAGNINI;LUCA CRISTOFOLINI;ALESSANDRO GASBARRINI;EUGENIO RIMONDI;COSTANTINO ERRANI","4.62;2.59;2.41;2.2;2.01;1.85;1.75;1.71;1.65;1.63;1.57;1.52;1.45;1.35;1.3;1.07;1.03;1.03;1.01;0.97","GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;MAURILIO MARCACCI;ROBERTO BUDA;ANNARITA CENACCHI;MARIO MERCURI;PIERO PICCI;LUCIANO MERLINI;MARCO ALBERGHINI;ELISABETTA FALCIERI;MICHELA BATTISTELLI;PATRIZIA SABATELLI;ANNA URCIUOLO;PAOLO BONALDO;PAOLO GRUMATI;NADIR M. MARALDI;MARCO VICECONTI;ALESSANDRO DI MARTINO;FRANCESCA VANNINI","1225;1222;1219;1198;979;794;793;774;703;633;597;597;594;578;578;578;544;517;502;499","GIUSEPPE FILARDO;ELIZAVETA KON;MAURILIO MARCACCI;SANDRO GIANNINI;ROBERTO BUDA;ANNARITA CENACCHI;PIERO PICCI;MARIO MERCURI;MARCO ALBERGHINI;PATRIZIA SABATELLI;NADIR M. MARALDI;MARCO VICECONTI;ALESSANDRO DI MARTINO;COSTANTINO ERRANI;DAVIDE CAMPOCCIA;PIETRO RUGGIERI;FRANCESCA VANNINI;MARCO CAVALLO;CARLA RENATA ARCIOLA;ANTONIO TIMONCINI","1225;1219;1198;1147;874;794;774;667;633;594;544;517;502;487;473;445;443;443;440;431","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MARCO ALBERGHINI;NICOLA BALDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;PIETRO RUGGIERI;STEFANO BORIANI;ALBERTO LEARDINI;D. VANEL;STEFANO ZAFFAGNINI;EUGENIO RIMONDI;GIORDANO NICOLETTI;COSTANTINO ERRANI;MARIA GRAZIA BENEDETTI;ANDREA ANGELINI;MILENA FINI","19;16;14;14;12;12;12;11;10;9;9;8;8;8;7;7;7;7;6;6","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATERIALS SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;PSYCHOLOGY;ART;ECONOMICS;POLITICAL SCIENCE;GEOLOGY;BUSINESS;HISTORY","169;84;36;31;28;27;20;19;9;6;3;3;3;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;CELL BIOLOGY;BIOCHEMISTRY;GENETICS;ANATOMY;CANCER RESEARCH;RADIOLOGY;IMMUNOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;PHYSICAL THERAPY;ONCOLOGY;ORTHODONTICS;QUANTUM MECHANICS;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;ENDOCRINOLOGY","92;65;54;45;38;37;34;30;24;20;18;18;18;14;14;13;12;11;10;9","GENE;ALTERNATIVE MEDICINE;CANCER;ORTHOPEDIC SURGERY;IN VITRO;RADIOGRAPHY;SIGNAL TRANSDUCTION;ARTHROPLASTY;CARTILAGE;OSTEOSARCOMA;POPULATION;RECEPTOR;APOPTOSIS;CHEMOTHERAPY;FEMUR;SARCOMA;IMMUNOHISTOCHEMISTRY;MYOCYTE;OSTEOPOROSIS;DISEASE;IMPLANT;REGENERATION (BIOLOGY);SOFT TISSUE;SPORTS MEDICINE","33;23;19;19;16;16;15;13;11;11;11;11;10;10;10;10;9;9;9;8;8;8;8;8","OSTEOARTHRITIS;TRANSCRIPTION FACTOR;METASTASIS;GENE EXPRESSION;ARTHRODESIS;FIXATION (POPULATION GENETICS);MYOGENESIS;OSTEOCLAST;PLATELET-RICH PLASMA;PROGRAMMED CELL DEATH;CARCINOGENESIS;CHONDROCYTE;BONE CEMENT;BONE MINERAL;CELLULAR DIFFERENTIATION;EWING'S SARCOMA;GAIT ANALYSIS;WNT SIGNALING PATHWAY;ACID PHOSPHATASE;ACTIVATOR (GENETICS);BREAST CANCER;CD34;CELL CYCLE;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DOXORUBICIN;EXTERNAL FIXATION;FEMORAL NECK;GENE KNOCKDOWN;KNEE REPLACEMENT;MICRORNA;OSTEOBLAST;PERIPROSTHETIC;PI3K/AKT/MTOR PATHWAY;PROTEIN KINASE A;PROTEIN KINASE C;PROTOCOL (SCIENCE);STAPHYLOCOCCUS AUREUS;TENDINOPATHY;TUMOR PROGRESSION;VALGUS DEFORMITY","11;10;8;7;6;6;6;6;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;C2C12;CD99;NUCLEAR PROTEIN;DNA-BINDING PROTEIN;IFOSFAMIDE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PROMOTER;VINCRISTINE;BETA-CATENIN;BONE METASTASIS;DKK1;GENE EXPRESSION PROFILING;IMATINIB MESYLATE;INSULIN RECEPTOR;INTERFACE (MATTER);MITOGEN-ACTIVATED PROTEIN KINASE KINASE;RANKL;TARTRATE-RESISTANT ACID PHOSPHATASE;ABDOMINAL OBESITY;ADJUVANT CHEMOTHERAPY;ADULT STEM CELL;ANNEXIN A2;BACTERIAL ADHESIN;BONE DENSITY CONSERVATION AGENTS;CANCER VACCINE;CANDIDA KRUSEI;CASPASE;CATENIN;CAVEOLIN 3;CD28;CD40;CENTROSOME;CHROMOSOME INSTABILITY;CLINKER (CEMENT);CYCLIN-DEPENDENT KINASE 2;CYTOGENETICS;DBM;DEBULKING;DEFENSIVE MEDICINE;DIACYLGLYCEROL KINASE;DNA FRAGMENTATION;DNA-BINDING DOMAIN;DYSKINESIA;ENTHESITIS;FEBRILE NEUTROPENIA;FLUORESCENCE IN SITU HYBRIDIZATION;FRIZZLED;GENE PRODUCT;GERIATRIC DEPRESSION SCALE;GIANT CELL ARTERITIS;HLA-B27;HSP70;IMPLANT STABILITY QUOTIENT;IRREVERSIBLE ELECTROPORATION;JURKAT CELLS;LACHMAN TEST;LOCALIZED DISEASE;LRP5;LRP6;MAGNETITE NANOPARTICLES;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MICROSATELLITE;MICROVESICLES;MMP2;MTORC1;NATIONAL CHOLESTEROL EDUCATION PROGRAM;NECROPTOSIS;NEOPLASTIC TRANSFORMATION;NFKB1;NILOTINIB;NUCLEAR EXPORT SIGNAL;NUCLEAR TRANSPORT;ONCOGENE;OSTEONECROSIS OF THE JAW;OSWESTRY DISABILITY INDEX;PHOSPHOINOSITIDE 3-KINASE;PIVOT-SHIFT TEST;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POLYMORPHISM (COMPUTER SCIENCE);PRIMARY TUMOR;PTEN;QUANTITATIVE COMPUTED TOMOGRAPHY;REPORTER GENE;RESONANCE FREQUENCY ANALYSIS;RIBOTYPING;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL HAIRPIN RNA;SOLITARY FIBROUS TUMOR;SOX9;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;STAUROSPORINE;THORACIC VERTEBRAE;TRANSACTIVATION;TRIPLE ARTHRODESIS;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VASCULAR DEMENTIA;WNT3A;ZINC FINGER","7;6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;ADULT;MIDDLE AGED;;AGED;TREATMENT OUTCOME;ANIMALS;ADOLESCENT;OSTEOSARCOMA;YOUNG ADULT;CELL DIFFERENTIATION;CHILD;CHONDROCYTES;KNEE JOINT;MICE;AGED, 80 AND OVER;RANGE OF MOTION, ARTICULAR","147;89;84;84;61;53;50;47;38;33;31;29;27;24;24;21;21;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOARTHRITIS AND CARTILAGE REPAIR;BIOMECHANICS OF RUNNING-RELATED INJURIES;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;EPIDEMIOLOGY AND TREATMENT OF CLAVICLE AND ACROMIOCLAVICULAR INJURIES;OSTEOPOROSIS;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH","14;14;12;11;9;7;7;6;6;5;5;5;3;3;3;3;3;2;2;2","TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;EWING'S SARCOMA;SPORTS MEDICINE;C2C12;PLATELET-RICH PLASMA;BONE TISSUE;METASTATIC SPINE TUMORS;SPINAL FUSION;ANEURYSMAL BONE CYST;BIOMECHANICS;BONE CEMENT;BONE REMODELING;CD99;EXTRACELLULAR MATRIX;FOOT (PROSODY);FOOT STRIKE PATTERNS;GIANT CELL TUMOR;HIP ARTHROPLASTY","14;12;9;8;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","TOTAL KNEE;KNEE ARTHROPLASTY;STEM CELLS;GIANT CELL;EWINGS SARCOMA;SURGICAL TREATMENT;AUTOLOGOUS CHONDROCYTE;BONE TISSUE;BONE TUMORS;COLLAGEN VI;KNEE REPLACEMENT;MESENCHYMAL STEM;OSTEOCHONDRAL LESIONS;PHYSIOLOGICAL HUMAN;PLATELET-RICH PLASMA;STROMAL CELLS;TOTAL HIP;VIRTUAL PHYSIOLOGICAL;ADULT PATIENTS;ADULT SUBJECTS;ANIMAL PET;BIOMEDICAL DATA;BONE CYST;BONE GRAFTING;BONE MARROW;BONE MINERAL;BONE PLATE;BONE REGENERATION;BONE STEM;BONE-MARROW-DERIVED CELLS","7;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","GIANT CELL;GIANT CELL-RICH;CELL TUMOR;CELL-RICH OSTEOSARCOMA;PUBMED SCOPUS;GIANT CELLS;CROSSREF PUBMED;MINT MINT;OSTEOGENIC SARCOMA;RADIOL -CROSSREF;OSTEOCLAST-LIKE GIANT;CC CELLS;CELL-RICH OSTEOSARCOMAORTHOPEDICS;CONVENTIONAL OSTEOSARCOMA;EL GIANT;MONTHS RANGE;OSTEOSARCOMAORTHOPEDICS -PUBMED;PAROSTAL OSTEOSARCOMA;PUBMED GOOGLE;STAALS EL;PROTEIN KINASE;STROMAL CELLS;CELL CYCLE;DAHLIN DC;DEDIFFERENTIATED PAROSTAL;DIFFERENTIAL DIAGNOSIS;GIANT-CELL TUMOR;HIGH-GRADE OSTEOCLAST-RICH;MALIGNANT COMPONENT;OSTEOCLAST-RICH OSTEOGENIC","75;60;55;44;44;39;34;28;22;18;16;13;12;12;12;12;12;12;12;12;11;11;9;9;9;9;9;9;9;9",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,3,5,5,1,0,1,0,0,0,0,0,12,2,1,2.75,3.53333333333333,6.85,1.93333333333333,0,10,8,0,0,4,2,2,3,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,7,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FINI MILENA;GIARDINO ROBERTO;BIGI ADRIANA;PANZAVOLTA SILVIA;ADRIANA BIGI;BONDIOLI ELENA;CATANI FABIO;LEARDINI ALBERTO;MELANDRI DAVIDE;MILENA FINI","6;6;4;4;2;2;2;2;2;2","ISTITUTO ORTOPEDICO RIZZOLI;UNIVERSITA DI BOLOGNA;UNIV BOLOGNA ALMA MATER;A U S L AZIENDA UNITA' SANITARIA LOCALE DI CESENA;ALMA MATER STUDIORUM UNIVERSITA‚Ñ¢ DI BOLOGNA;AUSL - AZIENDA UNITA SANITARIA LOCALE DI CESENA;CATANI FABIO;INSTITUTI ORTOPEDICI RIZZOLI;LEARDINI ALBERTO;PARENTI CASTELLI VINCENZO","14;4;3;1;1;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","26;13;2;1","CLINICAL RESEARCH;BIOENGINEERING;OSTEOPOROSIS;STEM CELL RESEARCH","2;1;1;1",NA,NA,"A61K35/12;A61L27/42;A61L27/46;A61L27/56;A61F2/34;A61B17/80;A61K31/715;A61K33/42;A61K38/18;A61L","4;4;4;4;3;2;2;2;2;2","A61L27/46;A61L27/56;A61P19/00;A61B17/8033;A61B17/8042;A61B17/8047;A61B17/86;A61F2/30749;A61F2/34;A61F2002/30378","7;7;6;3;3;3;3;3;3;3",10,4.83,1090,3.39,1,0.1,17.7,0,0,6,0,1,0,1,2,0,5,1,0,0,0,0,0,0,10,0,0,5,4,0,1,0,0,0,0,0,0,"Italy;Germany","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3209 NEUROSCIENCES","10;8;3;3;3;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PEDIATRIC;PEDIATRIC RESEARCH INITIATIVE;CHRONIC PAIN;NEUROSCIENCES;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC CANCER;RARE DISEASES;AGING;ARTHRITIS;HEMATOLOGY;MENTAL HEALTH;ORPHAN DRUG;OSTEOPOROSIS;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS","6;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER","4;3","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY","6;2;1","LEUKEMIA / LEUKAEMIA;SARCOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","2;1",6,4979661.67,436741.73,4.16666666666667,9.33333333333333,5,1,20.6,1066084.15892971,0.203548658126443,"ISTITUTO ORTOPEDICO RIZZOLI;CINECA;UNIVERSITY OF BEDFORDSHIRE;√âTABLISSEMENT FRAN√áAIS DU SANG;ALCIMED;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;AUTONOMOUS UNIVERSITY OF MADRID;CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES;CENTRE HOSPITALIER UNIVERSITAIRE DE TOURS;CHARIT√â - UNIVERSITY MEDICINE BERLIN;DELFT UNIVERSITY OF TECHNOLOGY;D√âL√âGATION PARIS 11;EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;ESI (FRANCE);EURAM (UNITED KINGDOM);FINCERAMICA (ITALY);FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH","6;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","6","COALITION S;EC & ERC - EUROPEAN UNION","6;6","FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);CP-IP - LARGE-SCALE INTEGRATING PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2009-SINGLE-STAGE (CALL FOR PROPOSAL);FP7-ICT-2009-4 (CALL FOR PROPOSAL);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);CSA - COORDINATION AND SUPPORT ACTION (FUNDING SCHEME);FP7-ICT-2009-5 (CALL FOR PROPOSAL);FP7-NMP - SPECIFIC PROGRAMME ""COOPERATION"": NANOSCIENCES, NANOTECHNOLOGIES, MATERIALS AND NEW PRODUCTION TECHNOLOGIES (PROGRAMME);FP7-NMP-2009-SMALL-3 (CALL FOR PROPOSAL)","3;2;2;2;2;2;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3203 DENTISTRY;3206 MEDICAL BIOTECHNOLOGY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING","3;3;2;2;1;1;1;1;1;1","ARTHRITIS;AGING;BIOENGINEERING;REGENERATIVE MEDICINE;BIOTECHNOLOGY;OSTEOARTHRITIS;STEM CELL RESEARCH;CLINICAL RESEARCH;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;TRANSPLANTATION","4;3;3;3;2;2;2;1;1;1;1;1;1","MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE","5;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES","2;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS;B12 ENGINEERING","2;2;2",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_RIZZOLI",2011,318,7.67610062893082,3.77358490566038,0.556603773584906,0.569182389937107,0.60062893081761,2.87769784172662,1.65420560747664,2.70149253731343,1.67543859649123,0.279874213836478,5,133,89,37,37,0.42,0.28,0.12,0.12,48.31,1.13567276844585,NA,0.361635220125786,0.811320754716981,0.528,0.501,0.519,0.486,"MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;MARCO ALBERGHINI;MASSIMO SERRA;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;EUGENIO RIMONDI;MARIA GRAZIA BENEDETTI;PANCRAS C.W. HOGENDOORN;FRANCESCO TRAINA","30;27;24;23;23;20;19;18;18;17;17;15;14;13;12;11;11;11;10;10","MARCO VICECONTI;MAURILIO MARCACCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ANDREAS F. MAVROGENIS;SANDRO GIANNINI;MILENA FINI;ELIZAVETA KON;ALBERTO LEARDINI;PIERO PICCI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;FRANCESCO TRAINA;ALDO TONI;D. VANEL;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;EUGENIO RIMONDI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARIO MERCURI","8.54;4.27;4.11;3.77;3.73;3.44;3.34;2.95;2.77;2.54;2.51;1.98;1.97;1.84;1.81;1.81;1.75;1.65;1.62;1.59","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;MARCO ALBERGHINI;MASSIMO SERRA;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;EUGENIO RIMONDI;MARIA GRAZIA BENEDETTI;PANCRAS C.W. HOGENDOORN;FRANCESCO TRAINA","30;27;24;23;23;20;19;18;18;17;17;15;14;13;12;11;11;11;10;10","MARCO VICECONTI;MAURILIO MARCACCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ANDREAS F. MAVROGENIS;SANDRO GIANNINI;MILENA FINI;ELIZAVETA KON;ALBERTO LEARDINI;PIERO PICCI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;FRANCESCO TRAINA;ALDO TONI;D. VANEL;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;EUGENIO RIMONDI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARIO MERCURI","8.54;4.27;4.11;3.77;3.73;3.44;3.34;2.95;2.77;2.54;2.51;1.98;1.97;1.84;1.81;1.81;1.75;1.65;1.62;1.59","GIUSEPPE FILARDO;MAURILIO MARCACCI;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MASSIMO SERRA;ANNE‚ÄêMARIE CLETON‚ÄêJANSEN;PANCRAS C.W. HOGENDOORN;MILENA FINI;PIER MARIA FORNASARI;ALESSANDRO DI MARTINO;MARIEKE L. KUIJJER;STEFANO ZAFFAGNINI;LUCA SANGIORGI;K√ÅROLY SZUHAI;MARCO ALBERGHINI;KATIA SCOTLANDI;MARCO VICECONTI;JUDITH V.M.G. BOV√âE;MARCO DELCOGLIANO","2492;2270;2130;1229;1218;1199;1128;1024;1018;984;959;947;924;876;832;785;777;757;736;732","GIUSEPPE FILARDO;MAURILIO MARCACCI;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MASSIMO SERRA;MILENA FINI;PIER MARIA FORNASARI;ALESSANDRO DI MARTINO;STEFANO ZAFFAGNINI;KATIA SCOTLANDI;MARCO VICECONTI;LUCA SANGIORGI;MARCO DELCOGLIANO;MARCO ALBERGHINI;STEFANO FERRARI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;ROBERTO BUDA;ANTONIO TIMONCINI;ELEONORA OLIVOTTO","2492;2270;2130;1229;1218;1199;1018;984;959;924;777;757;739;732;724;716;711;644;547;541","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;SANDRO GIANNINI;MILENA FINI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;PIETRO RUGGIERI;MASSIMO SERRA;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;MARIA GRAZIA BENEDETTI;FRANCESCO TRAINA;ALDO TONI;MARIA CRISTINA MANARA","30;27;24;23;23;20;18;17;17;15;14;13;13;11;11;11;11;10;9;9","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;ECONOMICS;GEOLOGY;ART;BUSINESS;SOCIOLOGY;GEOGRAPHY","269;116;63;45;35;35;29;18;13;6;5;4;4;2;2;2;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;CELL BIOLOGY;RADIOLOGY;GENETICS;CANCER RESEARCH;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;ENDOCRINOLOGY;ORTHODONTICS;IMMUNOLOGY;ORGANIC CHEMISTRY;DENTISTRY;ENVIRONMENTAL HEALTH;QUANTUM MECHANICS","152;117;95;54;54;49;47;43;36;26;26;25;24;22;21;20;20;19;16;14","ALTERNATIVE MEDICINE;GENE;SARCOMA;ORTHOPEDIC SURGERY;IN VITRO;OSTEOSARCOMA;RADIOGRAPHY;CARTILAGE;PROSTHESIS;OSTEOPOROSIS;CANCER;RECEPTOR;IMPLANT;CHEMOTHERAPY;ARTHROPLASTY;POPULATION;FEMUR;IMMUNOHISTOCHEMISTRY;MESENCHYMAL STEM CELL;STEM CELL","44;43;29;25;23;23;22;21;20;19;18;18;17;15;14;14;13;13;13;13","OSTEOARTHRITIS;METASTASIS;EWING'S SARCOMA;TRANSCRIPTION FACTOR;CELLULAR DIFFERENTIATION;GAIT ANALYSIS;PROGRAMMED CELL DEATH;STAPHYLOCOCCUS AUREUS;CHONDROCYTE;FEMORAL NECK;GENE EXPRESSION;MENISCUS;OSSEOINTEGRATION;OSTEOBLAST;OSTEOCLAST;PHENOTYPE;PLATELET-RICH PLASMA;ALKALINE PHOSPHATASE;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ARTERIAL EMBOLIZATION;CHROMOSOME;FIXATION (POPULATION GENETICS);GROWTH FACTOR;HARRIS HIP SCORE;TENDINOPATHY","32;9;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;MEDIAL MENISCUS;OSTEOCALCIN;RANKL;RUNX2;ADENOSINE RECEPTOR;CD99;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;CYTOGENETICS;CYTOLYSIS;DBM;ENTEROCOCCUS FAECALIS;EXTRACELLULAR POLYMERIC SUBSTANCE;FLI1;GENE EXPRESSION PROFILING;GLUTATHIONE S-TRANSFERASE;INSULIN-LIKE GROWTH FACTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INTRA ARTICULAR;KRAS;LOSS OF HETEROZYGOSITY;MITOCHONDRIAL MYOPATHY;NUCLEAR PROTEIN;OSTEOPROTEGERIN;PIVOT-SHIFT TEST;PRIMARY TUMOR;PROMOTER;PROPIDIUM IODIDE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SINGLE-NUCLEOTIDE POLYMORPHISM;STAPHYLOCOCCUS EPIDERMIDIS;SYNOVIAL FLUID;TRANSACTIVATION;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VINCRISTINE","12;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;ADULT;;AGED;TREATMENT OUTCOME;OSTEOSARCOMA;YOUNG ADULT;ADOLESCENT;CHILD;KNEE JOINT;RETROSPECTIVE STUDIES;CHONDROCYTES;SARCOMA, EWING;ANIMALS;OSTEOARTHRITIS;FOLLOW-UP STUDIES","214;134;130;124;99;95;82;74;54;53;46;43;39;37;34;33;33;32;31;30","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL RESTORATIVE MATERIALS;ENDODONTIC RESEARCH AND PRACTICE;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY","30;25;20;18;13;12;8;7;7;5;5;5;5;5;4;4;4;4;4;4","EWING'S SARCOMA;KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;OSTEOSARCOMA;HIP ARTHROPLASTY;BIOMECHANICS;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;SOFT TISSUE SARCOMA;AUTOLOGOUS CHONDROCYTE IMPLANTATION;HIP ARTHROSCOPY;HIP DYSPLASIA;MATRIX (CHEMICAL ANALYSIS);MENISCUS;MESENCHYMAL STEM CELLS;MUSCULOSKELETAL MODELING;ANEURYSMAL BONE CYST;ARTERIAL EMBOLIZATION;BONE METASTASES","19;19;19;14;12;10;9;9;9;9;7;6;5;5;5;5;5;4;4;4","EWINGS SARCOMA;MESENCHYMAL STEM;STEM CELLS;TOTAL HIP;HIP ARTHROPLASTY;AUTOLOGOUS CHONDROCYTE;BONE TUMORS;HIP PROSTHESIS;CELL LINES;CHONDROCYTE IMPLANTATION;COLLAGEN VI;GAIT ANALYSIS;GIANT CELL;KNEE ARTHROPLASTY;PHYSIOLOGICAL HUMAN;TOTAL KNEE;VIRTUAL PHYSIOLOGICAL;ARTHROSCOPIC AUTOLOGOUS;BONE MARROW;CARTILAGE REPAIR;CELL TUMOR;CLINICAL RESULTS;ELECTROMAGNETIC FIELDS;EWING SARCOMA;HIP JOINT;IIN VITROI;LONG-TERM RESULTS;METAL-ON-METAL HIP;MOBILE SPINE;OLLIER DISEASE","8;7;7;7;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;EWINGS SARCOMA;DYSPLASIA TYPE;HEARING LOSS;MANDIBULOACRAL DYSPLASIA;NK CELLS;CA RELEASE;Œë CHAIN;CARTILAGE REPAIR;HIGH-GRADE OSTEOSARCOMA;OLLIER DISEASE;GENE EXPRESSION;SARCOMA CELL;SURGICAL TREATMENT;ACRYLIC BONE;ARTICULAR CARTILAGE;BONE CEMENT;BONE MARROW;MAFFUCCI SYNDROME;MUSCULAR DYSTROPHY;OSTEOSARCOMA CELL;OSTEOSARCOMA CELLS;POSTOPERATIVE NEUROLOGIC;STEM CELLS;SYNOVIAL FLUID;TUMOR CELLS;CLINICAL OUTCOME;CO-CONTRACTION TIME;COLLAGEN VI;CONTROLLED STUDIES","29;16;13;13;13;13;12;12;11;9;9;8;8;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5",1,0,0.25,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,33,33,2,0,1,7,0,2,0,0,0,0,0,0,2,2,6,3,5.2,4.33,2.8,0,10,10,0,1,0,0,0,0,1,1,1,1,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,3,0,0,0,1,2,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"BIGI ADRIANA;FINI MILENA;GIARDINO ROBERTO;PANZAVOLTA SILVIA;ASCIONE ALESSANDRO;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FLEGO MICHELA;GELLINI MARA;MALLANO ALESSANDRA","7;7;7;7;3;3;3;3;3;3","ISTITUTO ORTOPEDICO RIZZOLI;UNIV BOLOGNA ALMA MATER;IST SUPERIORE SANITA;UNIVERSITA DI BOLOGNA;ASCIONE ALESSANDRO;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FLEGO MICHELA;GELLINI MARA;ISTITUTO SUPERIORE DI SANITA ISS","10;5;2;2;1;1;1;1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY","14;7;6;3","PEDIATRIC;RARE DISEASES;BIOENGINEERING","2;2;1",NA,NA,"A61L27/42;A61L27/46;A61L27/56;A61P35/00;C07K16/28;A61L27/00","5;5;5;2;2;1","A61L27/46;A61L27/56;A61P19/00;A61K2039/505;A61P35/00;C07K16/2896;C07K2317/21;C07K2317/34;C07K2317/622","7;7;7;3;3;3;3;3;3",10,6.3,144.4,2.56,2,0.2,10.6,0,0,3,0,1,0,1,5,0,7,3,0,0,0,0,0,0,10,0,0,10,0,0,0,0,0,0,0,0,0,"Italy;United States","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;3211 ONCOLOGY AND CARCINOGENESIS;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","10;8;4;4;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;REGENERATIVE MEDICINE;CHRONIC PAIN;PAIN RESEARCH;STEM CELL RESEARCH;ARTHRITIS;CANCER;PATIENT SAFETY;RARE DISEASES;BIOENGINEERING;NEUROSCIENCES;NUTRITION;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS;REHABILITATION;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","9;6;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER","5;2","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES;6.3 MEDICAL DEVICES;6.4 SURGERY;6.7 PHYSICAL","4;1;1;1;1;1;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","2;1",6,4182824.5,413378.09,4.66666666666667,9,4.83333333333333,0.833333333333333,36,1398152.871859,0.227442940182344,"ISTITUTO ORTOPEDICO RIZZOLI;EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;POMPEU FABRA UNIVERSITY;UNIVERSITY COLLEGE LONDON;UNIVERSITY OF SHEFFIELD;AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY;AG√àNCIA DE QUALITAT I AVALUACI√ì SANIT√ÄRIES DE CATALUNYA;ANDALUSIAN HEALTH SERVICE;ATOS (SPAIN);AUGUST PI I SUNYER BIOMEDICAL RESEARCH INSTITUTE;CINECA;CLAUDE BERNARD UNIVERSITY LYON 1;EINDHOVEN UNIVERSITY OF TECHNOLOGY;EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER;FINCERAMICA (ITALY);FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI;FRENCH INSTITUTE FOR RESEARCH IN COMPUTER SCIENCE AND AUTOMATION;HEIDELBERG UNIVERSITY;HOLOSTEM (ITALY);HOSPITAL CL√çNIC DE BARCELONA","6;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","5;1","COALITION S;EC & ERC - EUROPEAN UNION","5;5","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2011-TWO-STAGE (CALL FOR PROPOSAL);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);CSA - COORDINATION AND SUPPORT ACTION (FUNDING SCHEME);FP7-ICT-2009-6 (CALL FOR PROPOSAL);FP7-ICT-2011-7 (CALL FOR PROPOSAL);FP7-PEOPLE - SPECIFIC PROGRAMME ""PEOPLE"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);FP7-PEOPLE-IOF-2008 (CALL FOR PROPOSAL);MC-IOF - INTERNATIONAL OUTGOING FELLOWSHIPS (IOF) (FUNDING SCHEME);TELETHON GRANT PROJECTS - 2011 (PROGRAM)","2;2;2;2;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;40 ENGINEERING;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3208 MEDICAL PHYSIOLOGY;4003 BIOMEDICAL ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;4604 CYBERSECURITY AND PRIVACY","3;3;2;2;1;1;1;1;1;1;1","BIOENGINEERING;CLINICAL RESEARCH;RARE DISEASES;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;ORPHAN DRUG;REGENERATIVE MEDICINE;STEM CELL RESEARCH","2;2;2;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL;CANCER","3;2;1","5.2 CELLULAR AND GENE THERAPIES;1.3 CHEMICAL AND PHYSICAL SCIENCES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS;6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)","2;1;1;1;1","SARCOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1","B11 COMPUTER SCIENCE AND INFORMATICS;A01 CLINICAL MEDICINE;B12 ENGINEERING","3;2;1","3 GOOD HEALTH AND WELL BEING","1",2,"PUBLIC LIBRARY OF SCIENCE","2","31 BIOLOGICAL SCIENCES;3105 GENETICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES","4;2;1;1","CLINICAL RESEARCH;GENETICS;HUMAN GENOME;RARE DISEASES","1;1;1;1",NA,NA,"2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_RIZZOLI",2012,304,8.05263157894737,3.9078947368421,0.555921052631579,0.539473684210526,0.611842105263158,2.61098901098901,1.60952380952381,2.41176470588235,1.61739130434783,0.305921052631579,0,129,74,21,54,0.42,0.24,0.07,0.18,32.86,0.78668572180368,4.87507436049971,0.358552631578947,0.740131578947368,0.536,0.468,0.507,0.461,"MAURILIO MARCACCI;PIETRO RUGGIERI;SANDRO GIANNINI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;MILENA FINI;STEFANO ZAFFAGNINI;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;CLAUDIO BELVEDERE;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;EUGENIO RIMONDI;SILVIA PANSERI","35;23;22;21;20;18;16;16;15;15;13;12;11;11;10;10;9;9;9;9","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;PIERO PICCI;MILENA FINI;MARCO ALBERGHINI;MARIA GRAZIA BENEDETTI;CLAUDIO BELVEDERE;NICOLA BALDINI;ALDO TONI;SAVERIO AFFATATO;ANDREA ANGELINI;EUGENIO RIMONDI;FRANCESCO LOLLI;N. LOPOMO","5.23;4.11;3.32;3.18;3;2.72;2.52;2.29;2.02;2.02;2;1.96;1.8;1.69;1.68;1.65;1.61;1.52;1.5;1.45","MAURILIO MARCACCI;PIETRO RUGGIERI;SANDRO GIANNINI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;MILENA FINI;STEFANO ZAFFAGNINI;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;CLAUDIO BELVEDERE;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;EUGENIO RIMONDI;SILVIA PANSERI","35;23;22;21;20;18;16;16;15;15;13;12;11;11;10;10;9;9;9;9","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;PIERO PICCI;MILENA FINI;MARCO ALBERGHINI;MARIA GRAZIA BENEDETTI;CLAUDIO BELVEDERE;NICOLA BALDINI;ALDO TONI;SAVERIO AFFATATO;ANDREA ANGELINI;EUGENIO RIMONDI;FRANCESCO LOLLI;N. LOPOMO","5.23;4.11;3.32;3.18;3;2.72;2.52;2.29;2.02;2.02;2;1.96;1.8;1.69;1.68;1.65;1.61;1.52;1.5;1.45","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;NICOLA BALDINI;MILENA FINI;SILVIA PANSERI;STEFANO FERRARI;GIANLUCA GIAVARESI;S. RUBINA BAGLIO;STEFANO ZAFFAGNINI;D. MICHIEL PEGTEL;ALESSANDRO DI MARTINO;ALESSANDRO RUSSO;SANDRO GIANNINI;MARCO ALBERGHINI;BERARDO DI MATTEO;CARLA CUNHA;FRANCA FAGIOLI","1674;1163;888;843;825;783;730;678;591;589;540;509;499;483;478;472;458;444;434;398","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;MILENA FINI;NICOLA BALDINI;SILVIA PANSERI;STEFANO FERRARI;GIANLUCA GIAVARESI;S. RUBINA BAGLIO;STEFANO ZAFFAGNINI;ALESSANDRO DI MARTINO;MARCO ALBERGHINI;SANDRO GIANNINI;ALESSANDRO RUSSO;BERARDO DI MATTEO;CARLA CUNHA;PIER MARIA FORNASARI;MASSIMO SERRA","1674;1123;888;827;825;730;725;678;591;589;540;509;483;458;458;456;444;434;384;365","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;PIERO PICCI;SANDRO GIANNINI;GIUSEPPE FILARDO;MILENA FINI;ELIZAVETA KON;MARCO ALBERGHINI;STEFANO ZAFFAGNINI;STEFANO FERRARI;CLAUDIO BELVEDERE;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;SILVIA PANSERI;NICOLA BALDINI;EMANUELA PALMERINI","34;20;20;20;19;18;16;16;15;14;12;12;11;10;9;9;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;ART;ECONOMICS;HISTORY;BUSINESS;POLITICAL SCIENCE;SOCIOLOGY;GEOGRAPHY","255;109;59;46;46;41;28;12;8;6;5;3;3;3;2;2;2;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;CELL BIOLOGY;ANATOMY;BIOCHEMISTRY;RADIOLOGY;GENETICS;CANCER RESEARCH;BIOMEDICAL ENGINEERING;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;PHYSICAL MEDICINE AND REHABILITATION;IMMUNOLOGY;ARTIFICIAL INTELLIGENCE;OPTICS;ONCOLOGY;ORGANIC CHEMISTRY;CLASSICAL MECHANICS;ENDOCRINOLOGY","140;91;85;57;54;49;45;42;41;33;27;26;25;20;18;17;17;16;16;14;14","GENE;ALTERNATIVE MEDICINE;CANCER;IN VITRO;MESENCHYMAL STEM CELL;ORTHOPEDIC SURGERY;STEM CELL;CHEMOTHERAPY;OSTEOSARCOMA;REGENERATION (BIOLOGY);IMPLANT;RADIOGRAPHY;SOFT TISSUE;SCAFFOLD;TISSUE ENGINEERING;ARTHROPLASTY;CARTILAGE;KINEMATICS;SARCOMA;POPULATION","38;34;25;24;23;23;21;18;18;18;16;16;16;15;15;14;14;14;14;13","OSTEOARTHRITIS;BREAST CANCER;GAIT ANALYSIS;CHONDROCYTE;METASTASIS;OSTEOBLAST;CELL CYCLE;GENE EXPRESSION;GENOTYPE;CANCER CELL;CD34;CISPLATIN;FIXATION (POPULATION GENETICS);MICRORNA;PROTEIN KINASE B;ANKLE REPLACEMENT;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;CELLULAR DIFFERENTIATION;DYSTROPHIN;LOW BACK PAIN;MENISCUS;MUTATION;OSTEOCLAST;PLATELET-RICH PLASMA;PROGENITOR CELL;REGENERATIVE MEDICINE;SOFT TISSUE SARCOMA;TRANSFECTION","24;9;8;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;GENE EXPRESSION PROFILING;IFOSFAMIDE;COMPARATIVE GENOMIC HYBRIDIZATION;MEDIAL MENISCUS;MICROARRAY;SINGLE-NUCLEOTIDE POLYMORPHISM;ADULT STEM CELL;ALTERNATIVE SPLICING;CELL CYCLE CHECKPOINT;COPY-NUMBER VARIATION;CYANOACRYLATE;CYCLIN D1;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;METASTATIC BREAST CANCER;MICROARRAY ANALYSIS TECHNIQUES;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;OSWESTRY DISABILITY INDEX;OXFORD KNEE SCORE;PIVOT-SHIFT TEST;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBOSOME;SMALL INTERFERING RNA;SUPERPARAMAGNETISM;UNICOMPARTMENTAL KNEE ARTHROPLASTY","8;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;OSTEOSARCOMA;TREATMENT OUTCOME;ADOLESCENT;KNEE JOINT;MESENCHYMAL STEM CELLS;YOUNG ADULT;CHILD;OSTEOBLASTS;RETROSPECTIVE STUDIES;SARCOMA;ANIMALS;CELL PROLIFERATION","171;115;110;107;94;77;74;54;45;41;36;35;34;34;31;31;31;27;26;26","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MULTIPOTENT MESENCHYMAL STEM CELLS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANALYSIS OF THREE-DIMENSIONAL SHAPE STRUCTURES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES","25;18;17;13;12;12;9;7;6;6;6;5;4;4;4;4;4;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;SPINAL FUSION;BIOCOMPATIBILITY;EWING'S SARCOMA;HIP JOINT MECHANICS;MESENCHYMAL STEM CELLS;SCAFFOLDS;SOFT TISSUE SARCOMA;BONE REGENERATION;OSTEOSARCOMA;CHONDROSARCOMA;LIMB RECONSTRUCTION;OSTEOBLAST ADHESION;BIOMECHANICS;KYPHOSIS;POLYMERIC SCAFFOLDS;TREATMENT;ADOLESCENT IDIOPATHIC SCOLIOSIS","19;19;17;10;9;8;8;8;8;8;7;7;6;6;6;5;5;5;5;4","STEM CELLS;MESENCHYMAL STEM;SOFT TISSUE;SURGICAL TREATMENT;TOTAL KNEE;BREAST CANCER;TISSUE ENGINEERING;TOTAL ANKLE;ANKLE REPLACEMENT;BONE MARROW;BONE REGENERATION;CANCER CELLS;EWING SARCOMA;GAIT ANALYSIS;HUMAN BONE;KNEE REPLACEMENT;ANEURYSMAL BONE;BONE CYST;CELL TUMOR;CLINICAL STUDY;ENGINEERING APPLICATIONS;FDG PETCT;FUNCTIONAL PERFORMANCE;HUMAN MESENCHYMAL;KNEE ARTHROPLASTY;KNEE JOINT;MOTION ANALYSIS;POTENTIAL ROLE;STEM CELL;TISSUE SARCOMA","14;12;10;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ORTHOPAEDIC INSTITUTE;RIZZOLI ORTHOPAEDIC;EXTRACELLULAR MATRIX;CELL LINES;INSTITUTE BOLOGNA;STEM CELLS;BOLOGNA ITALY;MIR- MIR-;TISSUE ENGINEERING;BOLOGNA ITALYSEARCH;CANCER CELLS;HIP FRACTURE;MESENCHYMAL STEM;SURGICAL STUDIES;CELL PROLIFERATION;CHOI CRITERIA;ROTATOR CUFF;SOFT TISSUE;ADVANCED THERAPIES;BIOCOMPATIBILITY TECHNOLOGICAL;BONE TISSUE;CODIVILLAPUTTI RESEARCH;DEPARTMENT RIZZOLI;GAIT ANALYSIS;INSTITUTE RIZZOLI;LABORATORY CODIVILLAPUTTI;RESEARCH INSTITUTE;RIT DEPARTMENT;STUDIES LABORATORY;TECHNOLOGICAL INNOVATIONS","18;18;17;16;16;14;11;11;11;10;10;10;10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,4,4,0,1,0,0,0,0,0,0,7,1,2,9.5,3.9,3.28,2,0,8,5,0,0,3,0,1,2,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,1,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BARBUCCI ROLANDO;GIARDINO ROBERTO;ASCIONE ALESSANDRO;CATANI FABIO;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FLEGO MICHELA;GELLINI MARA;LEARDINI ALBERTO;MALLANO ALESSANDRA","3;3;2;2;2;2;2;2;2;2","ISTITUTO ORTOPEDICO RIZZOLI;BARBUCCI ROLANDO;GIARDINO ROBERTO;ISTITUTO SUPERIORE DI SANITA ISS;UNIVERSITA DI BOLOGNA;UNIV BOLOGNA ALMA MATER","10;3;2;2;2;1","40 ENGINEERING;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;4003 BIOMEDICAL ENGINEERING;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","6;4;4;3;2;2;2;2","BIOENGINEERING;NANOTECHNOLOGY;PEDIATRIC;RARE DISEASES;OSTEOPOROSIS;STEM CELL RESEARCH","2;2;2;2;1;1",NA,NA,"A61F2/38;A61P35/00;C07K16/28;C08B15/00;C08J3/075;C08J3/24;C08K3/00;A61B17/80;A61F2/34;A61K35/12","3;2;2;2;2;2;2;1;1;1","A61F2/08;A61F2/38;A61F2002/30639;A61F2002/30934;A61F2002/30943;A61K9/0009;A61K9/06;B82Y30/00;C08B11/12;C08B15/005","3;3;3;3;3;3;3;3;3;3",12,3.27,82.64,2.74,1,0.08,4.83,0,0,1,0,1,0,4,6,0,10,1,0,0,0,0,0,0,12,0,0,10,1,0,1,0,0,0,0,0,0,"Italy;United States;Japan","8;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3210 NUTRITION AND DIETETICS;3211 ONCOLOGY AND CARCINOGENESIS;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;52 PSYCHOLOGY","11;8;2;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;CHRONIC PAIN;PAIN RESEARCH;BIOENGINEERING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;REHABILITATION;ARTHRITIS;NEUROSCIENCES;AGING;BIOMEDICAL IMAGING;CANCER;DRUG ABUSE (NIDA ONLY);NEURODEGENERATIVE;NUTRITION;OBESITY;PATIENT SAFETY;PEDIATRIC;PHYSICAL REHABILITATION;PREVENTION;SUBSTANCE MISUSE","10;5;5;4;4;4;3;3;1;1;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER;METABOLIC AND ENDOCRINE;STROKE","7;2;1;1","6.4 SURGERY;6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES","4;3;1;1;1","SARCOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",1,77300,77300,3,1,1,0,12,1294871.21213678,0.234772382883038,"ISTITUTO ORTOPEDICO RIZZOLI","1","TELETHON FOUNDATION","1",NA,NA,"TELETHON - UILDM CLINICAL GRANT PROJECTS - 2011 (PROGRAM)","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY","1;1;1;1","BRAIN DISORDERS;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NUTRITION;RARE DISEASES","1;1;1;1;1","MUSCULOSKELETAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","10;3;3;3;2;2;1;1","BIOTECHNOLOGY;GENETICS;PEDIATRIC;RARE DISEASES;CANCER;HUMAN GENOME;PEDIATRIC CANCER","7;7;4;3;1;1;1","CANCER;GENERIC HEALTH RELEVANCE","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1","BIOMEDICAL","2","BASIC SCIENCE","3","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA","3",NA,NA
"IRCCS_RIZZOLI",2013,300,8.15333333333333,3.94,0.566666666666667,0.536666666666667,0.606666666666667,2.7337962962963,1.60377358490566,2.59677419354839,1.55555555555556,0.406666666666667,1,121,81,27,34,0.4,0.27,0.09,0.11,37.17,1.06536546290299,5.04373650107991,0.37,0.743333333333333,0.544,0.523,0.532,0.512,"MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;ELIZAVETA KON;FRANCESCA VANNINI;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;BERARDO DI MATTEO;NICOLA BALDINI;ALESSANDRO DI MARTINO;DAVIDE MAR√çA DONATI;PIETRO RUGGIERI;MARCO CAVALLO;FRANCESCO IACONO;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA FACCHINI","45;35;27;21;19;18;17;17;16;15;13;13;12;12;12;11;11;10;10;10","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;FRANCESCA VANNINI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;ROBERTO BUDA;ELIZAVETA KON;NICOLA BALDINI;BERARDO DI MATTEO;PIERO PICCI;ALBERTO BAZZOCCHI;MILENA FINI;ANDREAS F. MAVROGENIS;FULVIA TADDEI;DAVIDE MAR√çA DONATI;ALESSANDRO DI MARTINO;MARCO CAVALLO;FRANCESCO IACONO","6.63;6.04;3.73;2.9;2.86;2.79;2.79;2.52;2.51;2.29;2.02;1.96;1.95;1.92;1.89;1.75;1.67;1.6;1.57;1.53","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;ELIZAVETA KON;FRANCESCA VANNINI;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;BERARDO DI MATTEO;NICOLA BALDINI;ALESSANDRO DI MARTINO;DAVIDE MAR√çA DONATI;PIETRO RUGGIERI;MARCO CAVALLO;FRANCESCO IACONO;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA FACCHINI","45;35;27;21;19;18;17;17;16;15;13;13;12;12;12;11;11;10;10;10","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;FRANCESCA VANNINI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;ROBERTO BUDA;ELIZAVETA KON;NICOLA BALDINI;BERARDO DI MATTEO;PIERO PICCI;ALBERTO BAZZOCCHI;MILENA FINI;ANDREAS F. MAVROGENIS;FULVIA TADDEI;DAVIDE MAR√çA DONATI;ALESSANDRO DI MARTINO;MARCO CAVALLO;FRANCESCO IACONO","6.63;6.04;3.73;2.9;2.86;2.79;2.79;2.52;2.51;2.29;2.02;1.96;1.95;1.92;1.89;1.75;1.67;1.6;1.57;1.53","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;ALINA BERAUDI;STEFANO FERRARI;ELIZAVETA KON;PIERO PICCI;ALLISON PIOVESAN;EVA BIANCONI;FEDERICA FACCHIN;FLAVIA FRABETTI;FRANCESCO PIVA;LORENZA VITALE;MARIA CHIARA PELLERI;PIERLUIGI STRIPPOLI;RAFFAELLA CASADEI;SILVIA CANAIDER;SIMONE TASSANI;SOLEDAD P√âREZ‚ÄêAMODIO;ANDREA FACCHINI","1514;1393;1323;1006;983;961;949;896;896;896;896;896;896;896;896;896;896;896;896;776","MAURILIO MARCACCI;GIUSEPPE FILARDO;SANDRO GIANNINI;ALINA BERAUDI;STEFANO FERRARI;ELIZAVETA KON;PIERO PICCI;MILENA FINI;ROBERTO BUDA;STEFANO ZAFFAGNINI;ALESSANDRO DI MARTINO;FRANCESCA VANNINI;ANDREA FACCHINI;NICOLA BALDINI;BERARDO DI MATTEO;MARCO CAVALLO;GINA LISIGNOLI;CRISTINA MANFERDINI;PIETRO RUGGIERI;EMANUELA PALMERINI","1429;1323;1270;1006;983;961;949;727;652;635;622;621;579;565;490;425;385;381;369;364","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;FRANCESCA VANNINI;ELIZAVETA KON;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;STEFANO FERRARI;BERARDO DI MATTEO;ALESSANDRO DI MARTINO;PIETRO RUGGIERI;DAVIDE MAR√çA DONATI;MARCO CAVALLO;FRANCESCO IACONO;NICOLA BALDINI;ANDREA FACCHINI;ALBERTO BAZZOCCHI","43;33;27;21;19;18;18;17;16;15;14;13;12;12;11;11;11;11;10;9","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;COMPUTER SCIENCE;PHILOSOPHY;GEOLOGY;HISTORY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;ART;ECONOMICS;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","248;105;54;52;45;29;27;24;10;6;6;5;5;4;3;2;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;CELL BIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;RADIOLOGY;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;NANOTECHNOLOGY;IMMUNOLOGY;ONCOLOGY;OPTICS;ORGANIC CHEMISTRY","146;110;91;62;56;49;43;36;33;29;25;25;24;19;17;16;14;14;14;14","ALTERNATIVE MEDICINE;GENE;ORTHOPEDIC SURGERY;CANCER;IMPLANT;IN VITRO;SARCOMA;CARTILAGE;MESENCHYMAL STEM CELL;STEM CELL;ARTHROPLASTY;CHEMOTHERAPY;OSTEOSARCOMA;POPULATION;RADIOGRAPHY;OSTEOPOROSIS;ANKLE;SCAFFOLD;FEMUR;CELL;PROSTHESIS;TRANSPLANTATION","52;34;25;23;22;22;22;21;20;20;18;16;16;16;16;15;14;14;13;12;12;12","OSTEOARTHRITIS;CHONDROCYTE;METASTASIS;PLATELET-RICH PLASMA;CELL CYCLE;FIXATION (POPULATION GENETICS);GENE EXPRESSION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;CHONDROGENESIS;OSTEOBLAST;BREAST CANCER;CD34;GAIT ANALYSIS;TRANSCRIPTION FACTOR;ALKALINE PHOSPHATASE;ARTHRODESIS;CELLULAR DIFFERENTIATION;CISPLATIN;GENOTYPE;MICRORNA;OSTEOCLAST;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;REGENERATIVE MEDICINE;RHABDOMYOSARCOMA;VASCULITIS","42;8;8;8;7;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;HIGH TIBIAL OSTEOTOMY;UNICOMPARTMENTAL KNEE ARTHROPLASTY;WOMAC;OSTEOCALCIN;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SYNOVIAL FLUID;BONE METASTASIS;CD99;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;IFOSFAMIDE;ONCOGENE;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;ADULT STEM CELL;ANTHRACYCLINE;DUAL ENERGY;ELECTROCHEMOTHERAPY;GIANT CELL ARTERITIS;KNEE PAIN;NUCLEAR PROTEIN;PATELLAR LIGAMENT;QUANTITATIVE COMPUTED TOMOGRAPHY;V-ATPASE","14;7;6;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;ADULT;BONE NEOPLASMS;MIDDLE AGED;AGED;KNEE JOINT;TREATMENT OUTCOME;YOUNG ADULT;OSTEOSARCOMA;ADOLESCENT;SARCOMA;AGED, 80 AND OVER;CELL DIFFERENTIATION;CHONDROCYTES;FEMUR;ANIMALS;MESENCHYMAL STEM CELLS","183;115;113;95;92;83;78;60;49;46;44;43;42;33;32;32;31;31;30;30","SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;MULTIPOTENT MESENCHYMAL STEM CELLS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;OSTEOPOROSIS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ATP SYNTHASE FUNCTION AND REGULATION;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;INCIDENCE AND MANAGEMENT OF HIP FRACTURES","18;17;17;15;15;15;12;11;7;6;6;5;5;5;3;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;KNEE OSTEOARTHRITIS;SCAFFOLDS;CADAVERIC SPASM;SOFT TISSUE SARCOMA;BIOMECHANICS;EWING'S SARCOMA;HIGH TIBIAL OSTEOTOMY;OSTEOARTHRITIS TREATMENT;REVISION SURGERY;BONE MINERAL DENSITY;BONE REGENERATION;CHONDROGENESIS;MATRIX (CHEMICAL ANALYSIS);MESENCHYMAL STEM CELLS;METASTATIC SPINE TUMORS;OSTEOCHONDRAL LESIONS;OSTEOID OSTEOMA","33;25;15;11;10;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6","STEM CELLS;MESENCHYMAL STEM;BONE MARROW;OSTEOCHONDRAL ALLOGRAFT;TOTAL KNEE;ANTERIOR CRUCIATE;AUTOLOGOUS CHONDROCYTE;CRUCIATE LIGAMENT;FRESH OSTEOCHONDRAL;SOFT TISSUE;BIPOLAR FRESH;BONE METASTASIS;EWING SARCOMA;KNEE ARTHROPLASTY;KNEE OSTEOARTHRITIS;KNEE REPLACEMENT;STROMAL CELLS;TUMOR CELLS;ALLOGRAFT TRANSPLANTATION;CHONDROCYTE TRANSPLANTATION;GIANT CELL;HIP PROSTHESIS;HIP RESURFACING;II STUDY;IIN VITROI;KNEE IMPLANT;LUMBAR SPINE;MAGNETIC SCAFFOLDS;METAL-ON-METAL HIP;OSTEOGENIC DIFFERENTIATION","13;9;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;PUBMED SCOPUS;DEDIFFERENTIATED CHONDROSARCOMA;CROSSREF PUBMED;SOFT TISSUE;STEM CELLS;OSTEOID OSTEOMA;MESENCHYMAL CHONDROSARCOMA;BONE TUMORS;CELL CHONDROSARCOMA;HEPARAN SULFATE;MESENCHYMAL STEM;BONE MARROW;CLINICAL OUTCOME;GOLD STANDARD;HOGENDOORN PCW;MOM HR;OSTEOSARCOMA CELL;TUMOR CELLS;CHONDROSARCOMA SUBTYPES;FRESH OSTEOCHONDRAL;MESENCHYMAL CHONDROSARCOMAS;MUSCLE STRENGTH;STEM CELL;STROMAL CELLS;BONE METASTASIS;CELL ADHESION;CELL VIABILITY;CHONDROCYTE DIFFERENTIATION;CHONDROSARCOMA CELL","28;28;25;22;17;17;13;12;10;10;10;10;9;9;9;9;9;9;9;8;8;8;8;8;8;7;7;7;7;7",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,1,0,2,0,0,0,0,0,3,1,0,4,1.35,1.5,0,2,3,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DALLARI DANTE;PIGNATTI GIOVANNI;ASCIONE ALESSANDRO;BIGI ADRIANA;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FINI MILENA;FLEGO MICHELA;GELLINI MARA;GIARDINO ROBERTO","2;2;1;1;1;1;1;1;1;1","ISTITUTO ORTOPEDICO RIZZOLI;IST SUPERIORE SANITA;UNIVERSITA DI BOLOGNA","4;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","6;3","CLINICAL RESEARCH","1",NA,NA,"A61B17/80;A61F2/34;A61L27/42;A61L27/46;A61L27/56;C07K16/28","2;2;1;1;1;1","A61B17/8033;A61B17/8042;A61B17/8047;A61B17/86;A61F2/30749;A61F2/34;A61F2002/30378;A61F2002/30507;A61F2002/30538;A61F2002/3069","2;2;2;2;2;2;2;2;2;2",9,7.11,1742.89,2.24,3,0.33,3.44,0,1,0,0,1,0,1,6,0,7,2,0,0,0,0,0,0,9,0,0,9,0,0,0,0,0,0,0,0,0,"Italy;France","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;31 BIOLOGICAL SCIENCES;3105 GENETICS;46 INFORMATION AND COMPUTING SCIENCES;4604 CYBERSECURITY AND PRIVACY","7;5;3;3;2;2;2;2","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CHRONIC PAIN;PAIN RESEARCH;PATIENT SAFETY;COMPARATIVE EFFECTIVENESS RESEARCH;GENETICS;REHABILITATION;TRANSPLANTATION;ARTHRITIS;BIOENGINEERING;BIOTECHNOLOGY;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEMATOLOGY;NEURODEGENERATIVE;NEUROSCIENCES;NUTRITION;PERIPHERAL NEUROPATHY;RARE DISEASES;REGENERATIVE MEDICINE","8;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL","4","6.1 PHARMACEUTICALS;6.4 SURGERY;5.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES","2;2;1;1","NOT SITE-SPECIFIC CANCER","2","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","2",4,3309079.75,301553.09,5.75,10.5,4.5,1,117.75,1274352.96474747,0.23541358501053,"ISTITUTO ORTOPEDICO RIZZOLI;ANDALUSIAN HEALTH SERVICE;ASCOMP (SWITZERLAND);BASE PROTECTION (ITALY);BRUNEL UNIVERSITY LONDON;CASA SOLLIEVO DELLA SOFFERENZA;CENTRE L√âON B√âRARD;CLOUDSIGMA (SWITZERLAND);CMCL INNOVATIONS (UNITED KINGDOM);ENTE OSPEDALIERO OSPEDALI GALLIERA;ERASMUS MC;ESSEN UNIVERSITY HOSPITAL;EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;G-VOLUTION (UNITED KINGDOM);INSTITUT GUSTAVE ROUSSY;INSTITUTE CURIE;ISTITUTO GIANNINA GASLINI;JOHNSON & JOHNSON (UNITED KINGDOM);JOHNSON & JOHNSON (UNITED STATES)","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL;TELETHON FOUNDATION","2;1;1","COALITION S;EC & ERC - EUROPEAN UNION;UKRI - UK RESEARCH AND INNOVATION","3;2;1","CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-2013-NMP-ICT-FOF (CALL FOR PROPOSAL);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2013-INNOVATION-1 (CALL FOR PROPOSAL);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);RESEARCH GRANT (PROJECT CATEGORY);TELETHON NETWORK OF GENETIC BIOBANKS - RENEWAL 2012 (PROGRAM)","1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;31 BIOLOGICAL SCIENCES;3105 GENETICS;4003 BIOMEDICAL ENGINEERING;4014 MANUFACTURING ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;48 LAW AND LEGAL STUDIES;4807 PUBLIC LAW","2;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;ARTHRITIS;BIOENGINEERING;BIOTECHNOLOGY;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETIC TESTING;GENETICS;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC;RARE DISEASES;REHABILITATION","2;1;1;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;CANCER;MUSCULOSKELETAL","2;1;1","1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING);2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.4 SURGERY;8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)","1;1;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER;SARCOMA","1;1;1","5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;1.5 RESOURCES AND INFRASTRUCTURE;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;1;1;1;1","A01 CLINICAL MEDICINE;B12 ENGINEERING","2;2","3 GOOD HEALTH AND WELL BEING","1",22,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH","16;6","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3208 MEDICAL PHYSIOLOGY;47 LANGUAGE, COMMUNICATION AND CULTURE;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;3210 NUTRITION AND DIETETICS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;4705 LITERARY STUDIES","33;9;3;3;3;2;2;2;1;1;1;1;1;1;1;1","CANCER;RARE DISEASES;BREAST CANCER;CLINICAL RESEARCH;HEMATOLOGY;PEDIATRIC;STEM CELL RESEARCH;AGING;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;ORPHAN DRUG;OVARIAN CANCER;REGENERATIVE MEDICINE;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;TRANSPLANTATION","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL;BLOOD;INFLAMMATORY AND IMMUNE SYSTEM","3;2;1;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","3;2;1;1;1","BIOMEDICAL;CLINICAL","4;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","7;4","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BREAST CANCER;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;OVARIAN CANCER","8;6;3;2;1;1;1",NA,NA
"IRCCS_RIZZOLI",2014,300,8.40333333333333,3.94,0.566666666666667,0.543333333333333,0.703333333333333,2.72748267898383,1.50442477876106,2.62903225806452,1.56296296296296,0.42,4,144,82,17,32,0.48,0.27,0.06,0.11,31.51,0.833692736016197,5.08906098741529,0.366666666666667,0.803333333333333,0.567,0.458,0.498,0.472,"MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO ZAFFAGNINI;STEFANO BORIANI;PAOLO CARAVAGGI;KATIA SCOTLANDI;MILENA FINI;MARCO GAMBAROTTI;MARIA GRAZIA BENEDETTI;LISA BERTI;ALBERTO RIGHI;LUCIANO MERLINI;NICOLA BALDINI;UGO ALBISINNI;DAVIDE MAR√çA DONATI;STEFANO FERRARI","41;30;27;25;24;21;15;14;13;12;12;12;12;11;10;10;10;10;10;10","MAURILIO MARCACCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;PIERO PICCI;PAOLO CARAVAGGI;LUCIANO MERLINI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;LISA BERTI;NICOLA BALDINI;MILENA FINI;STEFANO BORIANI;ALBERTO RIGHI;MARCO GAMBAROTTI;BERARDO DI MATTEO;FRANCESCO PERDISA;DAVIDE MAR√çA DONATI","5.92;5.14;4.91;4.48;3.19;2.81;2.67;2.52;2.43;2.35;2.02;1.9;1.64;1.57;1.57;1.55;1.52;1.51;1.46;1.39","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO ZAFFAGNINI;STEFANO BORIANI;PAOLO CARAVAGGI;KATIA SCOTLANDI;MILENA FINI;MARCO GAMBAROTTI;MARIA GRAZIA BENEDETTI;LISA BERTI;ALBERTO RIGHI;LUCIANO MERLINI;NICOLA BALDINI;UGO ALBISINNI;DAVIDE MAR√çA DONATI;STEFANO FERRARI","41;30;27;25;24;21;15;14;13;12;12;12;12;11;10;10;10;10;10;10","MAURILIO MARCACCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;PIERO PICCI;PAOLO CARAVAGGI;LUCIANO MERLINI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;LISA BERTI;NICOLA BALDINI;MILENA FINI;STEFANO BORIANI;ALBERTO RIGHI;MARCO GAMBAROTTI;BERARDO DI MATTEO;FRANCESCO PERDISA;DAVIDE MAR√çA DONATI","5.92;5.14;4.91;4.48;3.19;2.81;2.67;2.52;2.43;2.35;2.02;1.9;1.64;1.57;1.57;1.55;1.52;1.51;1.46;1.39","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO FERRARI;MARCO GAMBAROTTI;STEFANO BORIANI;ALBERTO LEARDINI;NICOLA BALDINI;SANDRO GIANNINI;EMANUELA PALMERINI;FULVIA TADDEI;PIETRO RUGGIERI;ANDREA FACCHINI;ANTONIO LLOMBART‚ÄêBOSCH;ISIDRO MACHADO;PAOLO G. CASALI;CHARLES G. FISHER;JEREMY REYNOLDS;LAURENCE D. RHINES","1401;1399;956;858;751;643;625;608;551;545;528;523;481;447;442;442;414;412;412;412","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO FERRARI;MARCO GAMBAROTTI;STEFANO BORIANI;ALBERTO LEARDINI;NICOLA BALDINI;SANDRO GIANNINI;EMANUELA PALMERINI;FULVIA TADDEI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;DONATELLA GRANCHI;FRANCESCO PERDISA;ANDREA FACCHINI;ALBERTO BAZZOCCHI;KATIA SCOTLANDI;EMANUELA MARCHESI","1392;1360;956;858;751;643;625;608;551;545;528;523;481;366;355;332;330;321;318;302","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO BORIANI;STEFANO ZAFFAGNINI;STEFANO FERRARI;PAOLO CARAVAGGI;MILENA FINI;MARCO GAMBAROTTI;KATIA SCOTLANDI;LISA BERTI;ALBERTO RIGHI;MARIA GRAZIA BENEDETTI;NICOLA BALDINI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;ALBERTO GRASSI;BERARDO DI MATTEO","39;29;27;25;25;21;14;14;13;13;12;12;11;11;10;10;10;10;9;9","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;ART;ECONOMICS;POLITICAL SCIENCE;GEOLOGY;BUSINESS;HISTORY;SOCIOLOGY;GEOGRAPHY","258;115;51;48;40;33;28;22;14;10;7;7;7;6;4;4;3;2","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;CELL BIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;ORTHODONTICS;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;CLASSICAL MECHANICS;ONCOLOGY;IMMUNOLOGY;QUANTUM MECHANICS","138;107;98;55;53;52;46;46;33;33;29;27;24;24;23;22;21;20;17;16","GENE;ALTERNATIVE MEDICINE;CANCER;MESENCHYMAL STEM CELL;POPULATION;SARCOMA;ARTHROPLASTY;CARTILAGE;KINEMATICS;ANKLE;GAIT;IN VITRO;RADIOGRAPHY;CHEMOTHERAPY;CELL CULTURE;IMPLANT;OSTEOSARCOMA;SCAFFOLD;STEM CELL;ANTERIOR CRUCIATE LIGAMENT","52;49;39;22;22;21;20;20;20;19;18;18;18;14;13;13;13;13;13;12","OSTEOARTHRITIS;GENE EXPRESSION;CELL CYCLE;GAIT ANALYSIS;FIXATION (POPULATION GENETICS);CHONDROCYTE;METASTASIS;PLATELET-RICH PLASMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;HAZARD RATIO;BREAST CANCER;CARCINOGENESIS;DOXORUBICIN;PROGRAMMED CELL DEATH;ARTHRODESIS;BONE MINERAL;CLINICAL ENDPOINT;MICRORNA;RELIABILITY (SEMICONDUCTOR);VIABILITY ASSAY","42;16;14;13;12;9;9;8;7;7;6;6;6;6;5;5;5;5;5;5","ARTICULAR CARTILAGE;GENE EXPRESSION PROFILING;ONCOGENE;UNICOMPARTMENTAL KNEE ARTHROPLASTY;CD99;PIVOT-SHIFT TEST;BONE METASTASIS;GENETICALLY MODIFIED MOUSE;MAMMARY TUMOR;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;ACHILLES TENDON RUPTURE;ADJUVANT CHEMOTHERAPY;ANTEROLATERAL LIGAMENT;CYCLIN D1;DECORIN;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;EXOME SEQUENCING;FLUORESCENCE IN SITU HYBRIDIZATION;HYDROXYTYROSOL;INDUCED PLURIPOTENT STEM CELL;LACHMAN TEST;MESODERM;MITOCHONDRIAL MYOPATHY;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;PEPTIDYLPROLYL ISOMERASE;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;QUANTITATIVE COMPUTED TOMOGRAPHY;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME","10;7;7;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;ADULT;;MIDDLE AGED;KNEE JOINT;BONE NEOPLASMS;AGED;MESENCHYMAL STEM CELLS;YOUNG ADULT;OSTEOSARCOMA;ARTHROPLASTY, REPLACEMENT, KNEE;ADOLESCENT;OSTEOARTHRITIS, KNEE;CARTILAGE, ARTICULAR;APOPTOSIS;BIOMECHANICAL PHENOMENA;TREATMENT OUTCOME;SPINAL NEOPLASMS","198;120;113;89;88;83;73;66;54;42;42;41;37;33;32;29;28;27;27;26","PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;MULTIPOTENT MESENCHYMAL STEM CELLS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;PATHOGENESIS AND TREATMENT OF OSTEONECROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ADVANCEMENTS IN PROSTATE CANCER RESEARCH","21;20;16;16;15;15;10;10;8;7;7;6;5;5;4;4;3;3;3;2","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;FOOT (PROSODY);MESENCHYMAL STEM CELLS;OSTEOSARCOMA;SOFT TISSUE SARCOMA;BIOMECHANICS;OSTEOCHONDRAL LESIONS;PLATELET-RICH PLASMA;CHONDROSARCOMA;FOOT STRIKE PATTERNS;METASTATIC SPINE TUMORS;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;POLYMERIC SCAFFOLDS;SCAFFOLDS;ANEURYSMAL BONE CYST;BIOMATERIAL","27;24;17;11;10;9;9;9;8;8;8;7;7;7;6;6;6;6;5;5","STEM CELLS;EWING SARCOMA;MESENCHYMAL STEM;KNEE ARTHROPLASTY;PLATELET-RICH PLASMA;TOTAL KNEE;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;FINITE ELEMENT;LIGAMENT RECONSTRUCTION;MESENCHYMAL STROMAL;MUSCULAR DYSTROPHY;STROMAL CELLS;BONE MARROW;BONE METASTASIS;COLLAGEN VI;GAIT ANALYSIS;KNEE PROSTHESES;OSTEOCHONDRAL ALLOGRAFT;SOFT TISSUE;SURGICAL TREATMENT;UNICOMPARTMENTAL KNEE;ANEURYSMAL BONE;BIPOLAR FRESH;BONE REGENERATION;CELL LINES;COMBINED EFFECT;COMPARATIVE EVALUATION;CONGENITAL MUSCULAR;HIGH-GRADE OSTEOSARCOMA","10;9;9;8;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","TOTAL KNEE;RIZZOLI ORTHOPAEDIC;BOLOGNA ITALY;EWING SARCOMA;TOTAL HIP;MUSCULAR DYSTROPHY;GENE EXPRESSION;CELL LINES;HUMAN BODY;KNEE ARTHROPLASTY;CELL DEATH;STEM CELLS;CROSS-LINKED POLYETHYLENE;DATA NETWORK;OSTEOARTHRITIS OA;CONFIDENCE INTERVAL;GSKŒí INHIBITION;HAZARD RATIO;HEAD SIZE;MESENCHYMAL STEM;ORTHOPAEDIC INSTITUTE;OXIDATIVE STRESS;SKELETAL MUSCLE;COLLAGEN VI;DISTRIBUTED HEALTH;GROWTH FACTOR;HEALTH DATA;HIP ARTHROPLASTY;KNEE LAXITY;CLINICAL PRACTICE","22;20;17;17;17;15;14;13;13;13;12;12;11;11;11;10;10;10;10;10;10;10;10;9;9;9;9;9;9;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,1,0,0,0,0,0,0,1,1,2,0,4.5,1.52,1,0,0,3,0,0,0,0,0,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FINI MILENA;GIARDINO ROBERTO;SALAMANNA FRANCESCA;ASCIONE ALESSANDRO;BIANCHI MICHELE;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FLEGO MICHELA;GELLINI MARA;LOPOMO NICOLA FRANCESCO","2;2;2;1;1;1;1;1;1;1","ISTITUTO ORTOPEDICO RIZZOLI","4","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES","2;2;1;1","AGING;OSTEOPOROSIS;PEDIATRIC;RARE DISEASES","1;1;1;1",NA,NA,"A61K39/395;C07K16/30;G01N33/68","1;1;1","G01N2800/108;G01N33/6893;A61K2039/505;A61L2420/02;A61L2420/04;A61L2430/02;A61L2430/24;A61L2430/38;A61L27/306;A61P35/00","2;2;1;1;1;1;1;1;1;1",22,5.14,268.73,5.26,4,0.18,9.09,1,2,5,1,0,0,0,13,0,17,5,0,0,0,0,0,0,22,0,0,21,0,0,1,0,0,0,0,0,0,"Italy;United Kingdom;United States;Belgium;Japan;Canada;Norway;Spain","13;7;5;4;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;3105 GENETICS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;4604 CYBERSECURITY AND PRIVACY;51 PHYSICAL SCIENCES","17;13;6;4;4;4;3;3;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;CHRONIC PAIN;PAIN RESEARCH;PEDIATRIC;ARTHRITIS;GENETICS;ORPHAN DRUG;BIOENGINEERING;PATIENT SAFETY;PEDIATRIC CANCER;AGING;HUMAN GENOME;OSTEOARTHRITIS;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;AUTOIMMUNE DISEASE","18;9;7;6;6;6;6;5;5;4;3;3;3;2;2;2;2;2;2;1","CANCER;MUSCULOSKELETAL;INFLAMMATORY AND IMMUNE SYSTEM","7;6;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES;6.3 MEDICAL DEVICES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;6.7 PHYSICAL","10;3;2;2;1;1;1;1;1;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER;THYROID CANCER","8;5;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","8;2;2;2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,"PUBLIC LIBRARY OF SCIENCE","16","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3203 DENTISTRY;3206 MEDICAL BIOTECHNOLOGY;40 ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;46 INFORMATION AND COMPUTING SCIENCES;4612 SOFTWARE ENGINEERING;49 MATHEMATICAL SCIENCES;4905 STATISTICS","18;9;4;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1","PEDIATRIC;RARE DISEASES;CANCER;GENETICS;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL RESEARCH;GENETIC TESTING;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","3;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","5;1;1","BIOMEDICAL;CLINICAL","4;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","5;2","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER","4;3;2",NA,NA
"IRCCS_RIZZOLI",2015,291,8.5979381443299,3.68041237113402,0.54639175257732,0.512027491408935,0.618556701030928,2.75773195876289,1.44545454545455,2.25757575757576,1.44,0.460481099656357,8,121,80,17,35,0.42,0.27,0.06,0.12,29.95,0.80368474209076,4.81524249422632,0.34020618556701,0.790378006872852,0.507,0.429,0.506,0.445,"MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO BORIANI;SANDRO GIANNINI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;N. LOPOMO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;PAOLO CARAVAGGI;MARIA SERENA BENASSI;P√âTER VARGA;MARCO GAMBAROTTI;MICHAEL G. FEHLINGS;LAURENCE D. RHINES;CHARLES G. FISHER","32;26;25;19;17;16;16;16;13;12;11;11;10;10;10;10;10;9;9;9","MAURILIO MARCACCI;ALBERTO LEARDINI;MILENA FINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;PIERO PICCI;SANDRO GIANNINI;PAOLO CARAVAGGI;LORENZO CAVAZZUTI;SAVERIO AFFATATO;STEFANO BORIANI;GIOVANNA LATTANZI;COSTANTINO ERRANI;GIANLUCA GIAVARESI;N. LOPOMO;PAOLA TORRICELLI;KATIA SCOTLANDI;CLAUDIO BELVEDERE;DAVIDE MAR√çA DONATI;LISA BERTI","4.27;3.62;3.47;3.47;3.18;2.66;2.51;2.06;2;1.83;1.57;1.52;1.52;1.51;1.44;1.42;1.4;1.27;1.25;1.23","MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO BORIANI;SANDRO GIANNINI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;N. LOPOMO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;PAOLO CARAVAGGI;MARIA SERENA BENASSI;MARCO GAMBAROTTI;PAOLA TORRICELLI;STEFANO FERRARI;ELIZAVETA KON;MARK B. DEKUTOSKI","32;26;25;19;17;16;16;16;13;12;11;11;10;10;10;10;9;9;8;8","MAURILIO MARCACCI;ALBERTO LEARDINI;MILENA FINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;PIERO PICCI;SANDRO GIANNINI;PAOLO CARAVAGGI;LORENZO CAVAZZUTI;SAVERIO AFFATATO;STEFANO BORIANI;GIOVANNA LATTANZI;COSTANTINO ERRANI;GIANLUCA GIAVARESI;N. LOPOMO;PAOLA TORRICELLI;KATIA SCOTLANDI;CLAUDIO BELVEDERE;DAVIDE MAR√çA DONATI;LISA BERTI","4.27;3.62;3.47;3.47;3.18;2.66;2.51;2.06;2;1.83;1.57;1.52;1.52;1.51;1.44;1.42;1.4;1.27;1.25;1.23","MAURILIO MARCACCI;MILENA FINI;NICOLA BALDINI;PIERO PICCI;GIUSEPPE FILARDO;NICOLETTA ZINI;FRANCESCA PERUT;MARIA SERENA BENASSI;BENNO A. NAAIJKENS;D. MICHIEL PEGTEL;DANIJELA KOPPERS‚ÄêLALIC;FREDERIK J. VERWEIJ;HANS W.M. NIESSEN;KOOS ROOIJERS;M P√âREZ LANZ√ìN;S. RUBINA BAGLIO;LUCA SANGIORGI;ANDREA SUPERTI‚ÄêFURGA;CHRISTINE M HALL;DAVID SILLENCE","894;876;842;759;710;698;681;651;650;650;650;650;650;650;650;650;542;534;534;534","MILENA FINI;NICOLA BALDINI;MAURILIO MARCACCI;GIUSEPPE FILARDO;NICOLETTA ZINI;FRANCESCA PERUT;S. RUBINA BAGLIO;MARIA SERENA BENASSI;PIERO PICCI;LUCA SANGIORGI;ELIZAVETA KON;STEFANO FERRARI;GIANLUCA GIAVARESI;BERARDO DI MATTEO;ALESSANDRO DI MARTINO;PAOLA TORRICELLI;GIOVANNI ZITO;ANNARITA CENACCHI;KATIA SCOTLANDI;PIERMARIA FORNASARI","876;824;811;702;698;681;650;609;565;534;511;489;425;419;384;337;331;322;318;313","MAURILIO MARCACCI;MILENA FINI;PIERO PICCI;STEFANO ZAFFAGNINI;STEFANO BORIANI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO FERRARI;SANDRO GIANNINI;GIANLUCA GIAVARESI;KATIA SCOTLANDI;N. LOPOMO;DAVIDE MAR√çA DONATI;MARIA SERENA BENASSI;PAOLO CARAVAGGI;ALBERTO RIGHI;PAOLA TORRICELLI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;ALESSANDRO RUSSO","29;25;21;18;16;16;15;14;14;11;11;11;9;9;9;9;9;9;8;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;BUSINESS;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;ART;GEOGRAPHY;HISTORY;ENVIRONMENTAL SCIENCE","242;99;63;42;39;33;26;16;15;7;5;4;4;4;4;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;CANCER RESEARCH;CELL BIOLOGY;GENETICS;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;BIOMEDICAL ENGINEERING;PHYSICAL MEDICINE AND REHABILITATION;ONCOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ORGANIC CHEMISTRY;OPTICS","136;96;92;57;47;41;40;40;28;26;25;24;23;22;21;17;15;15;14;13","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;IN VITRO;OSTEOSARCOMA;SARCOMA;CHEMOTHERAPY;RADIOGRAPHY;ANKLE;CARTILAGE;POPULATION;RANGE OF MOTION;RECEPTOR;CELL;ENZYME;ANTERIOR CRUCIATE LIGAMENT;ARTHROPLASTY;IMPLANT;KINEMATICS;MESENCHYMAL STEM CELL;STEM CELL","43;41;33;27;25;20;20;17;16;14;13;13;13;13;12;12;11;11;11;11;11;11","OSTEOARTHRITIS;METASTASIS;OSTEOBLAST;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;CHONDROCYTE;SOFT TISSUE SARCOMA;MICRORNA;FIXATION (POPULATION GENETICS);GENE EXPRESSION;LAMIN;ARTHRODESIS;BREAST CANCER;ETOPOSIDE;PROSTATE CANCER;TRANSCRIPTION FACTOR;VIABILITY ASSAY;ACTIVATOR (GENETICS);ALKALINE PHOSPHATASE;CELL CYCLE;CHEMOKINE;CUBIC ZIRCONIA;CYCLOPHOSPHAMIDE;DOXORUBICIN;EWING'S SARCOMA;FOREFOOT;OSTEOCLAST;UNIVARIATE ANALYSIS","31;12;12;9;8;8;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;BONE METASTASIS;IFOSFAMIDE;ARTHROPATHY;CD99;MICROVESICLES;OSTEOPROTEGERIN;PIVOT-SHIFT TEST;PRIMARY TUMOR;WOMAC;ACETABULAR LABRUM;ANTEROLATERAL LIGAMENT;CATHEPSIN K;CELL CYCLE CHECKPOINT;COMPOUND HETEROZYGOSITY;CXCR4;CYCLIC VOLTAMMETRY;DYSTHYMIC DISORDER;ELECTROCHEMOTHERAPY;ENTEROCOCCUS FAECALIS;FLUOXETINE;HISTONE DEACETYLASE;IRREVERSIBLE ELECTROPORATION;JOINT DISEASE;KNEE SURGERY;LACHMAN TEST;LMNA;MAGNETIC HYPERTHERMIA;MEDIAL MENISCUS;RANKL;RUNX2;RYR1;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;STERILIZATION (ECONOMICS);VINCRISTINE","6;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;ADULT;AGED;OSTEOBLASTS;OSTEOSARCOMA;ANIMALS;KNEE JOINT;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;FEMUR;FOLLOW-UP STUDIES;OSTEOARTHRITIS, KNEE;CELL DIFFERENTIATION;YOUNG ADULT;ADOLESCENT","159;106;101;101;82;59;56;51;44;33;31;31;31;31;30;30;29;28;28;27","SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;APPLICATIONS OF ELECTROPORATION IN BIOTECHNOLOGY AND FOOD PROCESSING;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES","26;17;15;13;13;13;12;11;6;6;4;4;4;4;4;4;3;3;3;3","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;EWING'S SARCOMA;SOFT TISSUE SARCOMA;OSTEOSARCOMA;BIOMECHANICS;BONE REGENERATION;SPINAL FUSION;ATHLETIC REHABILITATION;FOOT STRIKE PATTERNS;OSTEOBLAST ADHESION;ANTERIOR CRUCIATE LIGAMENT;CHORDOMA;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;LIGAMENT RECONSTRUCTION;OSTEOARTHRITIS TREATMENT;OSTEOBLAST DIFFERENTIATION;OSTEOLYSIS","19;14;13;12;12;10;9;7;7;6;6;6;5;5;5;5;5;5;5;5","TOTAL KNEE;EWING SARCOMA;KNEE ARTHROPLASTY;BONE MARROW;CRUCIATE LIGAMENT;LIGAMENT RECONSTRUCTION;STEM CELLS;ANTERIOR CRUCIATE;BONE METASTASES;MESENCHYMAL STEM;SOFT TISSUE;SURGICAL TREATMENT;CLINICAL TRIAL;GIANT CELL;LOCAL RECURRENCE;MULTICENTER STUDY;OSTEOARTHRITIC CHONDROCYTES;PROGNOSTIC VARIABLES;BONE TISSUE;CELL TUMOR;CELLS TRANSPLANTATION;GROWTH HORMONE;ITALIAN SARCOMA;KNEE OSTEOARTHRITIS;MARROW CONCENTRATE;MINIMALLY INVASIVE;OSTEOSARCOMA CELLS;PLASMA DEPOSITION;PROSTATE CANCER;PULSED PLASMA","9;7;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;BOLOGNA ITALY;STEM CELLS;CELL LINES;FATTY ACID;PIVOT SHIFT;ANATOMICAL THEATRE;EWING SARCOMA;SURGICALLY TREATED;SURGICAL TREATMENT;TISSUE ENGINEERING;BONE EROSIONS;PRIMARY SPINAL;SIDEWAYS FALL;STROMAL CELLS;EN BLOC;MEMBRANE FATTY;OA CHONDROCYTES;PATIENTS UNDERWENT;ACID PROFILES;BLOC RESECTION;BONE TUMORS;COLLAGEN TYPE;DNA DAMAGE;GIANT CELL;LS BMD;OSTEOARTHRITIS OA;PATIENTS AFFECTED;SUBCHONDRAL BONE;ARCHIGINNASIO PALACE","37;16;16;15;14;14;13;13;13;12;12;11;11;11;11;10;10;10;10;9;9;9;9;9;9;9;9;9;9;8",2,0.01,3.19,2.5,0,0,0,0,2,0,0,2.5,0,0,1,0,1,0,0,1,0,0,0,44,44,2,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,5.33333333333333,1.5,2,0,3,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,"BONDIOLI ELENA;FINI MILENA;GIARDINO ROBERTO;MELANDRI DAVIDE;ASCIONE ALESSANDRO;CIANFRIGLIA MAURIZIO;DUPUIS MARIA LUISA;FLEGO MICHELA;GELLINI MARA;MALLANO ALESSANDRA","2;2;2;2;1;1;1;1;1;1","ISTITUTO ORTOPEDICO RIZZOLI;AUSL - AZIENDA UNITA SANITARIA LOCALE DI CESENA;ISTITUTO SUPERIORE DI SANITA ISS","3;2;1",NA,NA,NA,NA,NA,NA,"A61F2/10;A61N5/10;A61P35/00;C07K16/28","2;2;1;1","A61K41/0023;A61K41/10;A61K41/17;A61L2/0011;A61L2/0035;A61N2005/1098;A61N5/10;A61P37/02;A61K2039/505;A61P35/00","2;2;2;2;2;2;2;2;1;1",10,3.5,79.7,2.72,2,0.2,9.6,0,0,1,0,1,0,0,8,0,6,4,0,0,0,0,0,0,9,1,0,10,0,0,0,0,0,0,0,0,0,"Italy;Japan;United States","9;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;3211 ONCOLOGY AND CARCINOGENESIS;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS","10;8;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AGING;ARTHRITIS;BIOENGINEERING;RARE DISEASES;REHABILITATION;BIOMEDICAL IMAGING;BREAST CANCER;CHRONIC PAIN;LUNG;LUNG CANCER;OSTEOPOROSIS;PAIN RESEARCH;PATIENT SAFETY;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS;PREVENTION;TRANSPLANTATION;UTERINE CANCER","9;6;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER","5;2","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.4 SURGERY;6.4 SURGERY","3;2;2;2","BREAST CANCER;ENDOMETRIAL CANCER;LUNG CANCER;SARCOMA","1;1;1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1;1",3,8595416.33,281107.66,5.33333333333333,29.6666666666667,11.6666666666667,1,64.3333333333333,779227.072733407,0.373446983790254,"ISTITUTO ORTOPEDICO RIZZOLI;BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE - ERIC;BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS;D√âL√âGATION PARIS 11;EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK - ERIC;FINNISH INSTITUTE FOR HEALTH AND WELFARE;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;GERMAN CANCER RESEARCH CENTER;LEIDEN UNIVERSITY MEDICAL CENTER;MEDICAL UNIVERSITY OF GRAZ;NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY;UNIVERSITY MEDICAL CENTER GRONINGEN;UNIVERSITY OF TARTU;ANTONI VAN LEEUWENHOEK HOSPITAL;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;CAB INTERNATIONAL;CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST;CENTER FOR TRANSLATIONAL MOLECULAR MEDICINE;CENTRE FOR GENOMIC REGULATION;CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE","3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);H2020-EU.1.4.1.1. - DEVELOPING NEW WORLD-CLASS RESEARCH INFRASTRUCTURES (PROGRAMME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-INFRADEV-1-2014-1 (CALL FOR PROPOSAL);H2020-INFRADEV-1-2015-1 (CALL FOR PROPOSAL);H2020-PHC-2014-SINGLE-STAGE (CALL FOR PROPOSAL)","3;2;1;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;50 PHILOSOPHY AND RELIGIOUS STUDIES;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;AGING;ARTHRITIS;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;OSTEOARTHRITIS;PAIN RESEARCH;PATIENT SAFETY;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","2;1;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL","2;1","5.2 CELLULAR AND GENE THERAPIES;6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;8.1 ORGANISATION AND DELIVERY OF SERVICES","1;1;1;1","NOT SITE-SPECIFIC CANCER","1","1.5 RESOURCES AND INFRASTRUCTURE;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1;1;1","A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS","2;1","3 GOOD HEALTH AND WELL BEING","1",20,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;SPRINGER NATURE;THE CAMBRIDGE STRUCTURAL DATABASE","12;6;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;37 EARTH SCIENCES;3705 GEOLOGY;4003 BIOMEDICAL ENGINEERING;4205 NURSING;4207 SPORTS SCIENCE AND EXERCISE;51 PHYSICAL SCIENCES;5106 NUCLEAR AND PLASMA PHYSICS","13;8;6;4;3;2;1;1;1;1;1;1;1;1;1;1;1","GENETICS;AGING;ARTHRITIS;BIOTECHNOLOGY;CANCER;HUMAN GENOME;OSTEOARTHRITIS;PROSTATE CANCER;REGENERATIVE MEDICINE;UROLOGIC DISEASES","3;2;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY","2;1;1;1","BIOMEDICAL","3","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","4;4","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA;PROSTATE CANCER","5;2;1",NA,NA
"IRCCS_RIZZOLI",2016,309,8.74433656957929,3.89644012944984,0.563106796116505,0.546925566343042,0.72168284789644,2.80652680652681,1.53982300884956,2.22368421052632,1.60431654676259,0.40453074433657,0,138,84,12,38,0.45,0.27,0.04,0.12,29.15,0.897357332386841,4.67565290648694,0.394822006472492,0.779935275080906,0.494,0.457,0.489,0.458,"MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;MILENA FINI;ELIZAVETA KON;DAVIDE MAR√çA DONATI;ALBERTO GRASSI;N. LOPOMO;NICOLA BALDINI;STEFANO BORIANI;GIANLUCA GIAVARESI;FRANCESCO TRAINA;SAVERIO AFFATATO;STEFANO FERRARI;CESARE FALDINI;CECILIA SIGNORELLI;EMANUELA PALMERINI;MARIA GRAZIA BENEDETTI","34;27;25;21;18;18;17;17;14;14;13;13;12;12;11;11;10;10;10;10","MAURILIO MARCACCI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;MARIA GRAZIA BENEDETTI;PAOLO CARAVAGGI;NICOLA BALDINI;N. LOPOMO;FRANCESCO TRAINA;ANTONIO MAZZOTTI;STEFANO BORIANI;CESARE FALDINI;BERARDO DI MATTEO;DANTE DALLARI","4.45;3.67;3.6;3.44;2.84;2.6;2.48;2.26;2.1;2.06;1.94;1.88;1.82;1.6;1.58;1.5;1.45;1.35;1.24;1.24","MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;MILENA FINI;ELIZAVETA KON;DAVIDE MAR√çA DONATI;ALBERTO GRASSI;N. LOPOMO;NICOLA BALDINI;STEFANO BORIANI;GIANLUCA GIAVARESI;FRANCESCO TRAINA;SAVERIO AFFATATO;STEFANO FERRARI;CESARE FALDINI;CECILIA SIGNORELLI;EMANUELA PALMERINI;MARIA GRAZIA BENEDETTI","34;27;25;21;18;18;17;17;14;14;13;13;12;12;11;11;10;10;10;10","MAURILIO MARCACCI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;MARIA GRAZIA BENEDETTI;PAOLO CARAVAGGI;NICOLA BALDINI;N. LOPOMO;FRANCESCO TRAINA;ANTONIO MAZZOTTI;STEFANO BORIANI;CESARE FALDINI;BERARDO DI MATTEO;DANTE DALLARI","4.45;3.67;3.6;3.44;2.84;2.6;2.48;2.26;2.1;2.06;1.94;1.88;1.82;1.6;1.58;1.5;1.45;1.35;1.24;1.24","MAURILIO MARCACCI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;NICOLA BALDINI;PIERO PICCI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;SOFIA AVNET;GINA LISIGNOLI;SANDRINE FLEURY‚ÄêCAPPELLESSO;GIANLUCA GIAVARESI;N. LOPOMO;MILENA FINI;STEFANO BORIANI;STEFANO FERRARI;C. CYTEVAL;CHRISTIAN J√òRGENSEN;CHRISTOPHE DELFOUR;DANIEL HADDAD;DANI√àLE NO√ãL","1091;927;847;807;756;747;715;603;539;535;509;483;471;447;446;436;436;436;436;436","MAURILIO MARCACCI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;NICOLA BALDINI;PIERO PICCI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;SOFIA AVNET;GINA LISIGNOLI;MILENA FINI;STEFANO FERRARI;N. LOPOMO;ERMINIA MARIANI;NICOLETTA ZINI;GIANLUCA GIAVARESI;STEFANO BORIANI;BRUNELLA GRIGOLO;ALBERTO GRASSI;CAROLA CAVALLO;GEMMA DI POMPO","957;927;802;800;756;729;670;603;539;471;446;431;429;429;414;370;361;328;328;325","MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;STEFANO FERRARI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;ALBERTO GRASSI;CESARE FALDINI;NICOLA BALDINI;FRANCESCO TRAINA;N. LOPOMO;STEFANO BORIANI;SAVERIO AFFATATO;GIANLUCA GIAVARESI;EMANUELA PALMERINI;KATIA SCOTLANDI;ALESSANDRO RUSSO","30;27;24;21;18;18;16;16;15;14;13;13;12;12;12;11;10;10;9;9","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;SOCIOLOGY;GEOLOGY;ART;POLITICAL SCIENCE;BUSINESS;HISTORY","266;102;51;47;46;34;33;22;20;8;7;4;3;2;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;CELL BIOLOGY;GENETICS;CANCER RESEARCH;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;ONCOLOGY;IMMUNOLOGY;OPTICS;ENDOCRINOLOGY;CLASSICAL MECHANICS;ENVIRONMENTAL HEALTH;ORGANIC CHEMISTRY","156;99;97;53;51;42;37;36;35;32;31;28;26;25;22;20;20;19;15;15;15","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;SARCOMA;IN VITRO;CARTILAGE;CHEMOTHERAPY;MESENCHYMAL STEM CELL;IMPLANT;PROSTHESIS;ANTERIOR CRUCIATE LIGAMENT;BONE MARROW;CELL;POPULATION;RETROSPECTIVE COHORT STUDY;IMMUNOHISTOCHEMISTRY;KINEMATICS;RADIOGRAPHY;REHABILITATION","46;30;27;24;21;20;19;18;18;16;16;15;15;15;15;15;14;14;14;14","OSTEOARTHRITIS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;SOFT TISSUE SARCOMA;METASTASIS;CHONDROCYTE;CUBIC ZIRCONIA;GENE EXPRESSION;MENISCUS;BREAST CANCER;CANCER CELL;MICRORNA;ACL INJURY;DOXORUBICIN;GAIT ANALYSIS;OSTEOCLAST;POLYPHENOL;TUMOR MICROENVIRONMENT;AUTOPHAGY;BONE MINERAL;BONE SARCOMA;CELL CYCLE;CLINICAL ENDPOINT;COLLAGEN VI;DOWNREGULATION AND UPREGULATION;ETOPOSIDE;FIXATION (POPULATION GENETICS);GENOTYPE;PLATELET-RICH PLASMA;PROGRAMMED CELL DEATH;RETURN TO SPORT;TISSUE MICROARRAY","36;12;11;8;7;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;IFOSFAMIDE;HYDROXYTYROSOL;SIRTUIN;SYNOVIAL FLUID;WOMAC;ANTEROLATERAL LIGAMENT;BONE METASTASIS;CD99;DIFFERENTIAL ITEM FUNCTIONING;EPIRUBICIN;HIGH TIBIAL OSTEOTOMY;INTRA ARTICULAR;KNEE PAIN;MICROVESICLES;MISSENSE MUTATION;MITOPHAGY;MYELOPROLIFERATIVE NEOPLASM;ONCOGENE;OSTEOCALCIN;OSWESTRY DISABILITY INDEX;PRIMARY TUMOR;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;SIRTUIN 1;TAQMAN;TRABECTEDIN","8;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;BONE NEOPLASMS;KNEE JOINT;OSTEOSARCOMA;AGED;TREATMENT OUTCOME;YOUNG ADULT;ADOLESCENT;RETROSPECTIVE STUDIES;ANTERIOR CRUCIATE LIGAMENT INJURIES;MESENCHYMAL STEM CELLS;OSTEOARTHRITIS, KNEE;FEMUR;SARCOMA, EWING;TIBIA","172;121;115;114;75;74;57;57;57;56;52;41;39;36;33;33;31;29;28;27","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;MANAGEMENT OF SPINAL METASTATIC TUMORS;MULTIPOTENT MESENCHYMAL STEM CELLS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;ROLE OF AUTOPHAGY IN DISEASE AND HEALTH","27;25;24;15;13;13;11;9;9;6;6;5;5;5;4;4;4;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;ATHLETIC REHABILITATION;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;MENISCUS;TUMOR MICROENVIRONMENT;ACL INJURY;BIOMECHANICS;FOOT STRIKE PATTERNS;HIP ARTHROSCOPY;HIP JOINT MECHANICS;METASTATIC SPINE TUMORS;ANTERIOR CRUCIATE LIGAMENT;CANCER CELL METABOLISM","28;20;19;12;11;11;8;8;8;8;7;7;6;6;6;6;6;6;5;5","ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;LIGAMENT RECONSTRUCTION;SOFT TISSUE;TOTAL KNEE;MESENCHYMAL STROMAL;EWING SARCOMA;RANDOMIZED CONTROLLED;BONE MARROW;CONTROLLED TRIAL;KNEE ARTHROPLASTY;PRELIMINARY RESULTS;STROMAL CELLS;TISSUE SARCOMAS;TOTAL HIP;FEMORAL HEADS;ITALIAN SARCOMA;OSTEOSARCOMA CELLS;PLATELET-RICH PLASMA;STEM CELLS;ADULT SOFT;ANEURYSMAL BONE;BONE SARCOMA;BREAST CANCER;CHEMOTHERAPY CT;FINITE ELEMENT;HIGH-RISK ADULT;HIP REPLACEMENT;IIN VITROI;JOINT KINEMATICS","8;8;8;8;8;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;SYNOVIAL CELLS;CD CD;COLLAGEN VI;BOLOGNA ITALY;GENE EXPRESSION;OSTEOARTHRITIS OA;VASCULARIZED FIBULA;CANONICAL WNT;PATIENTS UNDERWENT;STROMAL CELLS;NICOLAES TULP;SYNOVIAL INFLAMMATION;SYNOVIAL MEMBRANE;CELL LINE;EXTRACELLULAR MATRIX;PATIENTS AFFECTED;STEM CELLS;SURGICALLY TREATED;BONE MARROW;PATIENTS UNDERGOING;RESIDUAL THIGH-SHANK;ADVERSE EVENTS;BONE METASTASES;CCL CCL;DNA DAMAGE;DR NICOLAES;EWS PATIENTS;HR CI;KNEE OA","22;19;18;18;17;15;14;13;12;12;12;11;11;11;10;10;10;10;10;9;9;9;8;8;8;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,1,2,0,0,1,1,0,0,1,0,4,3,0,1,4,2.33,2,0,5,4,0,1,3,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BORIANI STEFANO;CATANI FABIO;DE LUCA MARCO;DE OTO LUCIANO;GIROLAMI MAURO;LEARDINI ALBERTO;NUCCI MARIA CONCETTA;PARENTI CASTELLI VINCENZO;SANCISI NICOLA;BUDA ROBERTO","2;2;2;2;2;2;2;2;2;1","ISTITUTO ORTOPEDICO RIZZOLI;AUTOMOBILI LAMBORGHINI SPA;UNIVERSITA DI BOLOGNA;AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA MALPIGHI;AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA - MALPIGHI;UNIV PISA","7;2;2;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;34 CHEMICAL SCIENCES;3103 ECOLOGY;3202 CLINICAL SCIENCES;3402 INORGANIC CHEMISTRY;40 ENGINEERING","3;2;2;2;2;1;1;1;1","OSTEOPOROSIS;AGING;ARTHRITIS","2;1;1",NA,NA,"A61B17/62;A61B17/64;A61F2/38;A61K31/663;A61K35/28;A61K35/32;A61L27/38;C07C331/24;C07F9/38;G01N33/68","2;2;2;1;1;1;1;1;1;1","A61B17/62;A61B17/6441;A61B17/645;A61F2/08;A61F2/38;A61F2002/30639;A61F2002/30934;A61F2002/30943;A61K31/663;A61K35/28","2;2;2;2;2;2;2;2;1;1",18,2.89,210.72,4.44,3,0.17,6.72,0,0,2,0,0,0,4,12,0,9,9,0,0,0,0,0,0,18,0,0,18,0,0,0,0,0,0,0,0,0,"Italy;France;Ireland;Japan;Netherlands;Switzerland;United Kingdom","14;4;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;42 HEALTH SCIENCES;4003 BIOMEDICAL ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3402 INORGANIC CHEMISTRY;4203 HEALTH SERVICES AND SYSTEMS","16;13;4;4;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ARTHRITIS;AGING;CANCER;CHRONIC PAIN;PAIN RESEARCH;RARE DISEASES;OSTEOARTHRITIS;PATIENT SAFETY;PEDIATRIC;BIOENGINEERING;COMPARATIVE EFFECTIVENESS RESEARCH;COMPLEMENTARY AND INTEGRATIVE HEALTH;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;REHABILITATION;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","13;8;5;4;4;4;4;4;3;3;2;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;INJURIES AND ACCIDENTS","7;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.3 MEDICAL DEVICES;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;8.1 ORGANISATION AND DELIVERY OF SERVICES","5;1;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","2;2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1",1,4260521,532565.12,6,8,4,1,49,526131.149446971,0.587306036384269,"INTEGRUM (SWEDEN);ISTITUTO ORTOPEDICO RIZZOLI;LUND UNIVERSITY;SANT'ANNA SCHOOL OF ADVANCED STUDIES;SWISS CENTER FOR ELECTRONICS AND MICROTECHNOLOGY;UNIVERSITY OF ESSEX;UNIVERSITY OF GOTHENBURG;UNIVERSIT√Ä CAMPUS BIO-MEDICO","1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - LEADERSHIP IN ENABLING AND INDUSTRIAL TECHNOLOGIES - INFORMATION AND COMMUNICATION TECHNOLOGIES (ICT) (PROGRAMME);H2020-ICT-2015 (CALL FOR PROPOSAL);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","1;1;1;1","ASSISTIVE TECHNOLOGY;BIOENGINEERING;NEUROSCIENCES;PHYSICAL REHABILITATION;REHABILITATION","1;1;1;1;1","MUSCULOSKELETAL","1","5.3 MEDICAL DEVICES","1",NA,NA,NA,NA,"B12 ENGINEERING","1",NA,NA,17,"PUBLIC LIBRARY OF SCIENCE;AMERICAN CHEMICAL SOCIETY","16;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;51 PHYSICAL SCIENCES;5106 NUCLEAR AND PLASMA PHYSICS","14;12;3;3;2;2;1;1;1;1;1;1;1","CANCER;GENETICS;RARE DISEASES;STEM CELL RESEARCH;ARTHRITIS;BIOTECHNOLOGY;CLINICAL RESEARCH;INFECTIOUS DISEASES;NEURODEGENERATIVE;ORPHAN DRUG;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;VACCINE RELATED","4;2;2;2;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM","3;1;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT);6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS","3;2;1;1;1","BIOMEDICAL;CLINICAL","7;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","4;2","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER;SARCOMA","3;2;2",NA,NA
"IRCCS_RIZZOLI",2017,264,9.52651515151515,3.5719696969697,0.503787878787879,0.458333333333333,0.590909090909091,2.58356164383562,1.43010752688172,2.08620689655172,1.41818181818182,0.446969696969697,3,107,88,24,25,0.41,0.33,0.09,0.09,25.67,0.870793657978177,4.71331467413035,0.371212121212121,0.825757575757576,0.489,0.412,0.424,0.395,"PIERO PICCI;MAURILIO MARCACCI;MILENA FINI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;ELIZAVETA KON;EMANUELA PALMERINI;ALBERTO RIGHI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;NICOLA BALDINI;GIOVANNI GRIGNANI;STEFANO BORIANI;ALESSANDRO GASBARRINI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;SAVERIO AFFATATO;STEFANO FERRARI;KATIA SCOTLANDI;MICHELE BIANCHI","21;20;19;19;14;13;13;12;11;11;11;11;11;11;11;10;10;10;9;9","SAVERIO AFFATATO;MILENA FINI;MAURILIO MARCACCI;ALESSANDRA LONGHI;DAVIDE MAR√çA DONATI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;ALESSANDRO GASBARRINI;STEFANO ZAFFAGNINI;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA SAMBRI;ALBERTO RIGHI;ANTONIO MAZZOTTI;NICOLA BALDINI;CESARE FALDINI;MARCO GAMBAROTTI;MARCO BONTEMPI","2.89;2.63;2.36;2.32;2.1;1.9;1.82;1.8;1.64;1.63;1.49;1.49;1.41;1.37;1.34;1.32;1.28;1.19;1.14;1.12","PIERO PICCI;MAURILIO MARCACCI;MILENA FINI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;ELIZAVETA KON;EMANUELA PALMERINI;ALBERTO RIGHI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;NICOLA BALDINI;STEFANO BORIANI;ALESSANDRO GASBARRINI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;SAVERIO AFFATATO;STEFANO FERRARI;KATIA SCOTLANDI;MICHELE BIANCHI;GINA LISIGNOLI","21;20;19;19;14;13;13;12;11;11;11;11;11;11;10;10;10;9;9;9","SAVERIO AFFATATO;MILENA FINI;MAURILIO MARCACCI;ALESSANDRA LONGHI;DAVIDE MAR√çA DONATI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;ALESSANDRO GASBARRINI;STEFANO ZAFFAGNINI;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA SAMBRI;ALBERTO RIGHI;ANTONIO MAZZOTTI;NICOLA BALDINI;CESARE FALDINI;MARCO GAMBAROTTI;MARCO BONTEMPI","2.89;2.63;2.36;2.32;2.1;1.9;1.82;1.8;1.64;1.63;1.49;1.49;1.41;1.37;1.34;1.32;1.28;1.19;1.14;1.12","PIERO PICCI;DAVIDE MAR√çA DONATI;STEFANO FERRARI;EMANUELA PALMERINI;GIOVANNI GRIGNANI;MAURILIO MARCACCI;ANGELO PAOLO DEI TOS;EMANUELA MARCHESI;ALESSANDRO GRONCHI;VIRGINIA FERRARESI;GIUSEPPE FILARDO;NICOLA BALDINI;ELIZAVETA KON;PAOLO G. CASALI;SILVIA STACCHIOTTI;CARLO MOROSI;STEFANO ZAFFAGNINI;JEAN‚ÄêYVES BLAY;JAVIER MART√çN‚ÄêBROTO;ELENA PALASSINI","1068;953;900;769;687;608;599;592;527;509;503;489;468;466;465;441;427;423;421;414","PIERO PICCI;DAVIDE MAR√çA DONATI;STEFANO FERRARI;EMANUELA PALMERINI;EMANUELA MARCHESI;GIUSEPPE FILARDO;NICOLA BALDINI;STEFANO ZAFFAGNINI;MILENA FINI;MAURILIO MARCACCI;ALESSANDRO GASBARRINI;ALBERTO RIGHI;MICHELE BIANCHI;MARCO GAMBAROTTI;GINA LISIGNOLI;ANNA PAIOLI;CRISTINA MANFERDINI;ALESSANDRO RUSSO;ALESSANDRA LONGHI;GIUSEPPE TEDESCO","1068;953;890;769;592;503;489;427;376;328;327;326;308;298;296;277;277;250;247;239","PIERO PICCI;DAVIDE MAR√çA DONATI;MILENA FINI;STEFANO FERRARI;GIUSEPPE FILARDO;MAURILIO MARCACCI;EMANUELA PALMERINI;CESARE FALDINI;ALBERTO LEARDINI;NICOLA BALDINI;STEFANO ZAFFAGNINI;ALESSANDRO GASBARRINI;MICHELE BIANCHI;ALBERTO BAZZOCCHI;ALBERTO RIGHI;MARCO GAMBAROTTI;KATIA SCOTLANDI;SAVERIO AFFATATO;STEFANO BORIANI;ALESSANDRO RUSSO","21;19;18;15;14;13;13;12;11;11;11;11;10;10;10;10;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;ENGINEERING;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;BUSINESS;ECONOMICS;GEOGRAPHY;HISTORY;ART","236;96;57;47;31;29;25;13;9;6;6;5;4;3;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;GENETICS;CANCER RESEARCH;COMPOSITE MATERIAL;ANATOMY;CELL BIOLOGY;RADIOLOGY;ORTHODONTICS;PHYSICAL THERAPY;BIOMEDICAL ENGINEERING;IMMUNOLOGY;ORGANIC CHEMISTRY;ONCOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;NANOTECHNOLOGY;PALEONTOLOGY","123;105;99;53;34;32;32;30;30;28;25;25;24;20;20;16;14;13;13;12","ALTERNATIVE MEDICINE;CANCER;GENE;SARCOMA;IN VITRO;OSTEOPOROSIS;MESENCHYMAL STEM CELL;ORTHOPEDIC SURGERY;ARTHROPLASTY;IMPLANT;CHEMOTHERAPY;OSTEOSARCOMA;POPULATION;CARTILAGE;RECEPTOR;STEM CELL;STROMAL CELL;SOFT TISSUE;ANTERIOR CRUCIATE LIGAMENT;CLINICAL TRIAL;PROSPECTIVE COHORT STUDY;RADIOGRAPHY","31;31;29;25;21;19;18;17;15;15;14;14;14;13;11;11;11;10;9;9;9;9","OSTEOARTHRITIS;METASTASIS;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;BREAST CANCER;OSTEOBLAST;GIANT-CELL TUMOR OF BONE;OSTEOCLAST;GENE EXPRESSION;MUTATION;STAPHYLOCOCCUS AUREUS;ALKALINE PHOSPHATASE;CANCER CELL;CD34;CROSS-LINKED POLYETHYLENE;DENOSUMAB;SUNITINIB;ACTIVATOR (GENETICS);ALLELE;ANKLE REPLACEMENT;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DEPOSITION (GEOLOGY);DNA DAMAGE;DOWNREGULATION AND UPREGULATION;FIXATION (POPULATION GENETICS);GIANT CELL TUMORS;HIP FRACTURE;MICRORNA;PEEK;PERIPROSTHETIC;PHENOTYPE;RETURN TO SPORT;UNIVARIATE ANALYSIS;VIABILITY ASSAY","21;11;11;8;8;8;8;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;DUAL-ENERGY X-RAY ABSORPTIOMETRY;TRABECTEDIN;BONE METASTASIS;EPIRUBICIN;IFOSFAMIDE;PAZOPANIB;PRIMARY TUMOR;RANKL;ANTEROLATERAL LIGAMENT;CD99;CYSTATHIONINE BETA SYNTHASE;LOW-INTENSITY PULSED ULTRASOUND;OSWESTRY DISABILITY INDEX;PIVOT-SHIFT TEST;SYNOVIAL FLUID;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;WOMAC;ACHILLES TENDON RUPTURE;ADAMANTINOMA;ADIPOKINE;ALPHA (FINANCE);AMPK;ANTHRACYCLINE;ARTHROPATHY;ARTHROSPIRA;BREAST CARCINOMA;CD163;CD40;CD90;CEFTAZIDIME;CELL CYCLE CHECKPOINT;CHEMOKINE RECEPTOR;CLOFARABINE;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);CXCR4;CYCLIN;CYCLIN D1;DBM;DISKECTOMY;DISTANT METASTASIS;DNA METHYLATION;DUAL ENERGY;ENSTROPHY;ENTHESITIS;ESTROGEN RECEPTOR;EXOME SEQUENCING;EXTERNAL BEAM RADIOTHERAPY;FANCONI ANEMIA;FUSION PROTEIN;GENEXPERT MTB/RIF;GENOME INSTABILITY;GENOTYPE-PHENOTYPE DISTINCTION;GERMLINE MUTATION;GIANT CELL ARTERITIS;GOLIMUMAB;GRANZYME B;IMIPENEM;IMMUNE CHECKPOINT;INSULIN-LIKE GROWTH FACTOR;IRINOTECAN;KLEBSIELLA PNEUMONIAE;KNEE PAIN;LEISHMANIA INFANTUM;LMNA;M2 MACROPHAGE;MEROPENEM;MESALAZINE;METASTATIC BREAST CANCER;METHYLTRANSFERASE;MIRBASE;NEOADJUVANT THERAPY;ONCOGENE;ONCOGENE PROTEINS;OSTEOCALCIN;OSTEOCYTE;OSTEOPENIA;PENCIL-BEAM SCANNING;PITUITARY APOPLEXY;POLY ADP RIBOSE POLYMERASE;PONSETI METHOD;POSTERIOR INTEROSSEOUS NERVE;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;REFERENCE GENES;REPORTER GENE;RNA EXTRACTION;RNA INTERFERENCE;ROCK1;ROCK2;RUNX2;SANGER SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;SOLITARY FIBROUS TUMOR;SOX2;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;SYSTEMIC THERAPY;TAKAYASU ARTERITIS;TERIPARATIDE;THROMBOSPONDIN;TRANSCRIPTOME;TRANSLATION (BIOLOGY);TRANSSPHENOIDAL SURGERY;TRASTUZUMAB;TUMOR-INFILTRATING LYMPHOCYTES;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VANCOMYCIN;VASCULOGENESIS;VASCULOGENIC MIMICRY;VIRUS-LIKE PARTICLE","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;ADULT;BONE NEOPLASMS;MIDDLE AGED;AGED;YOUNG ADULT;ADOLESCENT;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;CARTILAGE, ARTICULAR;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;KNEE JOINT;NEOPLASM RECURRENCE, LOCAL;FOLLOW-UP STUDIES;SPINAL NEOPLASMS;OSTEOCLASTS","157;103;95;94;72;65;64;54;43;38;37;36;32;31;31;30;28;25;25;24","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;MANAGEMENT OF SPINAL METASTATIC TUMORS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;MULTIPOTENT MESENCHYMAL STEM CELLS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;BIOMEDICAL APPLICATIONS OF SILK BIOMATERIALS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;TREATMENT AND OUTCOMES OF HAND INJURIES;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES","27;18;14;14;12;11;10;6;6;5;5;4;4;3;3;3;3;3;3;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;SOFT TISSUE SARCOMA;TOTAL KNEE REPLACEMENT;OSTEOBLAST ADHESION;EWING'S SARCOMA;GIANT CELL TUMOR;OSTEOSARCOMA;ATHLETIC REHABILITATION;BONE REGENERATION;BONE REMODELING;METASTATIC SPINE TUMORS;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;LIMB RECONSTRUCTION;OSTEOCLAST DIFFERENTIATION;REVISION SURGERY;SPINAL FUSION;BIOMATERIAL;BONE HEALING","15;13;12;11;10;9;9;8;7;7;7;7;6;6;5;5;5;5;4;4","ANTERIOR CRUCIATE;CELL TUMOR;CRUCIATE LIGAMENT;EWING SARCOMA;GIANT CELL;SOFT TISSUE;STROMAL CELLS;MESENCHYMAL STEM;LIGAMENT RECONSTRUCTION;STEM CELLS;TOTAL KNEE;CONTROLLED TRIAL;MESENCHYMAL STROMAL;BONE METASTASES;CALCIUM PHOSPHATE;CLINICAL TRIAL;COHORT STUDY;COMPUTED TOMOGRAPHY;CRITICAL ANALYSIS;FEMORAL HEADS;HAND OSTEOARTHRITIS;HIP ARTHROPLASTY;KNEE ARTHROPLASTY;KNEE REPLACEMENT;LOCAL RECURRENCE;MINIMUM FOLLOW-UP;MULTICENTRE RANDOMIZED;OSTEOSARCOMA PATIENTS;RANDOMIZED CONTROLLED;SPINE TUMORS","7;7;7;7;7;7;7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","STEM CELLS;BOLOGNA ITALY;CELL LINES;DE LIUZZI;PRIMARY TUMOR;OSTEOGENIC DIFFERENTIATION;WEIGHT BEARING;BONE TISSUE;CELL VIABILITY;LOCAL RECURRENCE;STROMAL CELLS;LUNG METASTASES;MESENCHYMAL STEM;SOFT TISSUE;STATISTICALLY SIGNIFICANT;BONE METASTASES;CLINICAL TRIAL;CLINICAL TRIALS;KNEE LAXITY;MESENCHYMAL STROMAL;SYNOVIAL CELLS;ACL RECONSTRUCTION;CLINICAL RESEARCH;COORDINATION PATTERNS;GENE EXPRESSION;GIANT CELL;HIP FRACTURE;HUMAN BODY;HUMAN OSTEOSARCOMA;MECHANICAL PROPERTIES","16;13;11;11;11;10;10;9;9;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,7,2,0,2,0,0,0,0,0,0,8,2,1,3.33333333333333,4.90909090909091,5.73,2.72727272727273,0,11,9,1,1,2,1,1,2,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,3,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BORIANI STEFANO;DE LUCA MARCO;DE OTO LUCIANO;GIROLAMI MAURO;NUCCI MARIA CONCETTA;CALDERONE VINCENZO;CATANI FABIO;GRASSI FRANCESCO;LEARDINI ALBERTO;LISIGNOLI GINA","5;5;5;5;5;2;2;2;2;2","ISTITUTO ORTOPEDICO RIZZOLI;AUTOMOBILI LAMBORGHINI SPA;AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA - MALPIGHI;ST ORTOPEDICO RIZZOLI;UNIVERSITA DI PISA;AUTOMOBILI LAMBORGHINI S P A;AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA MALPIGHI;AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA POLICLINICO SORSOLA MALPIGHI;ISTITUTO SUPERIORE DI SANITA ISS;RIZZOLI DEPARTMENT OF ORTHOPEDICS RESEARCH INSTITUTE","10;4;3;3;2;1;1;1;1;1","31 BIOLOGICAL SCIENCES;33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;34 CHEMICAL SCIENCES;42 HEALTH SCIENCES;3402 INORGANIC CHEMISTRY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;4207 SPORTS SCIENCE AND EXERCISE;4208 TRADITIONAL, COMPLEMENTARY AND INTEGRATIVE MEDICINE","7;5;4;4;3;2;1;1;1;1","ARTHRITIS;OSTEOPOROSIS;PEDIATRIC;RARE DISEASES","1;1;1;1",NA,NA,"A61B17/62;A61B17/64;A61K31/663;C07C331/24;C07F9/38;A61F2/38;A61P35/00;C07K16/28","6;5;2;2;2;1;1;1","A61B17/62;A61B17/6441;A61B17/645;A61F2/08;A61F2/38;A61F2002/30639;A61F2002/30934;A61F2002/30943;A61K31/663;C07C331/24","5;5;5;2;2;2;2;2;2;2",21,4.9,165.62,5.98,6,0.29,19.05,0,3,2,0,1,0,4,11,0,17,4,0,0,0,0,0,0,21,0,0,20,0,0,1,0,0,0,0,0,0,"Italy;United States;Belgium;Spain;United Kingdom","9;5;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;31 BIOLOGICAL SCIENCES;3105 GENETICS;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4205 NURSING;46 INFORMATION AND COMPUTING SCIENCES;4604 CYBERSECURITY AND PRIVACY;50 PHILOSOPHY AND RELIGIOUS STUDIES","18;15;4;4;4;4;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;ARTHRITIS;CANCER;CHRONIC PAIN;PAIN RESEARCH;BIOENGINEERING;AGING;RARE DISEASES;OSTEOARTHRITIS;REGENERATIVE MEDICINE;CARDIOVASCULAR;COMPARATIVE EFFECTIVENESS RESEARCH;PREVENTION;REHABILITATION;STEM CELL RESEARCH;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;BIOTECHNOLOGY","19;12;8;6;6;6;6;5;4;4;3;3;2;2;2;2;2;1;1;1","MUSCULOSKELETAL;BLOOD;CANCER;INFLAMMATORY AND IMMUNE SYSTEM","10;1;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","11;4;2;1;1","SARCOMA;NOT SITE-SPECIFIC CANCER","2;1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",6,3854439.6,282711.26,5.16666666666667,9.5,3.83333333333333,0.5,12,675363.345124409,0.390900693539073,"ISTITUTO ORTOPEDICO RIZZOLI;NEWCASTLE UNIVERSITY;UNIVERSITY MEDICAL CENTER FREIBURG;UNIVERSITY OF BOLOGNA;UNIVERSITY OF ULM;ACADEMIC MEDICAL CENTER;ALLEANZA CONTRO IL CANCRO;AMGEN (BELGIUM);ANTWERP UNIVERSITY HOSPITAL;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;ASTRAZENECA (SWEDEN);AUGUST PI I SUNYER BIOMEDICAL RESEARCH INSTITUTE;AUTONOMOUS UNIVERSITY OF MADRID;BAMBINO GES√ô CHILDREN'S HOSPITAL;BAYER (GERMANY);CENTRE HOSPITALIER UNIVERSITAIRE DE TOURS;CHARIT√â - UNIVERSITY MEDICINE BERLIN;CHARLES RIVER LABORATORIES (GERMANY);D√âL√âGATION PARIS 11;ELI LILLY (UNITED KINGDOM)","6;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;CANCER RESEARCH UK","5;1","COALITION S;EC & ERC - EUROPEAN UNION;AMRC - ASSOCIATION OF MEDICAL RESEARCH CHARITIES;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","5;5;1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);3RD HEALTH PROGRAMME (PROGRAMME);H2020-JTI-IMI2-2015-07-TWO-STAGE (CALL FOR PROPOSAL)","3;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3105 GENETICS;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","5;2;2;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;ORPHAN DRUG;PEDIATRIC;BRAIN CANCER;BRAIN DISORDERS;COMPARATIVE EFFECTIVENESS RESEARCH;HEALTH SERVICES;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;REGENERATIVE MEDICINE;TRANSPLANTATION","4;3;2;2;2;2;2;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER","3;1","5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)","2;2;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","1;1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","4;2",NA,NA,24,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;KARGER PUBLISHERS;THE UNIVERSITY OF SHEFFIELD","15;5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3105 GENETICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;3009 VETERINARY SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;4003 BIOMEDICAL ENGINEERING;3101 BIOCHEMISTRY AND CELL BIOLOGY;3108 PLANT BIOLOGY;38 ECONOMICS;3801 APPLIED ECONOMICS;42 HEALTH SCIENCES;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4301 ARCHAEOLOGY;46 INFORMATION AND COMPUTING SCIENCES;4610 LIBRARY AND INFORMATION STUDIES","20;13;5;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","PREVENTION;RARE DISEASES;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL RESEARCH;EMERGING INFECTIOUS DISEASES;GENETICS;IMMUNIZATION;INFECTIOUS DISEASES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;OSTEOPOROSIS;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;VACCINE RELATED;VECTOR-BORNE DISEASES","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INFECTION;CANCER;GENERIC HEALTH RELEVANCE;INJURIES AND ACCIDENTS;MUSCULOSKELETAL","4;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES","2;2;1;1","BIOMEDICAL;CLINICAL","4;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","13;5","NOT SITE-SPECIFIC CANCER;LEUKEMIA / LEUKAEMIA;PROSTATE CANCER","4;1;1","3 GOOD HEALTH AND WELL BEING","3"
"IRCCS_RIZZOLI",2018,347,10.6599423631124,3.97406340057637,0.553314121037464,0.538904899135447,0.593659942363112,2.61174242424242,1.58677685950413,2.07777777777778,1.63492063492063,0.429394812680115,3,139,82,25,64,0.4,0.24,0.07,0.18,25.36,0.831352464878241,4.43272171253822,0.380403458213256,0.737752161383285,0.52,0.44,0.464,0.459,"PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;KATIA SCOTLANDI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;MAURILIO MARCACCI;SILVIA STACCHIOTTI;ALESSANDRO GASBARRINI;JAVIER MART√çN‚ÄêBROTO;ANGELO PAOLO DEI TOS;PAOLO CARAVAGGI;SAVERIO AFFATATO;PAOLO G. CASALI;GIOVANNI GRIGNANI","32;24;20;20;19;17;17;17;15;15;15;14;14;13;12;12;11;11;10;10","SAVERIO AFFATATO;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO BAZZOCCHI;SOFIA AVNET;MILENA FINI;PIERO PICCI;GIUSEPPE FILARDO;PAOLO CARAVAGGI;ALESSANDRO GASBARRINI;MAURILIO MARCACCI;ALBERTO GRASSI;CLAUDIO BELVEDERE;MASSIMILIANO BALEANI;MASSIMILIANO MEROLA;EMANUELA PALMERINI;PAOLO SPINNATO;KATIA SCOTLANDI","3.98;3.15;3.11;2.96;2.7;2.62;2.58;2.54;2.33;2.18;1.95;1.91;1.9;1.89;1.8;1.71;1.7;1.59;1.58;1.57","PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;KATIA SCOTLANDI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;MAURILIO MARCACCI;ALESSANDRO GASBARRINI;ANGELO PAOLO DEI TOS;PAOLO CARAVAGGI;SAVERIO AFFATATO;SOFIA AVNET;CLAUDIO BELVEDERE;STEFANO FERRARI;ALBERTO RIGHI","32;24;20;20;19;17;17;17;15;15;15;14;13;12;11;11;10;10;10;9","SAVERIO AFFATATO;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO BAZZOCCHI;SOFIA AVNET;MILENA FINI;PIERO PICCI;GIUSEPPE FILARDO;PAOLO CARAVAGGI;ALESSANDRO GASBARRINI;MAURILIO MARCACCI;ALBERTO GRASSI;CLAUDIO BELVEDERE;MASSIMILIANO BALEANI;MASSIMILIANO MEROLA;EMANUELA PALMERINI;PAOLO SPINNATO;KATIA SCOTLANDI","3.98;3.15;3.11;2.96;2.7;2.62;2.58;2.54;2.33;2.18;1.95;1.91;1.9;1.89;1.8;1.71;1.7;1.59;1.58;1.57","PIERO PICCI;SILVIA STACCHIOTTI;ANGELO PAOLO DEI TOS;GIOVANNI GRIGNANI;PAOLO G. CASALI;JAVIER MART√çN‚ÄêBROTO;ALESSANDRO GRONCHI;JEAN‚ÄêYVES BLAY;HANS GELDERBLOM;ANTONIO L√ìPEZ‚ÄìPOUSA;PIOTR RUTKOWSKI;ENRIQUE DE √ÅLAVA;ROBIN L. JONES;XAVIER GARC√çA DEL MURO;R. BIAGINI;KIRSTEN SUNDBY HALL;ANNA MARIA FREZZA;RAIMONDO PIANA;VIRGINIA FERRARESI;SEBASTIAN BAUER","3318;2962;2906;2882;2856;2813;2753;2724;2709;2704;2683;2646;2641;2634;2628;2604;2594;2593;2574;2548","PIERO PICCI;STEFANO FERRARI;S. FERRARI;NICOLA BALDINI;EMANUELA PALMERINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;SOFIA AVNET;KATIA SCOTLANDI;ALBERTO RIGHI;ALBERTO LEARDINI;MARCO GAMBAROTTI;ALESSANDRO DI MARTINO;ALBERTO BAZZOCCHI;ANNARITA CENACCHI;FILIPPO SELLERI;FRANCESCO TENTONI","3318;2270;688;512;500;437;434;389;371;361;321;310;280;249;234;232;223;204;204;204","PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO FERRARI;ALBERTO BAZZOCCHI;ALBERTO GRASSI;KATIA SCOTLANDI;ALESSANDRO GASBARRINI;PAOLO CARAVAGGI;SAVERIO AFFATATO;CLAUDIO BELVEDERE;SOFIA AVNET;ALBERTO RIGHI;GINA LISIGNOLI;CESARE FALDINI","32;24;20;19;19;17;17;17;16;15;15;15;13;11;11;10;10;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;HISTORY;SOCIOLOGY;BUSINESS;GEOLOGY;ART;ECONOMICS;ENVIRONMENTAL SCIENCE","308;101;54;42;37;34;26;26;8;8;8;5;5;4;4;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;CANCER RESEARCH;BIOCHEMISTRY;ORTHODONTICS;CELL BIOLOGY;PHYSICAL THERAPY;GENETICS;RADIOLOGY;BIOMEDICAL ENGINEERING;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;ONCOLOGY;COMPOSITE MATERIAL;ARTIFICIAL INTELLIGENCE;ORGANIC CHEMISTRY;STRUCTURAL ENGINEERING","176;127;123;51;49;48;45;43;43;42;37;27;25;25;24;24;23;16;16;14","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;POPULATION;SARCOMA;ARTHROPLASTY;CHEMOTHERAPY;IMPLANT;OSTEOSARCOMA;ANTERIOR CRUCIATE LIGAMENT;MESENCHYMAL STEM CELL;OSTEOPOROSIS;REHABILITATION;IN VITRO;RADIOGRAPHY;IMMUNOHISTOCHEMISTRY;PROSTHESIS;RETROSPECTIVE COHORT STUDY;STEM CELL","53;43;42;28;24;24;22;22;21;20;19;19;19;17;15;15;14;13;13;13","OSTEOARTHRITIS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;METASTASIS;SOFT TISSUE SARCOMA;BREAST CANCER;FIXATION (POPULATION GENETICS);CISPLATIN;GENE EXPRESSION;GENOTYPE;OSTEOCLAST;TRANSCRIPTION FACTOR;BONE CEMENT;BONE MINERAL;CD34;CHEMOKINE;DOWNREGULATION AND UPREGULATION;HIP FRACTURE;LOW BACK PAIN;OSTEOBLAST;RETURN TO SPORT;SUNITINIB","31;16;16;9;8;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","ARTICULAR CARTILAGE;PIVOT-SHIFT TEST;GENETIC ARCHITECTURE;IFOSFAMIDE;LMNA;PAZOPANIB;SINGLE-NUCLEOTIDE POLYMORPHISM;UNICOMPARTMENTAL KNEE ARTHROPLASTY;BONE METASTASIS;CD99;DNA METHYLATION;FLI1;HISTONE DEACETYLASE;PRIMARY TUMOR;TRABECTEDIN;CLOFARABINE;CXCR4;ENTHESITIS;EPIRUBICIN;INFRAPATELLAR FAT PAD;INSULIN-LIKE GROWTH FACTOR;INTRA ARTICULAR;LUCIFERASE;METASTATIC BREAST CANCER;MICROVESICLES;NIVOLUMAB;OSWESTRY DISABILITY INDEX;POSTERIOR INTEROSSEOUS NERVE;RADIAL HEAD FRACTURE;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;TRANSCRIPTOME;VARUS DEFORMITY","6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;BONE NEOPLASMS;ADULT;AGED;YOUNG ADULT;ADOLESCENT;TREATMENT OUTCOME;KNEE JOINT;RETROSPECTIVE STUDIES;OSTEOSARCOMA;AGED, 80 AND OVER;TIBIA;SARCOMA, EWING;MESENCHYMAL STEM CELLS;CHILD;FOLLOW-UP STUDIES","173;164;111;110;80;79;70;68;45;43;38;35;34;33;31;27;26;24;22;22","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MULTIPOTENT MESENCHYMAL STEM CELLS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION","28;26;22;15;14;11;11;10;10;10;10;8;8;8;8;5;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;EWING'S SARCOMA;SOFT TISSUE SARCOMA;ATHLETIC REHABILITATION;HIP ARTHROPLASTY;BIOMECHANICS;METASTATIC SPINE TUMORS;REHABILITATION;HIP FRACTURE;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;OSTEOSARCOMA;PROXIMAL HUMERUS FRACTURES;ANTERIOR CRUCIATE LIGAMENT;BONE REGENERATION;FOOT (PROSODY);INTERNAL FIXATION;OSTEOARTHRITIS TREATMENT","27;20;19;17;13;11;10;9;8;8;7;7;7;7;7;6;6;6;6;6","EWING SARCOMA;GIANT CELL;STEM CELLS;TOTAL KNEE;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;TOTAL HIP;KNEE ARTHROPLASTY;SOFT TISSUE;CONTROLLED TRIAL;HIP ARTHROPLASTY;LIGAMENT RECONSTRUCTION;MESENCHYMAL STEM;OBSERVATIONAL STUDY;PRELIMINARY RESULTS;BREAST CANCER;CLINICAL TRIAL;MESENCHYMAL STROMAL;SURGICAL TREATMENT;ASSOCIATION STUDY;BONE MARROW;CALCIUM PHOSPHATE;CEMENTLESS TOTAL;COHORT STUDY;GENOME-WIDE ASSOCIATION;HYALURONIC ACID;RADIAL HEAD;RANDOMISED CONTROLLED;STROMAL CELLS;TENOSYNOVIAL GIANT","10;10;9;9;8;8;8;7;7;6;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;CROSSREF PUBMED;GASTROINTESTINAL STROMAL;ONCOL -CROSSREF;SOFT TISSUE;CLIN ONCOL;ACL RECONSTRUCTION;ONCOL -ABSTRACT;CD CD;EWING SARCOMA;CELL LINES;PATIENTS TREATED;STEM CELLS;BONE TUMORS;STANDARD TREATMENT;ANTERIOR CRUCIATE;BONE SARCOMAS;CRUCIATE LIGAMENT;GROWTH FACTOR;STATISTICALLY SIGNIFICANT;STROMAL TUMORS;GENE EXPRESSION;IKDC CLINICAL;LOCAL RECURRENCE;BONE SARCOMA;CLINICAL PRACTICE;OXIDATIVE STRESS;PATIENTS UNDERGOING;CANCER -ABSTRACT;CELL DEATH","123;87;33;32;28;26;23;22;20;17;15;15;15;14;14;13;13;13;13;13;13;12;12;12;11;11;11;11;10;10",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,2,1,0,0,1,0,0,0,4,0,0,4,1.16,2.25,0,3,3,1,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CALDERONE VINCENZO;GRASSI FRANCESCO;LISIGNOLI GINA;RAPPOSELLI SIMONA;BORIANI STEFANO;DE LUCA MARCO;DE OTO LUCIANO;FINI MILENA;GIARDINO ROBERTO;GIROLAMI MAURO","2;2;2;2;1;1;1;1;1;1","ISTITUTO ORTOPEDICO RIZZOLI;UNIVERSITA DI PISA;AUTOMOBILI LAMBORGHINI SPA;AZIENDA OSPEDALIERO UNIV DI BOLOGNA POLICLINICO S ORSOLA MALPIGHI;ST ORTOPEDICO RIZZOLI","4;2;1;1;1","34 CHEMICAL SCIENCES;31 BIOLOGICAL SCIENCES;33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;3402 INORGANIC CHEMISTRY","2;1;1;1;1",NA,NA,NA,NA,"A61K31/663;C07C331/24;C07F9/38;A61B17/62;A61B17/64;C07C331/28;G01N33/68","2;2;2;1;1;1;1","A61K31/663;C07C331/24;C07C331/28;C07F9/38;C07F9/3873;A61B17/62;A61B17/6441;A61B17/645;G01N2800/108;G01N33/6893","2;2;2;2;2;1;1;1;1;1",29,3.59,158.93,5.8,3,0.1,5.14,1,0,3,0,1,0,0,24,0,14,15,0,0,0,0,0,0,29,0,0,29,0,0,0,0,0,0,0,0,0,"Italy;Sweden;Netherlands;United States","25;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;40 ENGINEERING;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;4207 SPORTS SCIENCE AND EXERCISE;31 BIOLOGICAL SCIENCES;3105 GENETICS;3203 DENTISTRY;3215 REPRODUCTIVE MEDICINE;4003 BIOMEDICAL ENGINEERING","21;15;6;5;5;3;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CANCER;BIOENGINEERING;BIOMEDICAL IMAGING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;ARTHRITIS;REHABILITATION;PATIENT SAFETY;AGING;BIOTECHNOLOGY;COMPARATIVE EFFECTIVENESS RESEARCH;PEDIATRIC CANCER;PREVENTION;CHRONIC PAIN;NEUROSCIENCES;ORPHAN DRUG;PAIN RESEARCH;PEDIATRIC RESEARCH INITIATIVE","19;10;6;6;6;6;6;5;5;4;3;3;3;3;3;2;2;2;2;2","MUSCULOSKELETAL;CANCER;BLOOD;CARDIOVASCULAR","9;4;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","6;3;3;1;1;1;1;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER","6;5;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","3;2;1;1;1",3,162194,162194,3,1,1,0,70,801132.611791075,0.433136780219469,"ISTITUTO ORTOPEDICO RIZZOLI","3","EUROPEAN COMMISSION;TELETHON FOUNDATION","2;1","COALITION S;EC & ERC - EUROPEAN UNION","2;2","3RD HEALTH PROGRAMME (PROGRAMME);CONNECTING EUROPE FACILITY (PROGRAMME)","1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;2","CLINICAL RESEARCH","1",NA,NA,NA,NA,NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C18 LAW","1;1",NA,NA,9,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;TAYLOR & FRANCIS GROUP","7;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY","6;4;3;1;1;1","BRAIN DISORDERS;CANCER;CLINICAL RESEARCH;GENETICS;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;RARE DISEASES;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1;1;1;1;1;1;1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1;1","BIOMEDICAL","2","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","3;1","MELANOMA","1",NA,NA
"IRCCS_RIZZOLI",2019,289,10.2491349480969,3.82352941176471,0.484429065743945,0.508650519031142,0.716262975778547,2.83333333333333,1.55555555555556,2.1304347826087,1.52205882352941,0.512110726643599,3,101,101,35,19,0.35,0.35,0.12,0.07,24.19,0.994652438687755,4.59889540904383,0.439446366782007,0.892733564013841,0.499,0.409,0.463,0.441,"STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;PIERO PICCI;ALBERTO LEARDINI;BARBARA BORDINI;GIANLUCA GIAVARESI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;NICOLA BALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;ALESSANDRA LONGHI;SILVIA STACCHIOTTI;MATTEO BERNI","24;21;21;19;17;17;13;13;12;11;11;11;11;10;10;9;9;9;9;9","STEFANO ZAFFAGNINI;LEVENT √ñZ√áAKAR;VINCENZO RICCI;SAVERIO AFFATATO;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO LEARDINI;PAOLO SPINNATO;ALBERTO GRASSI;SOFIA AVNET;MILENA FINI;NICOLA BALDINI;ALBERTO BAZZOCCHI;COSTANTINO ERRANI;MARCO VICECONTI;ALESSANDRO GASBARRINI;ALESSANDRO RUGGIERO","3.07;2.75;2.75;2.5;2.39;2.31;1.79;1.78;1.75;1.73;1.72;1.62;1.59;1.56;1.51;1.45;1.38;1.37;1.35;1.33","STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;PIERO PICCI;ALBERTO LEARDINI;BARBARA BORDINI;GIANLUCA GIAVARESI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;NICOLA BALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;ALESSANDRA LONGHI;MATTEO BERNI;FRANCESCO TRAINA","24;21;21;19;17;17;13;13;12;11;11;11;11;10;10;9;9;9;9;9","STEFANO ZAFFAGNINI;VINCENZO RICCI;SAVERIO AFFATATO;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO LEARDINI;PAOLO SPINNATO;ALBERTO GRASSI;SOFIA AVNET;MILENA FINI;NICOLA BALDINI;ALBERTO BAZZOCCHI;COSTANTINO ERRANI;MARCO VICECONTI;ALESSANDRO GASBARRINI;EMANUELA PALMERINI;FRANCESCO CASTAGNINI","3.07;2.75;2.5;2.39;2.31;1.79;1.78;1.75;1.73;1.72;1.62;1.59;1.56;1.51;1.45;1.38;1.37;1.35;1.31;1.26","EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;HANS GELDERBLOM;LUCA SANGIORGI;JEAN‚ÄêYVES BLAY;SILVIA STACCHIOTTI;ANDREA SUPERTI‚ÄêFURGA;CHRISTINE M HALL;DANIEL H. COHN;DAVID SILLENCE;DEBORAH KRAKOW;GEERT MORTIER;GEN NISHIMURA;MATTHEW L. WARMAN;RAVI SAVARIRAYAN;SHEILA UNGER;STEFAN MUNDLOS;STEPHEN P. ROBERTSON;VAL√âRIE CORMIER‚ÄêDAIRE","791;714;667;605;605;583;560;497;497;497;497;497;497;497;497;497;497;497;497;497","EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;LUCA SANGIORGI;ALBERTO GRASSI;MILENA FINI;DAVIDE MAR√çA DONATI;LUCA MACCHIAROLA;ALBERTO RIGHI;GIANLUCA GIAVARESI;CARLA RENATA ARCIOLA;ALBERTO BAZZOCCHI;DAVIDE CAMPOCCIA;ALBERTO LEARDINI;STEFANO RAVAIOLI;BRUNELLA GRIGOLO;GINA LISIGNOLI;KATIA SCOTLANDI;ALESSANDRO GASBARRINI;PIERO PICCI","791;696;667;605;481;416;350;328;322;316;299;288;286;278;265;243;223;219;206;196","STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIERO PICCI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;ALESSANDRA LONGHI;CESARE FALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;COSTANTINO ERRANI;NICOLA BALDINI","24;21;20;18;17;17;13;13;11;11;11;11;11;10;9;9;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;GEOLOGY;POLITICAL SCIENCE;BUSINESS;SOCIOLOGY;ART;ECONOMICS;HISTORY","248;82;53;40;38;33;27;26;9;9;8;7;5;5;4;4;3","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;BIOMEDICAL ENGINEERING;CANCER RESEARCH;CELL BIOLOGY;RADIOLOGY;COMPOSITE MATERIAL;GENETICS;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;ORTHODONTICS;ENVIRONMENTAL HEALTH;IMMUNOLOGY;OPTICS;ORGANIC CHEMISTRY;ARTIFICIAL INTELLIGENCE;ENDOCRINOLOGY","146;103;85;54;44;36;36;36;32;28;28;25;24;23;19;19;17;16;14;13","ALTERNATIVE MEDICINE;GENE;ARTHROPLASTY;POPULATION;CARTILAGE;OSTEOPOROSIS;CANCER;ORTHOPEDIC SURGERY;IN VITRO;MESENCHYMAL STEM CELL;SARCOMA;CHEMOTHERAPY;IMPLANT;INCIDENCE (GEOMETRY);ANTERIOR CRUCIATE LIGAMENT;COHORT;OSTEOSARCOMA;TENDON;RECEPTOR;RETROSPECTIVE COHORT STUDY;SCAFFOLD","42;36;21;20;19;18;16;16;15;15;14;13;13;13;12;12;12;12;11;11;11","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);MICRORNA;CHEMOKINE;MENISCUS;METASTASIS;BONE MINERAL;DENOSUMAB;GAIT ANALYSIS;HAZARD RATIO;MUTATION;NEURORADIOLOGY;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ETOPOSIDE;GENE EXPRESSION;GIANT-CELL TUMOR OF BONE;OSTEOBLAST;PERIPROSTHETIC;ACHILLES TENDON;ACL INJURY;BONE DENSITY;CHONDROCYTE;CHONDROGENESIS;EVIDENCE-BASED MEDICINE;GIANT CELL TUMORS;HARRIS HIP SCORE;KNEE REPLACEMENT;LAMIN;LOW BACK PAIN;OSSEOINTEGRATION;OSTEOCLAST;PATELLAR TENDON;PHASES OF CLINICAL RESEARCH;PHENOTYPE;RNA;SUBLUXATION;TUMOR MICROENVIRONMENT;UNIVARIATE ANALYSIS","27;10;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;MICROVESICLES;CXCR4;IFOSFAMIDE;ACHILLES TENDON RUPTURE;CD99;CHEMOKINE RECEPTOR;DIGITAL IMAGE;INDUCED PLURIPOTENT STEM CELL;MEDIAL MENISCUS;MERKEL CELL POLYOMAVIRUS;MULTIPLEX POLYMERASE CHAIN REACTION;RUNX2;TELOMERASE REVERSE TRANSCRIPTASE;TERIPARATIDE;WOMAC;ACTIN CYTOSKELETON;ADENOSINE KINASE;ADIPOSE TISSUE MACROPHAGES;AKT1;ANTIRETROVIRAL THERAPY;ATP7A;BONE DENSITY CONSERVATION AGENTS;BRILLOUIN SPECTROSCOPY;BUSULFAN;CARBONIC ANHYDRASE I;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CLASSIFICATION OF OBESITY;CLAUDICATION;COMPLEMENT COMPONENT 5;COMPLEMENT FACTOR B;COMPLEMENT MEMBRANE ATTACK COMPLEX;CONGENITAL MYOPATHY;CONGENITAL TALIPES EQUINOVARUS;CYCLIN-DEPENDENT KINASE 2;DEBULKING;DECORIN;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;ENTEROCOCCUS FAECALIS;EXCESSIVE DAYTIME SLEEPINESS;EXOME SEQUENCING;FACET (PSYCHOLOGY);FERROPORTIN;FLUORESCENCE IN SITU HYBRIDIZATION;GENE MUTATION;GENETICALLY MODIFIED MOUSE;GERMLINE MUTATION;HAMP;HISTONE DEACETYLASE;HYDROXYTYROSOL;IL-2 RECEPTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INTRA ARTICULAR;IRINOTECAN;IRON STATUS;ISCHEMIA-MODIFIED ALBUMIN;JOINT DISEASE;KNEE ARTHRITIS;LASER CAPTURE MICRODISSECTION;LENVATINIB;LMNA;LONG NON-CODING RNA;LOW-INTENSITY PULSED ULTRASOUND;MECHANOSENSITIVE CHANNELS;MENKES DISEASE;MERKEL CELL;METASTASECTOMY;METASTATIC BREAST CANCER;METATARSALGIA;METHYLTRANSFERASE;MINIMUM BACTERICIDAL CONCENTRATION;MISSENSE MUTATION;MITOGEN-ACTIVATED PROTEIN KINASE KINASE;MYOEPITHELIOMA;MYXOID LIPOSARCOMA;NEOADJUVANT THERAPY;NON-CODING RNA;NUCLEAR PROTEIN;OPHTHALMIC PATHOLOGY;OSWESTRY DISABILITY INDEX;OXFORD KNEE SCORE;OXYCODONE;P-GLYCOPROTEIN;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PATELLAR LIGAMENT;PAZOPANIB;PITTSBURGH SLEEP QUALITY INDEX;PIVOT-SHIFT TEST;PLACENTAL GROWTH FACTOR;POLYETHYLENIMINE;POROMECHANICS;PRDM16;PROBAND;RANKL;RNA EDITING;SOLITARY FIBROUS TUMOR;STAPHYLOCOCCUS EPIDERMIDIS;SYNDESMOSIS;SYNOVIAL FLUID;TETRAPLEGIA;TITIN;TOTAL IRON-BINDING CAPACITY;TRABECTEDIN;UNICOMPARTMENTAL KNEE ARTHROPLASTY;USUAL INTERSTITIAL PNEUMONIA;WILD TYPE","11;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;ARTHROPLASTY, REPLACEMENT, HIP;YOUNG ADULT;RETROSPECTIVE STUDIES;NEOPLASM RECURRENCE, LOCAL;KNEE JOINT;ADOLESCENT;ANTERIOR CRUCIATE LIGAMENT INJURIES;ANIMALS;CHONDROCYTES;ARTHROPLASTY, REPLACEMENT, KNEE","164;113;102;101;68;63;61;46;36;34;33;33;31;30;29;26;25;24;24;23","ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;MULTIPOTENT MESENCHYMAL STEM CELLS;HISTORY OF MEDICINE AND MEDICAL PRACTICES;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;3D BIOPRINTING TECHNOLOGY;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY","21;20;16;15;13;13;8;8;6;6;5;5;5;4;4;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;GIANT CELL TUMOR;TISSUE ENGINEERING;HIP ARTHROPLASTY;ANTERIOR CRUCIATE LIGAMENT;BONE REGENERATION;REVISION SURGERY;TENOSYNOVIAL GIANT CELL TUMOR;BIOMECHANICS;EWING'S SARCOMA;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;MENISCUS;ATHLETIC REHABILITATION;DENOSUMAB;3D PRINTING;BONE MINERAL DENSITY;BONE TISSUE","18;14;13;9;9;8;7;7;7;7;6;6;6;6;6;5;5;4;4;4","GIANT CELL;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;TOTAL HIP;CELL TUMOR;MESENCHYMAL STROMAL;EWING SARCOMA;KNEE ARTHROPLASTY;LIGAMENT RECONSTRUCTION;STROMAL CELLS;BONE TISSUE;COHORT STUDY;CONTROLLED TRIAL;TENOSYNOVIAL GIANT;BONE MARROW;MESENCHYMAL STEM;ROTATOR CUFF;SOFT TISSUE;STEM CELLS;TOTAL KNEE;ACHILLES TENDON;ACL RECONSTRUCTION;ADIPOSE TISSUE;ARTICULAR CARTILAGE;BODY COMPOSITION;BONE SARCOMA;BONE TUMORS;CELL LINES;CELL TUMORS","12;11;11;9;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;FUNDING INSTITUTION;GRANT FUNDING;RESEARCH GRANT;SACROILIAC JOINT;ADVISORY CONSULTANCY;OA MILIEU;ADIPOSE TISSUE;LACRIMAL GLAND;ACCOMMODATION EXPENSES;CELL LINES;CXCR CXCR;JOINT ARTHRODESIS;STEM CELLS;TRAVEL ACCOMMODATION;ARTICULAR CARTILAGE;BONE MARROW;FINITE ELEMENT;MIR- EXPRESSION;OXIDATIVE STRESS;STATISTICALLY SIGNIFICANT;SUBCHONDRAL BONE;TOTAL KNEE;BONE TISSUE;CELL MIGRATION;CONSERVATIVE MANAGEMENT;EXPENSES PERSONAL;GENE EXPRESSION;GLAND ACC;GROWTH FACTOR","17;16;16;16;15;14;14;13;12;10;10;10;10;10;10;9;9;9;9;9;9;9;9;8;8;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,1,0,1,0,2,0,0,0,0,1,3,1,1,4.2,1.9,2.8,1,4,4,0,0,2,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BORIANI STEFANO;DE LUCA MARCO;DE OTO LUCIANO;GIROLAMI MAURO;NUCCI MARIA CONCETTA;FILARDO GIUSEPPE;„Çπ„ÉÜ„Éï„Ç°„Éé„Éª„Éú„É™„Ç¢„Éº„Éã;„Éû„Ç¶„É≠„Éª„Ç∏„É≠„Éº„É©„Éü;„Éû„É™„Ç¢„Éª„Ç≥„É≥„ÉÅ„Çß„ÉÉ„Çø„Éª„Éå„ÉÉ„ÉÅ;„Éû„É´„Ç≥„Éª„Éá„Éª„É´„Ç´","3;3;3;3;3;1;1;1;1;1","ISTITUTO ORTOPEDICO RIZZOLI;AUTOMOBILI LAMBORGHINI SPA;AUTOMOBILI LAMBORGHINI S.P.A.;AZIENDA OSPEDALIERO UNIV DI BOLOGNA POLICLINICO S ORSOLA MALPIGHI;AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA POLICLINICO SORSOLA MALPIGHI;AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA - MALPIGHI;AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S ORSOLA-MALPIGHI;AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S. ORSOLA - MALPIGHI;ST ORTOPEDICO RIZZOLI","5;2;1;1;1;1;1;1;1","33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;31 BIOLOGICAL SCIENCES;3103 ECOLOGY;37 EARTH SCIENCES;51 PHYSICAL SCIENCES","3;2;1;1;1;1",NA,NA,NA,NA,"A61B17/62;A61B17/64;A61B17/15;A61B17/16;A61B17/17;A61F2/46","4;3;1;1;1;1","A61B17/62;A61B17/6441;A61B17/645;A61B17/15;A61B17/151;A61B17/1635;A61B17/17;A61B2017/1602;A61F2/4644","4;4;4;1;1;1;1;1;1",32,3.34,282.42,8.65,5,0.16,13.59,0,0,3,0,3,0,0,26,0,21,11,0,0,0,0,0,0,30,2,0,32,0,0,0,0,0,0,0,0,0,"Italy;United States;Belgium","31;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;3203 DENTISTRY;3206 MEDICAL BIOTECHNOLOGY;3215 REPRODUCTIVE MEDICINE;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4205 NURSING","26;22;10;6;6;5;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BIOENGINEERING;REHABILITATION;ARTHRITIS;AGING;CANCER;PREVENTION;RARE DISEASES;BIOMEDICAL IMAGING;CARDIOVASCULAR;CHRONIC PAIN;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;COMPARATIVE EFFECTIVENESS RESEARCH;OSTEOARTHRITIS;OSTEOPOROSIS;BEHAVIORAL AND SOCIAL SCIENCE;HEALTH SERVICES","27;10;7;7;6;5;5;4;4;3;3;3;3;3;3;2;2;2;1;1","MUSCULOSKELETAL;CANCER;BLOOD;CARDIOVASCULAR;INFECTION;NEUROLOGICAL","13;2;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS;1.4 METHODOLOGIES AND MEASUREMENTS;5.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES","6;2;2;2;2;1;1;1","NOT SITE-SPECIFIC CANCER;SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA","2;2;1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1",7,9772869.57,446965.41,4.28571428571429,23.5714285714286,7.14285714285714,0.714285714285714,60.4,1322795.0572017,0.218476776448925,"ISTITUTO ORTOPEDICO RIZZOLI;CENTRE L√âON B√âRARD;UNIVERSITY MEDICAL CENTER UTRECHT;AC CAMARGO HOSPITAL;ACADEMIC MEDICAL CENTER;ACADEMY OF FINLAND;ACIBADEM UNIVERSITY;AGENCE NATIONALE DE LA RECHERCHE;AGENZIA PER LA PROMOZIONE DELLA RICERCA EUROPEA;AIX-MARSEILLE UNIVERSITY;ANDALUSIAN HEALTH SERVICE;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;AUSTRIAN INSTITUTE OF TECHNOLOGY;AZIENDA OSPEDALIERA UNIVERSITARIA PISANA;AZIENDA OSPEDALIERA UNIVERSITARIA SENESE;AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE;BAMBINO GES√ô CHILDREN'S HOSPITAL;BAR-ILAN UNIVERSITY;BARCELONA SUPERCOMPUTING CENTER;BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE - ERIC","7;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;SARCOMA FOUNDATION OF AMERICA","6;1","COALITION S;EC & ERC - EUROPEAN UNION;HRA - HEALTH RESEARCH ALLIANCE","6;6;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);3RD HEALTH PROGRAMME (PROGRAMME);COFUND-EJP - COFUND (EUROPEAN JOINT PROGRAMME) (FUNDING SCHEME);CONNECTING EUROPE FACILITY (PROGRAMME);H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - LEADERSHIP IN ENABLING AND INDUSTRIAL TECHNOLOGIES - ADVANCED MATERIALS (PROGRAMME);THE LAST MILE SARCOMA RESEARCH GRANT (FUNDING PROGRAM)","3;3;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4205 NURSING","4;4;4;3;1;1;1;1","CANCER;CLINICAL RESEARCH;PAIN RESEARCH;RARE DISEASES;AGING;ARTHRITIS;BIOENGINEERING;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;OSTEOARTHRITIS","3;3;2;2;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","3;1","5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1","SARCOMA;NOT SITE-SPECIFIC CANCER","2;1","1.4 CANCER PROGRESSION AND METASTASIS;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1;1;1","A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;B12 ENGINEERING","5;1;1",NA,NA,19,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;MENDELEY DATA;THE UNIVERSITY OF SHEFFIELD","12;3;2;2","40 ENGINEERING;32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;3202 CLINICAL SCIENCES;4601 APPLIED COMPUTING;4003 BIOMEDICAL ENGINEERING;38 ECONOMICS;3801 APPLIED ECONOMICS;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;49 MATHEMATICAL SCIENCES;51 PHYSICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3210 NUTRITION AND DIETETICS;4905 STATISTICS;5107 PARTICLE AND HIGH ENERGY PHYSICS","11;10;6;5;4;4;3;2;2;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;GENETICS;AGING;ARTHRITIS;BIOENGINEERING;BIOMEDICAL IMAGING;DENTAL/ORAL AND CRANIOFACIAL DISEASE;NUTRITION;OSTEOARTHRITIS;OSTEOPOROSIS;PEDIATRIC;PREVENTION","5;5;3;3;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE","2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1","BIOMEDICAL;CLINICAL","2;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","3;2","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_RIZZOLI",2020,365,9.6958904109589,3.52876712328767,0.468493150684932,0.413698630136986,0.53972602739726,2.93621867881549,1.58333333333333,2.06849315068493,1.65,0.580821917808219,4,146,110,23,17,0.4,0.3,0.06,0.05,20.53,0.814897408600371,5.25542091836734,0.356164383561644,0.86027397260274,0.526,0.49,0.5,0.472,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;ANDREA SAMBRI;PIERO PICCI;SILVIA STACCHIOTTI;GIUSEPPE BIANCHI;GIOVANNI GRIGNANI;GIOVANNI BARBANTI BR√íDANO;FRANCESCO TRAINA;MARCO GAMBAROTTI;KATIA SCOTLANDI","47;31;26;22;18;17;16;16;15;15;13;13;13;12;11;11;11;10;10;9","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;GIUSEPPE FILARDO;ALBERTO LEARDINI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;VINCENZO RICCI;ALESSANDRO RUGGIERO;ALESSANDRO GASBARRINI;ANDREA SAMBRI;TIZIANA GREGGI;ANDREA TOGN√ô;FRANCESCO TRAINA;MARCO VICECONTI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;ALESSANDRA LONGHI;STEFANIA D‚ÄôADAMO","6.52;4.14;2.92;2.92;2.83;2.77;2.6;2.4;2.1;1.92;1.88;1.82;1.59;1.56;1.49;1.45;1.4;1.4;1.34;1.27","STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;ANDREA SAMBRI;PIERO PICCI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;FRANCESCO TRAINA;MARCO GAMBAROTTI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;NICOLA BALDINI","47;31;26;22;18;17;16;16;15;15;13;13;13;11;11;10;10;9;9;9","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;GIUSEPPE FILARDO;ALBERTO LEARDINI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;VINCENZO RICCI;ALESSANDRO GASBARRINI;ANDREA SAMBRI;TIZIANA GREGGI;ANDREA TOGN√ô;FRANCESCO TRAINA;MARCO VICECONTI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;ALESSANDRA LONGHI;STEFANIA D‚ÄôADAMO;NICOLA BALDINI","6.52;4.14;2.92;2.92;2.83;2.77;2.6;2.4;2.1;1.88;1.82;1.59;1.56;1.49;1.45;1.4;1.4;1.34;1.27;1.25","NICOLA BALDINI;SOFIA AVNET;ADINA WEINBERGER;ALEXANDRIA P. COGDILL;ALON BEN‚ÄêNUN;AMNON AMIT;ANAT RONAI;ARNON MELTSER;AVIRAM NISSAN;AVIVA ROTTER-MASKOWITZ;BELLA KAUFMAN;CHRISTIAN U. BLANK;DAN J. RAZ;DANIEL S. PEEPER;DEBORAH NEJMAN;EINAV NILI GAL‚ÄêYAM;EINAV YEHUDA‚ÄêSHNAIDMAN;ELINOR GIGI;ELISA A. ROZEMAN;ERAN SEGAL","1503;1415;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402","NICOLA BALDINI;SOFIA AVNET;STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;PIERO PICCI;CLAUDIA MARIA HATTINGER;EMANUELA PALMERINI;MARCO VICECONTI;MASSIMO SERRA;CARLA RENATA ARCIOLA;GIUSEPPE BIANCHI;KATIA SCOTLANDI;FRANCESCO URSINI;MILENA FINI;ALBERTO LEARDINI;VERONICA BRUSI;ALESSANDRO DI MARTINO;RICCARDO MELIC√íNI","1503;1415;761;596;504;477;449;352;345;328;326;318;318;300;288;268;244;198;188;186","STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;GIANLUCA GIAVARESI;KATIA SCOTLANDI;SAVERIO AFFATATO;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARCO VICECONTI;ALESSANDRO DI MARTINO;ANNA PAIOLI","42;31;22;22;18;17;16;15;14;14;13;10;10;9;9;9;8;8;8;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;GEOLOGY;BUSINESS;HISTORY;ART;GEOGRAPHY","325;98;47;47;44;40;39;26;18;14;11;11;7;6;5;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;RADIOLOGY;PHYSICAL THERAPY;GENETICS;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;ORTHODONTICS;CANCER RESEARCH;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;CELL BIOLOGY;ENVIRONMENTAL HEALTH;PALEONTOLOGY;IMMUNOLOGY;NANOTECHNOLOGY;ENDOCRINOLOGY","188;149;132;52;43;43;35;34;33;33;31;30;27;26;25;25;21;17;17;15","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;GENE;DISEASE;SARCOMA;CANCER;RETROSPECTIVE COHORT STUDY;IMPLANT;POPULATION;CHEMOTHERAPY;ARTHROPLASTY;OSTEOPOROSIS;IN VITRO;ANTERIOR CRUCIATE LIGAMENT;COHORT;ANKLE;MAGNETIC RESONANCE IMAGING;MESENCHYMAL STEM CELL;RADIOGRAPHY;PROSTHESIS;SOFT TISSUE","55;40;38;37;33;32;31;25;24;22;20;19;18;17;17;16;16;14;14;13;13","OSTEOARTHRITIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);METASTASIS;SOFT TISSUE SARCOMA;2019-20 CORONAVIRUS OUTBREAK;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;COLORECTAL CANCER;ARTHRODESIS;GAIT ANALYSIS;MUTATION;ACHILLES TENDON;ACL INJURY;DEPOSITION (GEOLOGY);FIXATION (POPULATION GENETICS);GENE SILENCING;SUBLUXATION;SURVIVORSHIP CURVE;BONE MINERAL;CHONDROCYTE;ETOPOSIDE;EWING'S SARCOMA;HAZARD RATIO;HIP FRACTURE;INJURY PREVENTION;MICRORNA;MYXOFIBROSARCOMA;PHENOTYPE;PROGRESSIVE DISEASE;TRANSCRIPTION FACTOR;VIABILITY ASSAY","41;17;12;10;9;7;7;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);ARTICULAR CARTILAGE;IFOSFAMIDE;TRABECTEDIN;IRINOTECAN;METASTASECTOMY;UNICOMPARTMENTAL KNEE ARTHROPLASTY;WOMAC;NUCLEAR PROTEIN;SYNOVIAL FLUID;ANTHRACYCLINE;BONE METASTASIS;CCL2;CTL*;CXCL10;EXOME SEQUENCING;IDH1;LMNA;MYXOID LIPOSARCOMA;QUANTITATIVE COMPUTED TOMOGRAPHY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS","17;5;5;5;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;BONE NEOPLASMS;AGED;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADOLESCENT;KNEE JOINT;YOUNG ADULT;ITALY;SOFT TISSUE NEOPLASMS;CHILD;SARCOMA;NEOPLASM RECURRENCE, LOCAL;OSTEOARTHRITIS, KNEE;OSTEOSARCOMA","215;140;72;72;51;47;45;40;36;28;24;23;22;20;20;19;19;18;18;18","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;MANAGEMENT OF SPINAL METASTATIC TUMORS;3D BIOPRINTING TECHNOLOGY;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;GENETIC DISORDERS CAUSING TISSUE MINERALIZATION ABNORMALITIES;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS","34;20;19;17;15;14;13;11;7;7;7;6;5;5;5;4;4;4;4;4","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;PANDEMIC;FOOT (PROSODY);HIP ARTHROPLASTY;BIOMECHANICS;FOOT STRIKE PATTERNS;2019-20 CORONAVIRUS OUTBREAK;CHONDROSARCOMA;KNEE OSTEOARTHRITIS;LIMB RECONSTRUCTION;BIOCOMPATIBILITY;MESENCHYMAL CHONDROSARCOMA;PROXIMAL HUMERUS FRACTURES;REVISION SURGERY;SHOULDER PATHOLOGY;SPINAL FUSION","28;22;20;18;13;13;10;10;9;9;8;8;8;8;6;6;6;6;6;6","KNEE ARTHROPLASTY;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;EWING SARCOMA;TOTAL KNEE;LIGAMENT RECONSTRUCTION;SOFT TISSUE;BONE MARROW;COVID- PANDEMIC;MESENCHYMAL STROMAL;TOTAL HIP;ITALIAN SARCOMA;RETROSPECTIVE STUDY;STROMAL CELLS;ACHILLES TENDON;CLINICAL TRIAL;GIANT CELL;HIP ARTHROPLASTY;LUNG METASTASES;MID-TERM FOLLOW-UP;OSTEOCHONDRITIS DISSECANS;PILOT STUDY;SPINE SURGERY;ACETABULAR CUPS;CHONDROCYTE TRANSPLANTATION;COMPUTED TOMOGRAPHY;FACTORS AFFECTING;FATTY ACIDS;FEMORAL HEADS;FUNCTIONAL EVALUATION","11;9;9;9;9;8;8;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","ISI GOOGLE;PATIENTS UNDERGOING;COVID PERIOD;COMPUTATIONAL BIOMEDICINE;ACHILLES TENDON;PATIENTS AFFECTED;SIGNIFICANT DIFFERENCES;BLOOD FLOW;GENE EXPRESSION;MUSCLE MASS;NO-COVID PERIOD;OS CELLS;CROSSREF PUBMED;INTERFACE FOCUS;LINK ISI;PUBMED ISI;AUTOIMMUNE SYSTEMIC;BONE DISEASES;DOIRSFS LINK;FOCUS DOIRSFS;MASS INDEX;MM PATIENTS;ADVERSE EVENTS;BODY MASS;CELL DEATH;CLINICAL PRACTICE;COVID- PANDEMIC;EXTRACELLULAR MATRIX;ISTITUTO ORTOPEDICO;KNEE ARTHROPLASTY","27;22;18;15;14;14;13;12;12;12;12;12;11;11;11;11;10;10;10;10;10;10;9;9;9;9;9;9;9;9",4,0.01,1.49,3,1,0,0,0,0,0,0,3.25,0,0,2.25,0,0,0,1,1,1.75,0,0,17,17,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0.08,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FILARDO GIUSEPPE","1","ISTITUTO ORTOPEDICO RIZZOLI","1",NA,NA,NA,NA,NA,NA,"A61B17/15;A61B17/16;A61B17/17;A61F2/46","1;1;1;1","A61B17/15;A61B17/151;A61B17/1635;A61B17/17;A61B2017/1602;A61F2/4644","1;1;1;1;1;1",32,4.9,235.06,7.42,3,0.09,11.56,0,0,5,0,1,0,1,25,0,17,14,0,0,0,0,0,0,32,0,0,31,1,0,0,0,0,0,0,0,0,"Italy;Japan;United Kingdom;United States;Netherlands","23;2;2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;3211 ONCOLOGY AND CARCINOGENESIS;46 INFORMATION AND COMPUTING SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3203 DENTISTRY;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4602 ARTIFICIAL INTELLIGENCE;4604 CYBERSECURITY AND PRIVACY","27;19;10;7;5;4;3;3;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BIOENGINEERING;PEDIATRIC;RARE DISEASES;CANCER;PATIENT SAFETY;GENETICS;REHABILITATION;ARTHRITIS;TRANSPLANTATION;AGING;BIOMEDICAL IMAGING;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;HEALTH SERVICES;HEMATOLOGY;PAIN RESEARCH;PEDIATRIC RESEARCH INITIATIVE;PHYSICAL REHABILITATION","24;11;7;7;7;6;6;5;5;3;3;2;2;2;2;2;2;2;2;2","MUSCULOSKELETAL;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","14;4;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;6.7 PHYSICAL;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES;6.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","8;3;2;2;2;1;1;1;1;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER","5;4;3","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;1;1;1",5,2512706,239921.3,4.8,6.4,4.8,0.6,14.8,1176907.49727493,0.310134824397956,"ISTITUTO ORTOPEDICO RIZZOLI;AALTO UNIVERSITY;AO FOUNDATION;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;CHARIT√â - UNIVERSITY MEDICINE BERLIN;ENGINSOFT (ITALY);GADETA (NETHERLANDS);GERMAN CANCER RESEARCH CENTER;GHENT UNIVERSITY;INSTITUTE CURIE;KEPLER UNIVERSIT√ÑTSKLINIKUM;LEIDEN UNIVERSITY MEDICAL CENTER;LUDWIG-MAXIMILIANS-UNIVERSIT√ÑT M√úNCHEN;OTTO-VON-GUERICKE UNIVERSITY MAGDEBURG;POLYTECHNIC UNIVERSITY OF TURIN;PRINCESS M√ÅXIMA CENTER;RIGA TECHNICAL UNIVERSITY;ROYAL MARSDEN HOSPITAL;RUHR UNIVERSITY BOCHUM;ST ANNA CHILDREN'S HOSPITAL","5;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ITALIAN ASSOCIATION FOR CANCER RESEARCH","3;2","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","3;3;2","H2020-EU.1.3. - EXCELLENT SCIENCE - MARIE SK≈ÅODOWSKA-CURIE ACTIONS (PROGRAMME);MSCA-ITN - MARIE SK≈ÅODOWSKA-CURIE INNOVATIVE TRAINING NETWORKS (ITN) (FUNDING SCHEME);3RD HEALTH PROGRAMME (PROGRAMME);H2020-MSCA-ITN-2019 (CALL FOR PROPOSAL);H2020-MSCA-ITN-2020 (CALL FOR PROPOSAL)","2;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","5;2;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CANCER;GENETICS;PEDIATRIC;ASSISTIVE TECHNOLOGY;BIOENGINEERING;BIOTECHNOLOGY;GENETIC TESTING;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;REGENERATIVE MEDICINE;REHABILITATION;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","4;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE","3;2;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.3 MEDICAL DEVICES;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)","3;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER;SARCOMA","2;1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;1.4 CANCER PROGRESSION AND METASTASIS;2.3 INTERACTIONS OF GENES AND/OR GENETIC POLYMORPHISMS WITH EXOGENOUS AND/OR ENDOGENOUS FACTORS;4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","2;2;1;1;1;1","A01 CLINICAL MEDICINE;C20 SOCIAL WORK AND SOCIAL POLICY;C23 EDUCATION","3;1;1","3 GOOD HEALTH AND WELL BEING","1",15,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;TAYLOR & FRANCIS GROUP;SCIELO JOURNALS;THE UNIVERSITY OF SHEFFIELD","9;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;40 ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3206 MEDICAL BIOTECHNOLOGY;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;38 ECONOMICS;3801 APPLIED ECONOMICS;4003 BIOMEDICAL ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4017 MECHANICAL ENGINEERING;4601 APPLIED COMPUTING","19;6;5;4;4;2;1;1;1;1;1;1;1;1;1;1","CANCER;RARE DISEASES;GENETICS;PEDIATRIC;ORPHAN DRUG;PEDIATRIC CANCER;BIOTECHNOLOGY;AUTOIMMUNE DISEASE;CLINICAL RESEARCH;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","9;7;6;6;5;5;4;1;1;1;1;1","CANCER;MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE","6;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.2 CELLULAR AND GENE THERAPIES","7;5;1;1","BIOMEDICAL;CLINICAL","8;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","8;4","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","6;4",NA,NA
"IRCCS_RIZZOLI",2021,381,11.3989501312336,3.86089238845144,0.47244094488189,0.467191601049869,0.640419947506562,3.26948775055679,1.62162162162162,2.40540540540541,1.77205882352941,0.677165354330709,5,134,95,33,20,0.35,0.25,0.09,0.05,15,0.972717765748049,5.41693244418673,0.388451443569554,0.876640419947507,0.538,0.482,0.451,0.469,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO RIGHI;GIUSEPPE FILARDO;ALESSANDRA LONGHI;STEFANO DI PAOLO;FRANCESCO URSINI;GIAN ANDREA LUCIDI;CESARE FALDINI;GIOVANNI TRISOLINO;ALESSANDRO GASBARRINI;ALBERTO LEARDINI;RICCARDO MELIC√íNI;PAOLO SPINNATO;GIOVANNI GRIGNANI;PIERO PICCI;GIACOMO DAL FABBRO","49;36;27;25;21;19;19;17;16;16;15;15;15;14;13;13;13;13;13;12","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;DAVIDE MAR√çA DONATI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;MILENA FINI;STEFANO DI PAOLO;GIAN ANDREA LUCIDI;MARCO VICECONTI;CESARE FALDINI;GIACOMO DAL FABBRO;ALBERTO LEARDINI;LUCA MACCHIAROLA;EMANUELA PALMERINI;BRUNELLA GRIGOLO;ALESSANDRO GASBARRINI;ALBERTO RIGHI;ALBERTO BAZZOCCHI;FRANCESCO URSINI","7.04;5.3;3.25;3.03;2.48;2.36;2.28;2.22;2.18;2.05;2.02;1.97;1.88;1.87;1.73;1.63;1.61;1.6;1.58;1.58","STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO RIGHI;GIUSEPPE FILARDO;ALESSANDRA LONGHI;STEFANO DI PAOLO;FRANCESCO URSINI;GIAN ANDREA LUCIDI;CESARE FALDINI;GIOVANNI TRISOLINO;ALESSANDRO GASBARRINI;ALBERTO LEARDINI;RICCARDO MELIC√íNI;PAOLO SPINNATO;PIERO PICCI;GIACOMO DAL FABBRO;STEFANO STALLONE","49;36;27;25;21;19;19;17;16;16;15;15;15;14;13;13;13;13;12;12","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;DAVIDE MAR√çA DONATI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;MILENA FINI;STEFANO DI PAOLO;GIAN ANDREA LUCIDI;MARCO VICECONTI;CESARE FALDINI;GIACOMO DAL FABBRO;ALBERTO LEARDINI;LUCA MACCHIAROLA;EMANUELA PALMERINI;BRUNELLA GRIGOLO;ALESSANDRO GASBARRINI;ALBERTO RIGHI;ALBERTO BAZZOCCHI;FRANCESCO URSINI","7.04;5.3;3.25;3.03;2.48;2.36;2.28;2.22;2.18;2.05;2.02;1.97;1.88;1.87;1.73;1.63;1.61;1.6;1.58;1.58","EMANUELA PALMERINI;SANDRA J. STRAUSS;VIRGINIA FERRARESI;ANGELO PAOLO DEI TOS;GIOVANNI GRIGNANI;JAVIER MART√çN‚ÄêBROTO;JEAN‚ÄêYVES BLAY;PAOLO G. CASALI;SILVIA STACCHIOTTI;KIRSTEN SUNDBY HALL;CARLO MOROSI;ALESSANDRO GRONCHI;KJETIL BOYE;MICHIEL A. J. VAN DE SANDE;PETER REICHARDT;HANS GELDERBLOM;JUDITH V.M.G. BOV√âE;MARTA SBARAGLIA;SEBASTIAN BAUER;MIKAEL ERIKSSON","1439;1236;1216;1209;1208;1205;1198;1196;1187;1185;1180;1173;1162;1157;1153;1148;1143;1141;1134;1128","EMANUELA PALMERINI;STEFANO ZAFFAGNINI;ALBERTO GRASSI;NICOLA BALDINI;DAVIDE MAR√çA DONATI;ALBERTO BAZZOCCHI;FRANCESCO URSINI;GIUSEPPE FILARDO;RICCARDO MELIC√íNI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MILENA FINI;GINA LISIGNOLI;ALBERTO RIGHI;MAURO PETRETTA;CESARE FALDINI;SOFIA AVNET;NICOLETTA ZINI;CHIARA GASPERINI;CAROLA CAVALLO","1439;509;482;446;309;291;291;287;266;261;255;239;227;209;206;199;197;191;178;173","STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;GIUSEPPE FILARDO;ALBERTO RIGHI;ALESSANDRA LONGHI;CESARE FALDINI;GIAN ANDREA LUCIDI;GIOVANNI TRISOLINO;FRANCESCO URSINI;ALBERTO LEARDINI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;RICCARDO MELIC√íNI;COSTANTINO ERRANI;LUCA MACCHIAROLA;PAOLA ZARANTONELLO;STEFANO STALLONE","44;36;27;25;21;19;18;17;15;15;15;14;13;13;13;13;12;12;12;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;GEOLOGY;BUSINESS;HISTORY;ART;GEOGRAPHY","334;104;55;54;47;44;43;27;17;16;15;13;8;7;6;4;3;3","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;PHYSICAL THERAPY;RADIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;CELL BIOLOGY;BIOMEDICAL ENGINEERING;PHYSICAL MEDICINE AND REHABILITATION;COMPOSITE MATERIAL;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ORTHODONTICS;ONCOLOGY;OPTICS;CLASSICAL MECHANICS;ARTIFICIAL INTELLIGENCE;BIOTECHNOLOGY","193;143;138;58;57;54;42;38;37;34;33;31;30;28;25;25;21;19;17;15;15","ALTERNATIVE MEDICINE;CANCER;GENE;SARCOMA;ORTHOPEDIC SURGERY;DISEASE;POPULATION;ANTERIOR CRUCIATE LIGAMENT;RADIOGRAPHY;IMPLANT;ARTHROPLASTY;MAGNETIC RESONANCE IMAGING;CHEMOTHERAPY;INCIDENCE (GEOMETRY);MESENCHYMAL STEM CELL;OSTEOSARCOMA;RETROSPECTIVE COHORT STUDY;IN VIVO;KINEMATICS;CARTILAGE;COHORT;OSTEOPOROSIS;SOFT TISSUE","56;39;35;33;32;30;28;23;23;22;21;20;18;17;17;17;17;16;16;13;13;13;13","OSTEOARTHRITIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MENISCUS;SOFT TISSUE SARCOMA;METASTASIS;ACL INJURY;BREAST CANCER;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;FIXATION (POPULATION GENETICS);2019-20 CORONAVIRUS OUTBREAK;BONE SARCOMA;GENE EXPRESSION;HARRIS HIP SCORE;PROINFLAMMATORY CYTOKINE;CLINICAL ENDPOINT;HIP FRACTURE;PHENOTYPE;SUBLUXATION;TUMOR MICROENVIRONMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES;AVASCULAR NECROSIS;CHONDROCYTE;CHONDROGENESIS;CISPLATIN;DNA DAMAGE;DOWNREGULATION AND UPREGULATION;MICRORNA;NEURORADIOLOGY;OSSEOINTEGRATION;PERIPROSTHETIC;PROGRESSIVE DISEASE;SYNOVIAL SARCOMA","42;16;14;12;11;10;10;8;8;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);ARTICULAR CARTILAGE;IFOSFAMIDE;WOMAC;GENOME INSTABILITY;INTRA ARTICULAR;METASTASECTOMY;BONE METASTASIS;MEDIAL MENISCUS;NEOADJUVANT THERAPY;ANTHRACYCLINE;CD163;DBM;FLI1;IŒöB KINASE;KNEE PAIN;LENVATINIB;MICROVESICLES;POSTURAL INSTABILITY;PRIMARY TUMOR;RANKL;STERILIZATION (ECONOMICS);TRABECTEDIN;TRANSCRIPTOME;TRANSLATION (BIOLOGY)","16;8;6;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;BONE NEOPLASMS;FEMALE;MALE;RETROSPECTIVE STUDIES;SARCOMA;ADULT;MIDDLE AGED;OSTEOSARCOMA;AGED;KNEE JOINT;TREATMENT OUTCOME;ADOLESCENT;ITALY;COVID-19;OSTEOARTHRITIS;FOLLOW-UP STUDIES;ANTERIOR CRUCIATE LIGAMENT INJURIES;CHILD","203;166;65;57;55;42;36;34;34;33;28;26;25;24;24;23;22;20;19;19","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BIOMECHANICS OF RUNNING-RELATED INJURIES;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;TREATMENT AND OUTCOMES OF HAND INJURIES;MANAGEMENT OF SPINAL METASTATIC TUMORS;EPIDEMIOLOGY OF SPORTS-RELATED MUSCULOSKELETAL INJURIES;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;3D BIOPRINTING TECHNOLOGY;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS","36;32;22;19;16;10;8;8;8;7;7;7;6;5;5;5;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;SOFT TISSUE SARCOMA;TOTAL KNEE REPLACEMENT;ANTERIOR CRUCIATE LIGAMENT;MENISCUS;BIOMECHANICS;ACL INJURY;HIP ARTHROPLASTY;EWING'S SARCOMA;INJURY RISK;MENISCUS INJURIES;ATHLETIC REHABILITATION;KNEE OSTEOARTHRITIS;OSTEOARTHRITIS TREATMENT;PANDEMIC;HIP ARTHROSCOPY;HIP FRACTURE;BIOMECHANICAL ANALYSIS;FOOT (PROSODY)","38;22;16;16;14;14;13;11;11;10;10;10;9;9;9;9;8;8;7;7","ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;SOFT TISSUE;TOTAL HIP;KNEE OSTEOARTHRITIS;BONE MARROW;MESENCHYMAL STROMAL;STEM CELLS;GIANT CELL;STROMAL CELLS;CELL TUMOR;LIGAMENT INJURY;LOWER LIMB;CUTTING GUIDE;EWING SARCOMA;HIP FRACTURE;HYALURONIC ACID;MESENCHYMAL STEM;TISSUE SARCOMA;TOTAL KNEE;AUTOIMMUNE SYSTEMIC;CLINICAL PRACTICE;COVID- PANDEMIC;ITALIAN SARCOMA;LIGAMENT RECONSTRUCTION;MUSCULOSKELETAL SYSTEM;PATIENTS TREATED;RANDOMIZED CONTROLLED;RETROSPECTIVE STUDY","15;14;11;11;11;10;8;8;8;7;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;BONE ALLOGRAFT;MASSIVE BONE;PATIENTS TREATED;SOFT TISSUE;EWING SARCOMA;ACL INJURY;CELL LINES;ANTERIOR CRUCIATE;CROSSREF PUBMED;CRUCIATE LIGAMENT;GIANT CELL;ONCOL -ABSTRACT;FREE FIBULA;INTERVENTIONAL PROCEDURES;KNEE OA;LOWER LIMB;OSTEOARTHRITIS OA;VASCULARIZED FREE;LIGAMENT ACL;ACL RECONSTRUCTION;ASD PATIENTS;BONE BRUISE;LOCAL RECURRENCE;PATIENTS UNDERGOING;RISK FACTORS;TOTAL HIP;CLINICAL OUTCOMES;CLINICAL PRACTICE;MINIMALLY INVASIVE","40;30;29;23;20;19;18;18;17;17;17;17;17;15;15;15;15;15;15;14;13;13;13;13;13;13;13;12;12;12",1,0,2.75,5,0,0,0,0,0,0,0,6,0,0,5,0,0,1,0,3,1,0,0,31,31,2,0,1,1,0,0,0,0,0,0,0,0,2,0,0,3,21,2.86,7,0,2,2,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CAFARELLI ANDREA;FEDUTIK YIRIJ;FINI MILENA;GABUSI ELENA;GAPINSKI TOMASZ;LENARTOWICZ KRZYSZTOF STANISLAW;LISIGNOLI GINA;MELICONI RICCARDO;NESSIM GILBERT DANIEL;RICOTTI LEONARDO","2;2;2;2;2;2;2;2;2;2","BAR ILAN UNIVERSITY;ISTITUTO ORTOPEDICO RIZZOLI;H & D WIRELESS;H&D WIRELESS AB;IMAGE GUIDANCE CO;IMAGE GUIDED THERAPY SA;PLASMACHEM PRODUKTIONS UND HANDEL GMBH;PRICE PRODUCTION AND TRADE CO LTD;SANTA ANA SCHOOL OF ADVANCED STUDIES;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANT ANNA","2;2;1;1;1;1;1;1;1;1","40 ENGINEERING;34 CHEMICAL SCIENCES;3403 MACROMOLECULAR AND MATERIALS CHEMISTRY;4016 MATERIALS ENGINEERING","4;2;2;2","BIOENGINEERING;BIOMEDICAL IMAGING;BIOTECHNOLOGY","1;1;1",NA,NA,"A61L27/38;A61L27/44;A61L27/52;A61M37/00;A61N1/20;A61N1/32;A61N7/00;B82Y5/00","1;1;1;1;1;1;1;1","A61L2400/06;A61L2400/12;A61L2430/06;A61L27/3834;A61L27/3852;A61L27/443;A61L27/446;A61L27/52;A61L27/58;A61M37/0092","1;1;1;1;1;1;1;1;1;1",41,3.05,184.93,9.56,6,0.15,8.07,0,0,5,1,1,0,0,34,0,27,14,0,0,0,0,0,0,41,0,0,41,0,0,0,0,0,0,0,0,0,"Italy;France;United Kingdom","32;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;3210 NUTRITION AND DIETETICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","36;29;11;7;6;3;3;3;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;ARTHRITIS;RARE DISEASES;PAIN RESEARCH;PEDIATRIC;PATIENT SAFETY;CHRONIC PAIN;PREVENTION;BIOMEDICAL IMAGING;REHABILITATION;BIOENGINEERING;BEHAVIORAL AND SOCIAL SCIENCE;ORPHAN DRUG;OSTEOARTHRITIS;PEDIATRIC CANCER;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS;AGING;COMPLEMENTARY AND INTEGRATIVE HEALTH","35;19;12;11;11;10;10;9;7;7;6;5;4;3;3;3;3;3;2;2","MUSCULOSKELETAL;CANCER;BLOOD;MENTAL HEALTH;METABOLIC AND ENDOCRINE;NEUROLOGICAL;STROKE","17;9;1;1;1;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.7 PHYSICAL;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES","15;8;3;2;2;2;1;1;1;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER","5;4;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","4;1;1;1;1;1",3,3389051,354828.52,4,12,4,0.666666666666667,12,1350797.48139615,0.28205560437247,"ISTITUTO ORTOPEDICO RIZZOLI;ERASMUS MC;ACADEMIC MEDICAL CENTER;ASSISTANCE PUBLIQUE - H√îPITAUX DE PARIS;AZIENDA OSPEDALIERA UNIVERSITARIA PISANA;AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE;BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS;CENTRE L√âON B√âRARD;DEUTSCHES INSTITUT F√úR NORMUNG;D√âL√âGATION PARIS 11;EINDHOVEN UNIVERSITY OF TECHNOLOGY;EUROPEAN ADVANCED TRANSLATIONAL RESEARCH INFRASTRUCTURE - ERIC;HOSPICES CIVILS DE LYON;HOSPITAL UNIVERSITARIO LA PAZ;H√îPITAUX UNIVERSITAIRES DE STRASBOURG;KU LEUVEN;LEIDEN UNIVERSITY MEDICAL CENTER;MADRID HEALTH SERVICE;MAPI RESEARCH TRUST;RADBOUD UNIVERSITY NIJMEGEN","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);CONNECTING EUROPE FACILITY (PROGRAMME);CSA - COORDINATION AND SUPPORT ACTION (FUNDING SCHEME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","2;1;1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;48 LAW AND LEGAL STUDIES;4806 PRIVATE LAW AND CIVIL OBLIGATIONS","2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES","1;1",NA,NA,NA,NA,NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","2;1","3 GOOD HEALTH AND WELL BEING","2",20,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;ORDA - THE UNIVERSITY OF SHEFFIELD RESEARCH DATA CATALOGUE AND REPOSITORY;THE UNIVERSITY OF SHEFFIELD","9;5;3;3","32 BIOMEDICAL AND CLINICAL SCIENCES;40 ENGINEERING;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;46 INFORMATION AND COMPUTING SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;37 EARTH SCIENCES;4601 APPLIED COMPUTING;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3705 GEOLOGY;4003 BIOMEDICAL ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;51 PHYSICAL SCIENCES;5106 NUCLEAR AND PLASMA PHYSICS","13;8;7;6;4;4;4;3;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;BIOENGINEERING;GENETICS;RARE DISEASES;CANCER;CHILDHOOD LEUKEMIA;HEMATOLOGY;NEUROSCIENCES;PEDIATRIC;PEDIATRIC CANCER;AGING;ARTHRITIS;CHRONIC PAIN;HUMAN GENOME;INFECTIOUS DISEASES;NEURODEGENERATIVE;OSTEOARTHRITIS","8;5;5;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER;NEUROLOGICAL","5;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","4;2","BIOMEDICAL;CLINICAL","4;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","8;4","LEUKEMIA / LEUKAEMIA","2",NA,NA
"IRCCS_RIZZOLI",2022,339,10.9026548672566,4.15634218289086,0.507374631268437,0.492625368731563,0.584070796460177,2.92323651452282,1.40983606557377,2.35211267605634,1.66386554621849,0.769911504424779,1,114,81,20,10,0.34,0.24,0.06,0.03,6.48,0.725665407899942,4.95876887340299,0.336283185840708,0.911504424778761,0.504,0.462,0.437,0.443,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;CESARE FALDINI;MILENA FINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;TONI IBRAHIM;FRANCESCA BARILE;ALBERTO RIGHI;BARBARA BORDINI;MARCO MANZETTI;EMANUELA PALMERINI;FRANCESCO URSINI;ALESSANDRO GASBARRINI;BRUNELLA GRIGOLO;ALBERTO LEARDINI;NICOLA BALDINI;GIAN ANDREA LUCIDI;GIOVANNI BARBANTI BR√íDANO","40;20;20;19;19;17;16;14;14;13;13;13;13;12;12;11;11;11;11;11","STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;CESARE FALDINI;MILENA FINI;BARBARA BORDINI;ANGELO BOFFA;FRANCESCA BARILE;GIANCARLO FACCHINI;NICOLA BALDINI;SOFIA AVNET;GIAN ANDREA LUCIDI;DAVIDE MAR√çA DONATI;MARCO MANZETTI;STEFANO DI PAOLO;ALBERTO LEARDINI;MARIA GRAZIA BENEDETTI;MARCO VICECONTI;ALBERTO BAZZOCCHI;FRANCESCO TRAINA","5.24;2.72;2.64;2.51;2.4;1.79;1.75;1.64;1.59;1.59;1.58;1.57;1.55;1.5;1.49;1.49;1.48;1.4;1.39;1.3","STEFANO ZAFFAGNINI;ALBERTO GRASSI;CESARE FALDINI;MILENA FINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;TONI IBRAHIM;FRANCESCA BARILE;ALBERTO RIGHI;BARBARA BORDINI;MARCO MANZETTI;EMANUELA PALMERINI;FRANCESCO URSINI;ALESSANDRO GASBARRINI;BRUNELLA GRIGOLO;ALBERTO LEARDINI;NICOLA BALDINI;GIAN ANDREA LUCIDI;GIOVANNI BARBANTI BR√íDANO","40;20;20;19;19;17;16;14;14;13;13;13;13;12;12;11;11;11;11;11","STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;CESARE FALDINI;MILENA FINI;BARBARA BORDINI;ANGELO BOFFA;FRANCESCA BARILE;GIANCARLO FACCHINI;NICOLA BALDINI;SOFIA AVNET;GIAN ANDREA LUCIDI;DAVIDE MAR√çA DONATI;MARCO MANZETTI;STEFANO DI PAOLO;ALBERTO LEARDINI;MARIA GRAZIA BENEDETTI;MARCO VICECONTI;ALBERTO BAZZOCCHI;FRANCESCO TRAINA","5.24;2.72;2.64;2.51;2.4;1.79;1.75;1.64;1.59;1.59;1.58;1.57;1.55;1.5;1.49;1.49;1.48;1.4;1.39;1.3","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ANGELO BOFFA;ALBERTO GRASSI;ALESSANDRO DI MARTINO;MILENA FINI;LUCA ANDRIOLO;BRUNELLA GRIGOLO;ANNARITA CENACCHI;DAVIDE MAR√çA DONATI;IACOPO ROMANDINI;TONI IBRAHIM;KATIA SCOTLANDI;FRANCESCO URSINI;NICOLA BALDINI;ELIZAVETA KON;STEFANO DI PAOLO;PIERO RUSCITTI;ROBERTO GIACOMELLI;SANTE ALESSANDRO ALTAMURA","344;249;188;163;159;149;138;115;114;109;98;94;90;88;83;82;77;75;75;75","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ANGELO BOFFA;ALBERTO GRASSI;ALESSANDRO DI MARTINO;MILENA FINI;LUCA ANDRIOLO;BRUNELLA GRIGOLO;DAVIDE MAR√çA DONATI;IACOPO ROMANDINI;KATIA SCOTLANDI;NICOLA BALDINI;TONI IBRAHIM;FRANCESCO URSINI;SANTE ALESSANDRO ALTAMURA;CESARE FALDINI;EMANUELA PALMERINI;MARCO VICECONTI;SPARTACO SANTI;ALBERTO RIGHI","329;249;188;163;159;149;138;115;109;98;90;83;82;81;75;74;74;74;69;67","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;GIUSEPPE FILARDO;MILENA FINI;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;BARBARA BORDINI;FRANCESCA BARILE;EMANUELA PALMERINI;ALBERTO RIGHI;TONI IBRAHIM;MARCO MANZETTI;ALESSANDRO GASBARRINI;ALBERTO RUFFILLI;GIOVANNI BARBANTI BR√íDANO;ALBERTO LEARDINI;FRANCESCO URSINI;ANGELO BOFFA;GIAN ANDREA LUCIDI","38;22;20;19;19;17;16;13;13;13;13;13;12;12;12;11;11;11;11;11","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;PSYCHOLOGY;BUSINESS;POLITICAL SCIENCE;GEOLOGY;SOCIOLOGY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","293;103;48;44;41;40;31;21;17;15;7;7;4;4;3;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;RADIOLOGY;BIOCHEMISTRY;GENETICS;PHYSICAL THERAPY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;ENVIRONMENTAL HEALTH;CELL BIOLOGY;ORTHODONTICS;ONCOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;OPTICS;ARTIFICIAL INTELLIGENCE;GEOMETRY;PALEONTOLOGY","181;126;108;56;51;46;42;40;39;35;32;31;27;25;24;24;20;18;16;14;14","ALTERNATIVE MEDICINE;GENE;ORTHOPEDIC SURGERY;RETROSPECTIVE COHORT STUDY;POPULATION;CANCER;CHEMOTHERAPY;DISEASE;MAGNETIC RESONANCE IMAGING;OSTEOPOROSIS;ARTHROPLASTY;CARTILAGE;RADIOGRAPHY;IMPLANT;OSTEOSARCOMA;SARCOMA;ANTERIOR CRUCIATE LIGAMENT;CLINICAL TRIAL;MESENCHYMAL STEM CELL;RANDOMIZED CONTROLLED TRIAL","57;39;37;34;32;29;19;19;19;19;18;17;17;16;16;16;14;14;14;14","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);METASTASIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;PLATELET-RICH PLASMA;CISPLATIN;CLINICAL ENDPOINT;EPIGENETICS;MICRORNA;MENISCUS;CHONDROGENESIS;GENOTYPE;GIANT-CELL TUMOR OF BONE;HAZARD RATIO;IMPLANT FAILURE;METHYLATION;STAPHYLOCOCCUS AUREUS;SURVIVORSHIP CURVE;SYNOVITIS;TRANSCRIPTION FACTOR;TUMOR MICROENVIRONMENT;VIABILITY ASSAY","45;11;11;8;8;7;7;7;6;6;6;6;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;CORONAVIRUS DISEASE 2019 (COVID-19);BONE METASTASIS;IFOSFAMIDE;KNEE PAIN;DNA METHYLATION;HIGH TIBIAL OSTEOTOMY;INTRA ARTICULAR;MEDIAL MENISCUS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SINGLE-NUCLEOTIDE POLYMORPHISM;THORACIC VERTEBRAE;TRABECTEDIN;ANKLE ARTHRODESIS;CD99;CONNECTIVE TISSUE DISEASE;COPY-NUMBER VARIATION;DEBULKING;EPITHELIAL‚ÄìMESENCHYMAL TRANSITION;GENOTYPING;INDUCED PLURIPOTENT STEM CELL;LMNA;MICROVESICLES;NUCLEAR PROTEIN;SPASTIC CEREBRAL PALSY;STAPHYLOCOCCUS EPIDERMIDIS;VANCOMYCIN","10;8;6;6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;BONE NEOPLASMS;RETROSPECTIVE STUDIES;OSTEOARTHRITIS, KNEE;TREATMENT OUTCOME;FEMALE;KNEE JOINT;MALE;MAGNETIC RESONANCE IMAGING;ADULT;ANTERIOR CRUCIATE LIGAMENT INJURIES;OSTEOSARCOMA;NEOPLASM RECURRENCE, LOCAL;PAIN;CHILD;SARCOMA, EWING;ARTHROPLASTY, REPLACEMENT, HIP;FEMUR;PROSPECTIVE STUDIES","168;158;53;43;26;26;25;25;23;22;21;21;19;18;18;16;16;15;14;14","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BONE TISSUE ENGINEERING AND BIOMATERIALS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS","23;22;15;14;11;10;10;9;7;6;6;6;5;5;5;4;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;SOFT TISSUE SARCOMA;SPINAL FUSION;BONE METASTASES;CLINICAL ENDPOINT;DISTAL RADIUS FRACTURES;EWING'S SARCOMA;FOOT (PROSODY);MENISCUS INJURIES;OSTEOARTHRITIS TREATMENT;REPEATABILITY;TREATMENT;3D PRINTED;ATHLETIC REHABILITATION;GIANT CELL TUMOR;HIP ARTHROSCOPY","24;22;15;10;9;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6","KNEE ARTHROPLASTY;BONE MARROW;GIANT CELL;TOTAL KNEE;ANTERIOR CRUCIATE;CONTROLLED TRIAL;CRUCIATE LIGAMENT;EWING SARCOMA;RANDOMIZED CONTROLLED;HIP ARTHROPLASTY;PLATELET-RICH PLASMA;SOFT TISSUE;CLINICAL OUTCOMES;COHORT STUDY;KNEE OSTEOARTHRITIS;LIGAMENT RECONSTRUCTION;MESENCHYMAL STROMAL;RISK FACTORS;STROMAL CELLS;BONE METASTASES;CEREBRAL PALSY;COMPARATIVE STUDY;RETROSPECTIVE COHORT;RETROSPECTIVE STUDY;SURGICAL SITE;TOTAL HIP;ASPIRATE CONCENTRATE;CELL TUMOR;MAGNETIC RESONANCE;MARROW ASPIRATE","11;10;9;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4","BONE MARROW;STATISTICALLY SIGNIFICANT;BONE METASTASES;MAGNETIC RESONANCE;PATIENTS TREATED;CELL LINES;CLINICAL OUTCOMES;ACL RECONSTRUCTION;CLINICAL FAILURE;PATIENTS UNDERGOING;RISK FACTORS;SURVIVAL RATE;ADVERSE EVENTS;CEREBRAL PALSY;MIGRATION PERCENTAGE;INCLUDED PATIENTS;KNEE OA;PRESSURE ULCERS;AML CELLS;BONE METASTASIS;GENE EXPRESSION;GOLD STANDARD;MONTHS NA;OSTEOARTHRITIS OA;PROTEIN INTAKE;SOFT TISSUE;SSC PATIENTS;STROMAL CELLS;BLOC RESECTION;CONSECUTIVE PATIENTS","23;21;16;16;16;15;15;14;14;14;14;14;13;13;13;12;12;12;11;11;11;11;11;11;11;11;11;11;10;10",1,0,1.75,4,0,0,0,0,0,0,0,4,0,0,4,0,0,1,0,2,1,0,0,6,6,2,0,1,0,4,0,0,0,0,0,0,0,5,0,0,3,9,3.19,3.4,3,2,3,0,0,2,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ZAFFAGNINI STEFANO;BERGSTEN P√ÑR;CAFARELLI ANDREA;DUMONT ERIK JEAN-CLAUDE;ERIKSSON MAGNUS;FEDUTIK YIRIJ;FINI MILENA;GABUSI ELENA;GAPINSKI TOMASZ;JERNBERGER √ÖKE","5;2;2;2;2;2;2;2;2;2","ISTITUTO ORTOPEDICO RIZZOLI;BAR ILAN UNIVERSITY;H&D WIRELESS AB;IMAGE GUIDED THERAPY SA;PLASMACHEM PRODUKTIONS UND HANDEL GMBH;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANTANNA;VIMEX SPOLKA Z OGRANICZONA ODOWIEDZIALNOSCIA VIMEX;VIMEX SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA VIMEX","5;2;2;2;2;2;1;1","40 ENGINEERING;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;34 CHEMICAL SCIENCES;3403 MACROMOLECULAR AND MATERIALS CHEMISTRY;4016 MATERIALS ENGINEERING;3009 VETERINARY SCIENCES;37 EARTH SCIENCES;3705 GEOLOGY;4006 COMMUNICATIONS ENGINEERING","5;4;2;2;2;1;1;1;1","BIOMEDICAL IMAGING;BIOTECHNOLOGY","2;1",NA,NA,"A61L27/38;A61F2/08;A61L27/44;A61L27/52;A61M37/00;A61N1/20;A61N1/32;B82Y5/00","4;3;2;2;2;2;2;2","A61F2/08;A61F2/0811;A61F2002/0882;A61F2210/0004;A61F2220/0016;A61F2220/005;A61F2220/0058;A61F2220/0075;A61F2230/0006;A61F2230/0017","3;3;3;3;3;3;3;3;3;3",32,2.38,87.83,6.96,2,0.06,3.88,0,0,0,1,0,0,0,31,0,19,13,0,0,0,0,0,0,32,0,0,32,0,0,0,0,0,0,0,0,0,"Italy","31","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;40 ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4003 BIOMEDICAL ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4207 SPORTS SCIENCE AND EXERCISE;31 BIOLOGICAL SCIENCES;3203 DENTISTRY;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4206 PUBLIC HEALTH;4208 TRADITIONAL, COMPLEMENTARY AND INTEGRATIVE MEDICINE","27;22;12;8;8;4;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;ARTHRITIS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AGING;CHRONIC PAIN;PAIN RESEARCH;REHABILITATION;BIOENGINEERING;NEUROSCIENCES;PEDIATRIC;RARE DISEASES;CANCER;ASSISTIVE TECHNOLOGY;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BIOTECHNOLOGY;COMPLEMENTARY AND INTEGRATIVE HEALTH;INFECTIOUS DISEASES;LUNG;PATIENT SAFETY","29;9;9;7;7;7;7;6;4;4;4;3;2;2;2;2;2;2;2;2","MUSCULOSKELETAL;CANCER;INFECTION;NEUROLOGICAL;CARDIOVASCULAR","20;2;2;2;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY;6.7 PHYSICAL;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.3 MEDICAL DEVICES","7;2;2;2;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA","2;1",NA,NA,3,8783630.67,837318.85,4.33333333333333,10,5.33333333333333,0.666666666666667,7,1971716.80266808,0.171931384639657,"ISTITUTO ORTOPEDICO RIZZOLI;ACADEMIC MEDICAL CENTER;ANTICANCER FUND;CAPITAL REGION OF DENMARK;DOMP√â (ITALY);EUROPEAN ADVANCED TRANSLATIONAL RESEARCH INFRASTRUCTURE - ERIC;EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK - ERIC;FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES;FRAUNHOFER SOCIETY;GERMAN SPORT UNIVERSITY COLOGNE;GLASGOW CALEDONIAN UNIVERSITY;ISTITUTO NAZIONALE TUMORI IRCCS ""FONDAZIONE G. PASCALE"";KAROLINSKA INSTITUTET;KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST;MAASTRICHT UNIVERSITY;MADRID HEALTH SERVICE;MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH;NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT;TEAMIT RESEARCH (SPAIN);UNIVERSITY OF AMSTERDAM","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","EU4HEALTH PROGRAMME (EU4H) (PROGRAMME);HORIZON-HLTH-2021-DISEASE-04 (CALL FOR PROPOSAL);HORIZON-MSCA-2021-DN-01 (CALL FOR PROPOSAL);HORIZON-RIA - HORIZON  RESEARCH AND INNOVATION ACTIONS (FUNDING SCHEME);HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA DOCTORAL NETWORKS (FUNDING SCHEME);HORIZON.1.2 - MARIE SK≈ÅODOWSKA-CURIE ACTIONS (MSCA) (PROGRAMME);HORIZON.2.1 - HEALTH (PROGRAMME)","1;1;1;1;1;1;1","42 HEALTH SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE","2;1;1;1;1","BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CLINICAL RESEARCH;DIABETES;PATIENT SAFETY;PREVENTION","1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL","2;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C17 BUSINESS AND MANAGEMENT STUDIES","2;1",NA,NA,24,"FRONTIERS;THE CAMBRIDGE STRUCTURAL DATABASE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","19;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;42 HEALTH SCIENCES;3204 IMMUNOLOGY;3103 ECOLOGY;37 EARTH SCIENCES;4003 BIOMEDICAL ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;46 INFORMATION AND COMPUTING SCIENCES;4612 SOFTWARE ENGINEERING","27;21;11;7;5;3;3;3;2;1;1;1;1;1;1;1;1","PREVENTION;GENETICS;GENETIC TESTING;BIOTECHNOLOGY;CLINICAL RESEARCH;BIOENGINEERING;AGING;CANCER;CHRONIC PAIN;PAIN RESEARCH;ARTHRITIS;BIODEFENSE;BIOMEDICAL IMAGING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;LUNG;NEUROSCIENCES;OSTEOARTHRITIS;OSTEOPOROSIS","13;12;8;7;7;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","2;2","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT);6.4 SURGERY","11;5;1;1","BIOMEDICAL;HEALTH SERVICES & SYSTEMS;CLINICAL","5;4;3","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","9;3","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;SARCOMA","1;1;1;1;1",NA,NA
"IRCCS_RIZZOLI",2023,338,10.9467455621302,4.22189349112426,0.464497041420118,0.464497041420118,0.526627218934911,3.23582766439909,1.61855670103093,2.12162162162162,1.6036036036036,0.781065088757396,0,119,59,23,21,0.35,0.17,0.07,0.06,3.6,0.820798478519907,4.63951899426074,0.369822485207101,0.931952662721893,0.526,0.494,0.431,0.476,"STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;FRANCESCO TRAINA;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;FRANCESCO URSINI;ALBERTO DI MARTINO;ALBERTO RIGHI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;PAOLO SPINNATO;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIACOMO DAL FABBRO;KATIA SCOTLANDI;ALBERTO LEARDINI","32;32;24;23;18;18;17;17;16;16;16;15;15;14;14;14;14;13;13;12","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO DI MARTINO;DAVIDE MAR√çA DONATI;ANTONIO MAZZOTTI;PAOLO SPINNATO;GIACOMO DAL FABBRO;ALBERTO LEARDINI;GIANLUCA GIAVARESI;FRANCESCO CASTAGNINI;GIUSEPPE FILARDO;MILENA FINI;MARIA GRAZIA BENEDETTI;JACOPO CIAFFI;MARCO INNOCENTI;ELENA ARTIOLI;MATTEO BRUNELLO","4.48;4.09;3.21;2.65;2.42;2.11;2.02;2;1.93;1.88;1.85;1.85;1.8;1.76;1.71;1.68;1.67;1.58;1.58;1.47","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;FRANCESCO TRAINA;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;FRANCESCO URSINI;ALBERTO DI MARTINO;ALBERTO RIGHI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;PAOLO SPINNATO;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIACOMO DAL FABBRO;KATIA SCOTLANDI;ALBERTO LEARDINI","32;32;24;23;18;18;17;17;16;16;16;15;15;14;14;14;14;13;13;12","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO DI MARTINO;DAVIDE MAR√çA DONATI;ANTONIO MAZZOTTI;PAOLO SPINNATO;GIACOMO DAL FABBRO;ALBERTO LEARDINI;GIANLUCA GIAVARESI;FRANCESCO CASTAGNINI;GIUSEPPE FILARDO;MILENA FINI;MARIA GRAZIA BENEDETTI;JACOPO CIAFFI;MARCO INNOCENTI;ELENA ARTIOLI;MATTEO BRUNELLO","4.48;4.09;3.21;2.65;2.42;2.11;2.02;2;1.93;1.88;1.85;1.85;1.8;1.76;1.71;1.68;1.67;1.58;1.58;1.47","STEFANO ZAFFAGNINI;CESARE FALDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIOVANNI GRIGNANI;SILVIA STACCHIOTTI;BRUNO VINCENZI;PALMA DILEO;RAVIN RATAN;PETER REICHARDT;HANS GELDERBLOM;ALLISON LIM;BERND KASPER;BREELYN A. WILKY;BRIAN A. VAN TINE;CHARLOTTE BENSON;ELIZABETH T. LOGGERS;F MAZZEO;GABRIEL TINOCO;GINA Z. D‚ÄôAMATO","146;135;134;121;118;115;113;109;109;100;98;97;97;97;97;97;97;97;97;97","STEFANO ZAFFAGNINI;EMANUELA PALMERINI;CESARE FALDINI;GIUSEPPE FILARDO;ANGELO BOFFA;LUCA ANDRIOLO;BARBARA BORDINI;DAVIDE MAR√çA DONATI;MILENA FINI;TONI IBRAHIM;ALBERTO DI MARTINO;GIANLUCA GIAVARESI;MATTEO BRUNELLO;ALBERTO GRASSI;PAOLO SASSU;PAOLO SPINNATO;KATIA SCOTLANDI;ALBERTO LEARDINI;ELETTRA PIGNOTTI;MARCO FRANCESCHINI","144;134;123;121;73;73;70;64;64;63;62;55;54;49;48;47;45;44;44;44","CESARE FALDINI;STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;ALBERTO RIGHI;ALBERTO DI MARTINO;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;FRANCESCO URSINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;PAOLO SPINNATO;KATIA SCOTLANDI;GIACOMO DAL FABBRO;FRANCESCO CASTAGNINI;FRANCESCO TRAINA","34;31;23;21;17;17;17;16;15;15;15;14;14;14;14;14;13;13;12;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;ENGINEERING;MATHEMATICS;PHILOSOPHY;ECONOMICS;GEOLOGY;SOCIOLOGY;PSYCHOLOGY;POLITICAL SCIENCE;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","302;96;47;42;39;38;31;21;13;9;8;8;7;6;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;PHYSICAL THERAPY;GENETICS;BIOMEDICAL ENGINEERING;CANCER RESEARCH;PHYSICAL MEDICINE AND REHABILITATION;RADIOLOGY;CELL BIOLOGY;IMMUNOLOGY;ONCOLOGY;ORTHODONTICS;COMPOSITE MATERIAL;NURSING;ENVIRONMENTAL HEALTH;NUCLEAR MEDICINE;OPTICS","177;123;113;43;43;43;39;33;32;32;32;30;27;25;25;19;18;17;17;17","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;GENE;CANCER;RETROSPECTIVE COHORT STUDY;ARTHROPLASTY;IMPLANT;SARCOMA;DISEASE;RADIOGRAPHY;COHORT;IN VITRO;POPULATION;CHEMOTHERAPY;ANTERIOR CRUCIATE LIGAMENT;MESENCHYMAL STEM CELL;RANDOMIZED CONTROLLED TRIAL;VALGUS;COMPLICATION;CONFIDENCE INTERVAL;PROSTHESIS;SOFT TISSUE","51;41;33;31;30;29;27;21;20;20;18;17;15;14;13;13;13;13;12;12;12;12","OSTEOARTHRITIS;SOFT TISSUE SARCOMA;METASTASIS;GENE EXPRESSION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MENISCUS;PERIPROSTHETIC;VIABILITY ASSAY;BONE MINERAL;OSSEOINTEGRATION;OSTEOBLAST;PHENOTYPE;UNIVARIATE ANALYSIS;3D BIOPRINTING;ALKALINE PHOSPHATASE;ANEURYSMAL BONE CYST;ARTHRODESIS;BONE SARCOMA;CD8;CLINICAL ENDPOINT;DECELLULARIZATION;FIXATION (POPULATION GENETICS);FOREFOOT;HAZARD RATIO;LIPOSARCOMA;ROTATOR CUFF INJURY;SURVIVORSHIP CURVE","43;9;8;7;6;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);HIGH TIBIAL OSTEOTOMY;IFOSFAMIDE;ARTICULAR CARTILAGE;CD3;MEDIAL MENISCUS;SYNOVIAL FLUID;TRANSCRIPTOME;WOMAC;ANTHRACYCLINE;ANTIRETROVIRAL THERAPY;BONE METASTASIS;CD163;CHROMATIN REMODELING;GIANT CELL ARTERITIS;KNEE PAIN;LACHMAN TEST;LENVATINIB;LMNA;METHYLENETETRAHYDROFOLATE REDUCTASE;MICROVESICLES;MYXOID LIPOSARCOMA;OSTEOCYTE;OSTEOPENIA;OSWESTRY DISABILITY INDEX;STAPHYLOCOCCUS EPIDERMIDIS;SUPERPARAMAGNETISM;TRABECTEDIN","6;6;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;RETROSPECTIVE STUDIES;BONE NEOPLASMS;TREATMENT OUTCOME;ADULT;FEMALE;MALE;ARTHROPLASTY, REPLACEMENT, HIP;KNEE JOINT;SARCOMA;AGED;MIDDLE AGED;ANTERIOR CRUCIATE LIGAMENT INJURIES;OSTEOARTHRITIS, KNEE;QUALITY OF LIFE;OSTEOARTHRITIS;OSTEOSARCOMA;PAIN;OSTEOTOMY","163;160;47;41;34;33;31;30;26;26;26;22;21;20;20;18;17;17;17;15","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;3D BIOPRINTING TECHNOLOGY;MANAGEMENT OF SPINAL METASTATIC TUMORS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;RHEUMATOID ARTHRITIS;TREATMENT AND OUTCOMES OF HAND INJURIES;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING","27;24;20;14;14;10;10;9;9;8;8;7;7;5;4;4;4;4;4;3","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;SPINAL FUSION;BONE REGENERATION;FOOT (PROSODY);LIMB RECONSTRUCTION;OSTEOSARCOMA;SYSTEMIC SCLEROSIS;BONE METASTASES;HIP ARTHROSCOPY;REVISION SURGERY;ATHLETIC REHABILITATION;HIGH TIBIAL OSTEOTOMY;MENISCUS;OSTEOBLAST ADHESION;SHOULDER PATHOLOGY;UNIVARIATE ANALYSIS","26;25;18;16;15;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6","HIP ARTHROPLASTY;TOTAL HIP;SYSTEMIC SCLEROSIS;CRUCIATE LIGAMENT;RETROSPECTIVE STUDY;ANTERIOR CRUCIATE;TIBIAL OSTEOTOMY;COMPARATIVE STUDY;KNEE ARTHROPLASTY;LIGAMENT RECONSTRUCTION;PHASE II;SOFT TISSUE;ANEURYSMAL BONE;BONE LOSS;BONE MARROW;COHORT STUDY;DIRECT ANTERIOR;EWING SARCOMA;KNEE OSTEOARTHRITIS;LOWER LIMB;MINIMALLY INVASIVE;RETROSPECTIVE ANALYSIS;ROTATOR CUFF;STILLS DISEASE;SURGICAL TECHNIQUE;ACL RECONSTRUCTION;ADULT-ONSET STILLS;ANKLE ARTHROPLASTY;ANTERIOR APPROACH;BONE CYST","16;14;10;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","RISK FACTORS;SSC PATIENTS;SYSTEMIC SCLEROSIS;CLINICAL PRACTICE;PATIENTS TREATED;HIP ARTHROPLASTY;HR CI;PATIENTS AFFECTED;TOTAL HIP;OBESE PATIENTS;ROTATOR CUFF;SIGNIFICANT DIFFERENCES;PATIENTS UNDERGOING;REVISION SURGERY;ACL RECONSTRUCTION;ASSESSMENT QUESTIONNAIRE-DISABILITY;GENE EXPRESSION;HEALTH ASSESSMENT;QUESTIONNAIRE-DISABILITY INDEX;RETROSPECTIVE STUDY;SURGICAL TECHNIQUE;IRCCS ISTITUTO;ISTITUTO ORTOPEDICO;LOCAL RECURRENCE;LOWER LIMB;ORTOPEDICO RIZZOLI;SOFT TISSUE;SURVIVAL RATES;BOLOGNA ITALYSEARCH;CLINICAL OUTCOMES","25;25;23;19;19;18;18;18;18;17;17;16;15;15;14;14;14;14;14;14;14;13;13;13;13;13;13;13;12;12",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,0,3,1,0,21,5.89,6.25,0,4,3,0,0,2,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BERGSTEN P√ÑR;CAFARELLI ANDREA;DUMONT ERIK JEAN-CLAUDE;ERIKSSON MAGNUS;FEDUTIK YIRIJ;FINI MILENA;GABUSI ELENA;GAPINSKI TOMASZ;JERNBERGER √ÖKE;JOST CARSTEN","3;3;3;3;3;3;3;3;3;3","BAR ILAN UNIVERSITY;ISTITUTO ORTOPEDICO RIZZOLI;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANTANNA;H&D WIRELESS AB;IMAGE GUIDED THERAPY SA;PLASMACHEM PRODUKTIONS UND HANDEL GMBH;VIMEX SPOLKA Z OGRANICZONA ODOWIEDZIALNOSCIA VIMEX;H & D WIRELESS;IMAGE GUIDANCE CO;PRICE PRODUCTION AND TRADE CO LTD","4;4;3;2;2;2;2;1;1;1","40 ENGINEERING;4016 MATERIALS ENGINEERING;34 CHEMICAL SCIENCES;3403 MACROMOLECULAR AND MATERIALS CHEMISTRY","4;2;1;1","BIOENGINEERING;BIOTECHNOLOGY","1;1",NA,NA,"A61L27/38;A61L27/44;A61L27/52;A61M37/00;A61N1/20;A61N1/32;B82Y5/00","4;4;4;4;4;4;4","A61L2400/06;A61L2400/12;A61L2430/06;A61L27/3834;A61L27/3852;A61L27/443;A61L27/446;A61L27/52;A61L27/58;A61M37/0092","4;4;4;4;4;4;4;4;4;4",26,2.46,134.12,5.96,1,0.04,7.69,0,0,0,0,1,0,0,25,0,19,7,0,0,0,0,0,0,26,0,0,26,0,0,0,0,0,0,0,0,0,"Italy;United States;Sweden;Canada","23;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4207 SPORTS SCIENCE AND EXERCISE;33 BUILT ENVIRONMENT AND DESIGN;3302 BUILDING;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;48 LAW AND LEGAL STUDIES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","24;18;11;5;3;3;3;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;BIOENGINEERING;PREVENTION;AGING;PAIN RESEARCH;ARTHRITIS;CHRONIC PAIN;RARE DISEASES;REHABILITATION;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;CANCER;NEUROSCIENCES;PEDIATRIC;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS;BIOTECHNOLOGY;CARDIOVASCULAR;COMPARATIVE EFFECTIVENESS RESEARCH","22;11;8;6;5;4;4;3;3;3;3;2;2;2;2;2;2;1;1;1","MUSCULOSKELETAL;CANCER;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM;INJURIES AND ACCIDENTS","9;2;1;1;1","6.4 SURGERY;6.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","6;4;2;2;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",1,5087743,423978.58,6,12,7,1,0,1829888.7436403,0.184710683190279,"AO FOUNDATION;BUDA HEALTH CENTER;CHARIT√â - UNIVERSITY MEDICINE BERLIN;ETH ZURICH;EUROPEAN RESEARCH AND PROJECT OFFICE;ISTITUTO ORTOPEDICO RIZZOLI;PHILIPS (GERMANY);UNIVERSITY MEDICAL CENTER UTRECHT;UNIVERSITY OF BOLOGNA;UNIVERSITY OF SHEFFIELD;UNIVERSITY OF SZEGED;UNIVERSITY OF ZARAGOZA","1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","HORIZON-HLTH-2022-TOOL-12-TWO-STAGE (CALL FOR PROPOSAL);HORIZON-RIA - HORIZON  RESEARCH AND INNOVATION ACTIONS (FUNDING SCHEME);HORIZON.2.1 - HEALTH (PROGRAMME)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES","1;1;1;1","BIOENGINEERING;CANCER;PATIENT SAFETY","1;1;1","CANCER","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.3 MANAGEMENT AND DECISION MAKING","1;1;1",NA,NA,NA,NA,"B12 ENGINEERING","1",NA,NA,34,"FRONTIERS;AMERICAN ASSOCIATION FOR CANCER RESEARCH;PUBLIC LIBRARY OF SCIENCE","20;12;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3210 NUTRITION AND DIETETICS;40 ENGINEERING;3105 GENETICS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3209 NEUROSCIENCES;4003 BIOMEDICAL ENGINEERING;48 LAW AND LEGAL STUDIES;4807 PUBLIC LAW","36;18;12;7;6;5;5;5;4;4;4;3;2;2;2;1;1","CLINICAL RESEARCH;GENETICS;NEUROSCIENCES;BRAIN DISORDERS;CANCER;CEREBRAL PALSY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PHYSICAL REHABILITATION;REHABILITATION;ARTHRITIS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;FIBROMYALGIA;NUTRITION;OBESITY;PAIN RESEARCH;RARE DISEASES;AUTOIMMUNE DISEASE;BIOENGINEERING;BIOTECHNOLOGY","14;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3","CANCER;NEUROLOGICAL;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL","9;5;4;3;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.1 PHARMACEUTICALS","8;5;5;5;1;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","9;8;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","14;9;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NOT SITE-SPECIFIC CANCER;SARCOMA;BREAST CANCER;MELANOMA;PROSTATE CANCER","9;4;4;1;1;1","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_RIZZOLI",2024,370,10.8351351351351,4.32972972972973,0.521621621621622,0.508108108108108,0.559459459459459,3.59192825112108,1.48461538461538,2.61111111111111,1.68292682926829,0.702702702702703,4,139,62,25,13,0.38,0.17,0.07,0.04,0.77,0.808799109848019,4.00838635049162,0.372972972972973,0.937837837837838,0.54,0.447,0.441,0.415,"STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ROBERTO TEDESCHI;CESARE FALDINI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;FABIO VITA;ELENA ARTIOLI;CESARE FALDINI;DANILO DONATI;EMANUELA PALMERINI;PAOLO SPINNATO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;SIMONE OTTAVIO ZIELLI;KATIA SCOTLANDI;TONI IBRAHIM","49;30;25;23;22;20;19;19;17;17;16;16;16;16;15;15;15;14;13;13","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ROBERTO TEDESCHI;ALBERTO GRASSI;GABRIELA GRAZIANI;ANTONIO MAZZOTTI;PAOLO SPINNATO;FRANCESCO TRAINA;GIANLUCA GIAVARESI;CESARE FALDINI;DANILO DONATI;NICOLA BALDINI;DANIELA PLATANO;CLAUDIO BELVEDERE;ELENA ARTIOLI;FABIO VITA;CESARE FALDINI;KATIA SCOTLANDI;SIMONE OTTAVIO ZIELLI;MILENA FINI","6.37;4.01;3.53;3.14;3.13;2.56;2.55;2.5;2.49;2.36;2.28;2.15;2.12;2.06;2.03;2.01;1.87;1.85;1.77;1.65","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ROBERTO TEDESCHI;CESARE FALDINI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;FABIO VITA;ELENA ARTIOLI;CESARE FALDINI;DANILO DONATI;EMANUELA PALMERINI;PAOLO SPINNATO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;SIMONE OTTAVIO ZIELLI;KATIA SCOTLANDI;TONI IBRAHIM","49;30;25;23;22;20;19;19;17;17;16;16;16;16;15;15;15;14;13;13","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ROBERTO TEDESCHI;ALBERTO GRASSI;GABRIELA GRAZIANI;ANTONIO MAZZOTTI;PAOLO SPINNATO;FRANCESCO TRAINA;GIANLUCA GIAVARESI;CESARE FALDINI;DANILO DONATI;NICOLA BALDINI;DANIELA PLATANO;CLAUDIO BELVEDERE;ELENA ARTIOLI;FABIO VITA;CESARE FALDINI;KATIA SCOTLANDI;SIMONE OTTAVIO ZIELLI;MILENA FINI","6.37;4.01;3.53;3.14;3.13;2.56;2.55;2.5;2.49;2.36;2.28;2.15;2.12;2.06;2.03;2.01;1.87;1.85;1.77;1.65","ROBERTO TEDESCHI;DANILO DONATI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;CESARE FALDINI;THOMAS TISCHER;DANIELA PLATANO;ALBERTO GRASSI;BARI≈û KOCAOƒûLU;DAVIDE MAR√çA DONATI;ELIZAVETA KON;J√âR√âMY MAGALON;LAURA DE GIROLAMO;LIOR LAVER;MARKO OSTOJIƒÜ;MIKEL S√ÅNCHEZ;PHILIPPE BEAUFILS;RAM√ìN CUGAT;RICARDO BASTOS;RODICA MARINESCU","46;41;40;32;30;30;28;27;22;22;22;22;22;22;22;22;22;22;22;22","GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;CESARE FALDINI;DANIELA PLATANO;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;COSTANTINO ERRANI;L√öCIA MARTINI;MATILDE TSCHON;GINA LISIGNOLI;PAOLO SPINNATO;CHIARA DELBALDO;CRISTINA MANFERDINI;DIEGO TRUCCO;ELENA GABUSI;ENRICO LENZI;FABIO VITA;GIORGIA CODISPOTI","40;31;28;28;27;22;21;19;17;17;16;15;15;14;14;14;14;14;14;14","STEFANO ZAFFAGNINI;CESARE FALDINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;ELENA ARTIOLI;EMANUELA PALMERINI;FABIO VITA;NICOLA BALDINI;PAOLO SPINNATO;SIMONE OTTAVIO ZIELLI;LUCA ANDRIOLO;MARCO MICELI;KATIA SCOTLANDI;TONI IBRAHIM;DAVIDE MAR√çA DONATI;ANGELO BOFFA","48;42;27;25;23;19;18;17;16;16;16;15;15;14;13;13;13;13;13;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHYSICS;ENGINEERING;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;POLITICAL SCIENCE;PHILOSOPHY;ECONOMICS;GEOLOGY;SOCIOLOGY;ART;BUSINESS;HISTORY;GEOGRAPHY","328;91;60;56;43;42;41;23;18;15;12;7;7;7;3;3;3;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;PHYSICAL THERAPY;ANATOMY;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;RADIOLOGY;GENETICS;COMPOSITE MATERIAL;BIOCHEMISTRY;ORTHODONTICS;CELL BIOLOGY;CANCER RESEARCH;ARTIFICIAL INTELLIGENCE;PALEONTOLOGY;IMMUNOLOGY;NANOTECHNOLOGY;LAW;OPTICS","189;125;105;69;53;44;42;39;38;36;33;31;30;27;22;19;18;16;15;15","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;ARTHROPLASTY;CANCER;IMPLANT;GENE;COHORT;RETROSPECTIVE COHORT STUDY;SARCOMA;ANKLE;RANGE OF MOTION;CLINICAL TRIAL;RADIOGRAPHY;ANTERIOR CRUCIATE LIGAMENT;CHEMOTHERAPY;OSTEOSARCOMA;RANDOMIZED CONTROLLED TRIAL;SOFT TISSUE;TIBIA;VALGUS","67;45;31;26;26;25;23;21;16;15;15;14;14;13;13;13;13;13;13;13","OSTEOARTHRITIS;OSSEOINTEGRATION;LOW BACK PAIN;PERIPROSTHETIC;CLINICAL ENDPOINT;MENISCUS;FIBULA;IDIOPATHIC SCOLIOSIS;PLATELET-RICH PLASMA;SURVIVORSHIP CURVE;CAPSULITIS;CELL CYCLE;IMMUNOTHERAPY;STAPHYLOCOCCUS AUREUS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BIOFILM;HIP ARTHROPLASTY;OSTEOCLAST;ACL INJURY;ARTHRODESIS;BREAST CANCER;CHONDROGENESIS;COBB ANGLE;COLLAGEN VI;DENOSUMAB;ETOPOSIDE;EWING'S SARCOMA;FIRST METATARSAL;FIXATION (POPULATION GENETICS);FOREFOOT;IN SILICO;LIPOSARCOMA;METASTASIS;OSTEOBLAST;PLACEBO;SOFT TISSUE SARCOMA;SPONDYLOLISTHESIS;TUMOR MICROENVIRONMENT;UNIVARIATE ANALYSIS;VIABILITY ASSAY","52;11;8;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;HIGH TIBIAL OSTEOTOMY;MEDIAL MENISCUS;OSWESTRY DISABILITY INDEX;UNICOMPARTMENTAL KNEE ARTHROPLASTY;IFOSFAMIDE;BONE METASTASIS;CANCER IMMUNOTHERAPY;CD99;CHIMERIC ANTIGEN RECEPTOR;FLI1;KNEE PAIN;NEOADJUVANT THERAPY;NIVOLUMAB;QUANTITATIVE COMPUTED TOMOGRAPHY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;WOMAC;ANTIRETROVIRAL THERAPY;BALLET DANCER;C2C12;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CELL COUNTING;CERVICAL CARCINOMA;CHROMATIN REMODELING;CORONAVIRUS DISEASE 2019 (COVID-19);CUT;CYCLIN;CYCLIN-DEPENDENT KINASE 1;DBM;DESMIN;DNA METHYLATION;ELECTROCHEMOTHERAPY;ENDOSCOPIC CARPAL TUNNEL RELEASE;ENTEROCOCCUS FAECALIS;FACET (PSYCHOLOGY);FLUORESCENCE IN SITU HYBRIDIZATION;GATA3;GENETIC ARCHITECTURE;GERMLINE MUTATION;HAMSTRING INJURY;HAPLOTYPE;HEME OXYGENASE;INTERMEDIATE FILAMENT;INTRA ARTICULAR;IRINOTECAN;JOINT INFECTIONS;KNEE ARTHRITIS;LACHMAN TEST;LACTOBACILLUS PLANTARUM;LENVATINIB;LMNA;LOW LEVEL LASER THERAPY;LOW-INTENSITY PULSED ULTRASOUND;MATRIX GLA PROTEIN;METHACRYLATE;MICROFILAMENT;MICROVESICLES;MONOCLONAL;MULTIFIDUS MUSCLE;MYXOID LIPOSARCOMA;ONCOGENE;OSTEOCALCIN;OSTEONECROSIS OF THE JAW;OSTEOPENIA;OXFORD KNEE SCORE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PERICYTE;PIVOT-SHIFT TEST;RPOB;SYNOVIAL FLUID;TELEHEALTH;TRABECTEDIN;TURNOUT;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;VANCOMYCIN;VENETOCLAX","6;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;BONE NEOPLASMS;YOUNG ADULT;ADOLESCENT;ANIMALS;FOLLOW-UP STUDIES;PROSPECTIVE STUDIES;KNEE JOINT;CHILD;ITALY;OSTEOARTHRITIS, KNEE;OSTEOSARCOMA","240;124;61;58;39;38;32;26;21;16;15;14;13;12;12;11;10;10;10;8","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;TREATMENT AND OUTCOMES OF HAND INJURIES;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY OF SPORTS-RELATED MUSCULOSKELETAL INJURIES;3D BIOPRINTING TECHNOLOGY;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE","32;24;19;17;14;13;12;10;9;8;7;7;7;7;6;6;5;5;5;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;BIOMECHANICS;HIP ARTHROPLASTY;BONE REGENERATION;SPINAL FUSION;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT;EWING'S SARCOMA;KNEE OSTEOARTHRITIS;MICROSURGICAL RECONSTRUCTION;OSTEOARTHRITIS;CLINICAL ENDPOINT;MENISCUS;OSTEOBLAST ADHESION;REHABILITATION;BIOCOMPATIBILITY;BONE TISSUE;IDIOPATHIC SCOLIOSIS","30;20;17;14;14;12;12;11;9;9;9;9;8;7;7;7;7;6;6;6","ANTERIOR CRUCIATE;KNEE OSTEOARTHRITIS;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;KNEE ARTHROPLASTY;RETROSPECTIVE STUDY;TOTAL HIP;RANDOMIZED CONTROLLED;TOTAL ANKLE;ANKLE ARTHROPLASTY;CLINICAL OUTCOMES;CONTROLLED TRIAL;GIANT CELL;IDIOPATHIC SCOLIOSIS;MINIMALLY INVASIVE;PILOT STUDY;REGISTRY STUDY;TOTAL KNEE;ADHESIVE CAPSULITIS;ADOLESCENT IDIOPATHIC;BONE TISSUE;CLINICAL STUDY;COHORT STUDY;CROSS-SECTIONAL STUDY;EWING SARCOMA;SOFT TISSUE;TENOSYNOVIAL GIANT;ALLOGRAFT TRANSPLANTATION;BONE TUMORS;CELL TUMOR","11;11;10;9;9;9;9;8;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4","KNEE OA;OSTEOARTHRITIS OA;ABSTRACT PURPOSE;PATIENTS LOST;STATISTICALLY SIGNIFICANT;CLINICAL OUTCOMES;SIGNIFICANT DIFFERENCES;SOFT TISSUE;TOTAL HIP;ADVERSE EVENTS;CLINICAL SCORES;HIP ARTHROPLASTY;POSTAMPUTATION PAIN;RANDOMIZED CONTROLLED;COLLAGEN VI;KNEE OSTEOARTHRITIS;CLINICAL PRACTICE;MINIMALLY INVASIVE;ANTERIOR CRUCIATE;CLINICAL RESULTS;CONTROLLED TRIAL;CRUCIATE LIGAMENT;HR CI;KNEE ARTHROPLASTY;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;RISK FACTORS;STUDY DESIGN;ANALOG SCALE;FUNCTIONAL OUTCOMES;IKDC SUBJECTIVE","23;17;16;16;16;15;15;15;15;14;14;14;14;14;13;13;12;12;11;11;11;11;11;11;11;11;11;10;10;10",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,1.67,444.67,0.68,0,0,4,0,0,0,0,0,0,0,3,0,1,2,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"Italy","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4205 NURSING","2;2;1;1;1;1","CLINICAL RESEARCH;AGING;ARTHRITIS;BIOMEDICAL IMAGING;CANCER;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PAIN RESEARCH","3;1;1;1;1;1;1;1","MUSCULOSKELETAL","1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","2;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES","1;1;1;1","CLINICAL RESEARCH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;OSTEOGENESIS IMPERFECTA;PEDIATRIC;RARE DISEASES","1;1;1;1;1","MUSCULOSKELETAL","1",NA,NA,"CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
